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Samenvatting
Hoofdstuk 1: Introductie
De voornaamste doodsoorzaak in Westerse landen zijn de hart- en vaatziek-
ten. Ze veroorzaken jaarlijks 48% van de sterfgevallen in Europa [1]. Ver-
nauwingen (stenosen) van de coronaire slagaders of kransslagaders die het
hart van zuurstofrijk bloed voorzien liggen aan de basis van een belang-
rijk deel van deze sterfgevallen. Deze vernauwingen zijn een ophoping van
lipo¨ıden, cholesterol,... Een uitgesproken vernauwing van een kransslagader
kan voor zuurstoftekort zorgen in een deel van het hart - stroomafwaarts van
de stenose - met een hartaanval als gevolg. Het heropenen van deze stenosen
in e´e´n enkel bloedvat is heel wat vereenvoudigd door de ontwikkeling van
stents (cilindrische, meestal metalen structuren die in de arterie worden in-
gebracht, ook soms hartveertje genoemd). Via een kleine incisie in de lies of
in de arm wordt de stent met een katheter ter plaatse gebracht en ontplooid
via het opblazen van een ballon. De stent duwt de vernauwing open en
de bloedtoevoer wordt hersteld. Deze minimaal invasieve ingreep vormt in
veel gevallen een zeer degelijk alternatief voor de invasieve overbruggings-
of bypass operaties, waarbij een vaatomlegging het afgesloten of vernauwd
gedeelte van de arterie overbrugt. In 2004 werden in Europa dan ook meer
dan 770000 stents geplaatst [2].
De eerste generatie stents gaf in 20-30% van de gevallen aanleiding tot
hervernauwing of restenosis van het gestente bloedvat. Door de introductie
van stents die medicijnen afgeven aan de vaatwand werd het optreden van
hervernauwing gereduceerd tot minder dan 10% voor niet-vertakte bloed-
vaten.
Men heeft echter vastgesteld dat vaatwandvernauwingen hoofdzakelijk
voorkomen op specifieke plaatsen, namelijk ter hoogte van vertakkingen (bi-
furcaties) en bochten [3] en dit wordt onder andere in verband gebracht met
de daar voorkomende wijzigingen in de bloedstroming. Ondanks de behoor-
lijke resultaten van de stenting procedures voor niet-vertakte bloedvaten
blijft het stenten van coronaire bifurcaties een belangrijk klinisch probleem.
Restenosis treedt op in 15% van de gevallen [4] en het mogelijks optreden
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van bloedklonters (thrombose) is een bijkomend probleem. Er zijn reeds heel
wat technieken bedacht waarbij stents ontworpen voor niet-vertakte bloed-
vaten worden geplaatst ter hoogte van bifurcaties (bijvoorbeeld T-stenting,
V-stenting, culotte stenting,...) maar al deze technieken hebben belang-
rijke beperkingen en zijn vaak complex om toe te passen in de klinische
praktijk [5]. De kostprijs van deze technieken loopt ook vaak erg hoog op
aangezien meerdere stents en ballonnen noodzakelijk zijn.
Er is duidelijk nood aan stents, specifiek ontworpen voor bifurcaties, die
de complexiteit van deze ingrepen reduceert. Aangezien de markt voor
dergelijke producten aanzienlijk is, gaan dan ook heel wat bedrijven op
zoek naar de ideale ‘bifurcatie-stent’. Het gebruik van deze producten is
tot op heden beperkt. Heel veel van deze producten zitten nog in een
ontwikkelingsfase en enkele van de producten die reeds op de markt zijn
gekomen hadden een beperkte gebruiksvriendelijkheid.
De traditionele aanpak om deze technieken en producten te bestuderen en
te optimaliseren bestaat erin stents te implanteren in vertakte silicone buis-
jes en de optredende stentvervormingen daarna te visualiseren met behulp
van micro-CT (Computed Tomography) [6]. Op deze manier zijn reeds
heel wat interessante studies uitgevoerd, maar deze aanpak is tijdrovend en
vereist het gebruik van zeer veel (dure) stents. Bovendien laat deze onder-
zoeksmethode enkel toe om reeds geproduceerde stents te bestuderen.
Tijdens dit doctoraatsonderzoek werd naast de traditionele experimentele
aanpak ook gebruik gemaakt van innovatieve eindige elementen simulaties
om de problematiek van bifurcatie stenting te bestuderen. Deze techniek
levert extra informatie ten opzichte van in-vitro tests, zoals spanningen en
rekken in de stent en de bloedvatwand. Bovendien laten deze simulaties
toe heel wat parameters te bestuderen vooraleer over te gaan tot fabri-
catie. Deze aanpak heeft dan ook het potentieel om innovatieve stents te
ontwerpen en de tijd om het product op de markt te brengen drastisch te
reduceren.
Het doctoraatsonderzoek had tot doel om:
 inzicht te krijgen in de beperkingen van de huidige stents en technieken
voor het behandelen van vernauwingen ter hoogte van coronaire bi-
furcaties.
 inzicht te verwerven in de nodige ontwerpparameters voor een ideale
bifurcatie stent.
 richtlijnen te verstrekken aan artsen omtrent stentselectie.
 simulatiestrategiee¨n te ontwikkelen die toelaten om nieuwe stents te
onderzoeken en te optimaliseren.
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Hoofdstuk 2: Innovatieve eindige elementen simulaties
van stents
Het is van groot belang realistische basismodellen te ontwikkelen van bal-
lonopblaasbare stents vooraleer over te gaan tot het simuleren van stentim-
plantaties ter hoogte van bifurcaties. Daarom is in eerste instantie een model
ontwikkeld dat toelaat om de vrije stentexpansie te bestuderen. Dit model
toont een zeer goede overeenkomst met zowel kwalitatieve als kwantitatieve
experimentele data en vormt dus een goede basis om het mechanische gedrag
van ballonopblaasbare stents te bestuderen en te optimaliseren. Een huidige
beperking van deze stents is dat ze niet altijd uniform ontplooien, dit zowel
in de lengterichting als in de omtreksrichting. Nochtans is een uniforme ex-
pansie gewenst aangezien dit de beschadiging van endotheelcellen reduceert
en leidt tot een uniforme afgifte van medicijn. De resultaten van een pa-
rameterstudie op basis van het gevalideerde model tonen aan dat zowel de
ballonlengte als de opplooivorm van de ballon een grote impact hebben op
de uniformiteit van de stentexpansie. Een verminderde ballonlengte leidt
tot een uniformere expansie in de lengterichting, terwijl het verhogen van
het aantal plooien in de opgevouwen ballon de uniformiteit in de omtreks-
richting positief be¨ınvloedt.
Naast het ontwikkelen van accurate computermodellen van stents is ook het
versnellen en automatiseren van de opbouw van deze modellen van belang
om vele verschillende stents en implantatieprocedures efficie¨nt te kunnen
onderzoeken. Zo is het bijvoorbeeld tijdrovend om een computermodel van
een stent op te bouwen op basis van een beschikbaar exemplaar van deze
stent. De typische procedure om dit te doen bevat een aantal tijdsrovende
stappen, zoals het opmeten van de exacte stent- en strutafmetingen en het
natekenen van de opgemeten geometrie met CAD (Computer Aided Design)
software. In dit hoofdstuk wordt een alternatieve methode voorgesteld die
toelaat om op basis van micro-CT beelden op een quasi automatische manier
over te gaan naar een stentmodel dat gebruikt kan worden voor eindige
elementen simulaties. De efficie¨ntie en nauwkeurigheid van de ontwikkelde
procedure wordt aangetoond voor de Multi-Link Vision stent.
Hoofdstuk 3: Eindige elementen analyse van de toegang
tot de zijtak na het plaatsen van een stent in de hoofdtak
Dit hoofdstuk bespreekt een veel toegepaste techniek voor het behandelen
van vernauwingen ter hoogte van coronaire bifurcaties, namelijk het plaat-
sen van een stent in de hoofdtak, gevolgd door het opblazen van een ballon
die zich gedeeltelijk in de hoofd- en zijtak bevindt (en dus doorheen de
zijkant van de reeds ontplooide stent gaat). Het opblazen van deze ballon
heeft tot doel de toegang tot de zijtak te verbeteren aangezien bepaalde
struts van de stent de stroming naar de zijtak belemmeren. Experimenteel
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onderzoek heeft reeds aangetoond dat deze balloninflatie inderdaad positief
is voor de toegang naar de zijtak, maar dat deze procedure soms leidt tot
een verslechterde situatie in de hoofdtak.
Deze studie had enerzijds tot doel om de haalbaarheid na te gaan om met
behulp van computersimulaties de optredende stentvervorming tijdens een
dergelijke complexe procedure realistisch te gaan voorspellen. De goede
overeenkomst van de numerieke resultaten met reeds gepubliceerde experi-
mentele observaties toont duidelijk aan dat computersimulaties een rol kun-
nen spelen bij het bestuderen van bifurcatie stenting. Anderzijds werd ook
de impact van stent- of ballonkeuze bestudeerd. Het opblazen van een
grotere ballon doorheen de zijkant van een stent leidt duidelijk tot een betere
toegang tot de zijtak. Daarnaast werd ook vastgesteld het vervormingspa-
troon van de stent sterk afhankelijk is van het stenttype. Deze ingreep
veroorzaakte bijvoorbeeld slechts voor e´e´n van de twee onderzochte stents
een obstructie in de hoofdtak.
Hoofdstuk 4: Virtuele stentimplantatie in een patie¨nt-
specifieke coronaire bifurcatie
De studie beschreven in dit hoofdstuk vergelijkt het mechanisch gedrag van
drie verschillende stents. De stents werden virtueel ge¨ımplanteerd in een
gebogen hoofdtak van een bifurcatie, waarvan de geometrie gebaseerd is op
patie¨nt-specifieke klinische beelden. Het beschrijven van het mechanisch
gedrag van de drie verschillende arterie¨le lagen (intima, media en adventi-
tia) vormt een belangrijk onderdeel van dit hoofdstuk. Een bestaand model
dat toelaat om het anisotroop gedrag van elk van deze lagen te beschrij-
ven werd ge¨ımplementeerd in het eindige elementen pakket Abaqus en de
correctheid van de implementatie werd nagegaan, door het virtuele mech-
anische gedrag te vergelijken met experimentele en analytische data. Het
gebruik van anisotrope materialen vereist het vastleggen van locale materi-
aalorie¨ntaties. Daarom wordt ook een nieuwe techniek voorgesteld om de
vezelorie¨ntatie ter hoogte van de bifurcatie te definie¨ren. Ook op het gebied
van stentmodellering werd progressie gemaakt. Door de gekromde vorm van
het bloedvat was het bijvoorbeeld noodzakelijk om een innovatieve simula-
tiestrategie te ontwikkelen waarbij de stent ingebracht wordt door middel
van een voerdraad, net zoals in realiteit.
Uit de resultaten blijkt dat alle stents leiden tot een gelijkaardige recht-
trekking van het bloedvat, maar dat de veroorzaakte spanningen in de bloed-
vatwand daarentegen sterk afhankelijk zijn van het stenttype. Door gebruik
te maken van parametrische modellering worden ook enkele stentvarianten
voorgesteld die de spanningen in de bloedvatwand beperken. Dit toont
duidelijk de kracht van deze computersimulaties. Verschillende ontwerp-
varianten kunnen worden bestudeerd vooraleer over te gaan tot fabricatie.
vHoofdstuk 5: Geometrische analyse van stents
Cardiologen worden overstelpt met het aanbod aan verschillende stenttypes.
Het is dan ook belangrijk deze verschillende stents op basis van objectieve
criteria te vergelijken, zodat artsen een weloverwogen keuze kunnen maken
rekening houdend met het te behandelen letsel. Bij het plaatsen van een
stent ter hoogte van een bifurcatie is de grootte van de openingen in de stent
van groot belang. Een stent geplaatst in de hoofdtak vormt een obstructie
voor de stroming naar de zijtak. Daarom wordt veelal een ballon doorheen
e´e´n van deze openingen opgeblazen met als doel deze opening zo groot
mogelijk te maken en alle struts tegen de bloedvatwand aan te drukken.
In dit hoofdstuk worden de stentopeningen van vijf verschillende stents op
een nieuwe manier opgemeten en geanalyseerd. Op basis van micro-CT
beelden worden de driedimensionale (3D) stentgeometriee¨n virtueel gere-
construeerd, wat resulteert in een oppervlaktebeschrijving van de 3D ob-
jecten met driehoeken. Deze stentmodellen worden verder geanalyseerd
met behulp van het softwarepakket pyFormex. Na een aantal operaties,
zoals bijvoorbeeld het ontrollen van de cilindrische geometrie in een vlak,
wordt de planaire omtrek van e´e´n stentopening afgezonderd en opgemeten.
Uit de resultaten blijkt dat de omtrek (of dus de maximale grootte) van de
openingen van de onderzochte stents sterk verschilt.
Het combineren van de informatie over de grootte van de stentopeningen
met anatomische informatie (diameter hoofdtak, diameter zijtak, bifur-
catiehoek) laat toe om vooraf te gaan voorspellen welke stents geschikt
zijn voor een bepaalde bifurcatie. Het plaatsen van een stent waarvan de
omtrek van de openingen kleiner is dan de omtrek van de opening naar de
zijtak zal bijna altijd resulteren in een obstructie van de stroming naar de
zijtak.
Hoofdstuk 6: Virtuele optimalisatie van een nieuwe bi-
furcatie stent
In hoofdstuk 6 worden eindige elementen simulaties gebruikt om de haal-
baarheid van een nieuwe specifieke bifurcatiestent en een aangepaste proce-
dure te onderzoeken. De stent is bedoeld om in de hoofdtak ge¨ımplanteerd te
worden en heeft een specifiek strutpatroon in het centrale gedeelte, dat toe-
laat om ter hoogte van de bifurcatie een grotere stentdiameter te bereiken.
Dit is van belang om een gedeeltelijke ondersteuning van de ingang van de
zijtak te bekomen. De aangepaste procedure bestaat uit een postdilatatie
van de reeds gee¨xpandeerde stent met een specifieke ballon (bijvoorbeeld
een ‘bulge’ of een compliante ballon). Deze postdilatatie heeft tot doel om:
 de stentopeningen ter hoogte van de toegang naar de zijtak gedeeltelijk
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open te duwen zodat het inbrengen van een ballonkatheter in de zijtak
eenvoudiger wordt.
 reeds voor een gedeeltelijke ondersteuning van de ingang van de zijtak
te zorgen.
In een eerste deel van deze studie worden de ballonmodellen en de vrije stent-
expansie gevalideerd aan de hand van experimentele data. Daarna worden
deze gevalideerde modellen gebruikt om de volledige bifurcatie stenting pro-
cedure te simuleren. De nauwkeurigheid van de gesimuleerde vervormingen
na de postdilatatie wordt geverifieerd met een in-vitro experiment waarbij
een identieke procedure wordt gevolgd.
Op basis van het eindige elementen model wordt de impact van een aantal
parameters bestudeerd (ballondruk, balloongrootte, compliantie, stentont-
werp en bifurcatiegeometrie) op de finale vervorming van de struts. Uit deze
numerieke resultaten blijkt welke parameters een grote impact hebben op
de stentvervorming en deze inzichten laten dan ook toe om het stentontwerp
en de procedure verder te optimaliseren.
Hoofdstuk 7: Richtlijnen voor stentontwerp en finale
opmerkingen
Het finale hoofdstuk geeft een overzicht van de voornaamste bevindingen en
bevat enkele richtlijnen omtrent stentontwerp en stentselectie. Daarnaast
worden ook enkele suggesties voor verder onderzoek geformuleerd.
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Chapter 1: Introduction
Cardiovascular disease is the most common cause of death in Western coun-
tries, accounting for 48% of all deaths in Europe [1]. One of the most impor-
tant cardiovascular diseases is atherosclerosis, which often leads to narrowed
(or stenosed) arteries that obstruct the flow of oxygen rich blood. In the
case of coronary arteries, this may limit the oxygen delivery to the heart
muscle and can lead to a heart attack. The blood flow through these nar-
rowed arteries is often restored by inserting scaffolding structures, named
stents. These small tube-like devices are mounted on the end of a catheter
that is inserted into the arterial tree through a small incision. After posi-
tioning the stent in the narrowed artery, it is deployed by inflating a balloon.
The deformed stent is left in place to keep the artery open and to restore
the blood flow. Using stents to treat stenosed arteries is much less invasive
as compared to the more traditional bypass surgery, where an alternative
conduit is used to restore the blood flow to the downstream tissue. It is
therefore not surprising that European physicians used more than 770000
stents in 2004 [2].
The first stent generation was associated with 20-30% in-stent restenosis
rates (i.e. a re-narrowing of the stented vessel). The introduction of drug-
eluting stents further improved the outcome and the occurrence of restenosis
was reduced to less than 10% for unbranched vessels.
There is a tendency for atherosclerosis to develop at specific arterial sites
such as bifurcations and curvatures [3] and this has been related to the spe-
cific blood flow patterns at those locations. Even with drug-eluting stents,
the treatment of bifurcation lesions remains a clinical challenge for interven-
tional cardiologists, due to the technical complexity and high re-intervention
rate. Restenosis occurs in 15% of the cases [4] and in addition, bifurcation
stenting is associated with an increased thrombosis risk. Many different
bifurcation stenting techniques have been proposed with various levels of
complexity (e.g. T-stenting, V-stenting, culotte stenting,...) and each of
them having one or more limitations [5]. The cost of these interventions
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can be very high as most techniques require the use of multiple stents and
balloons.
There is a clear need for user-friendly dedicated bifurcation stents which
further improve the current outcomes but that also reduce the technical
difficulty. The market for such dedicated products is considerable. This
attracts the attention of large medical device companies but also leads to
a number of start-ups focusing on this niche market. However, the use of
these dedicated products has been rather limited. Many of these products
are currently undergoing clinical trials and some of the products that have
been approved had a limited user-friendliness.
The previously mentioned bifurcation stenting techniques and dedicated
devices are usually investigated and optimized by deploying the stents in
bifurcated silicone tubes (in-vitro testing). The resulting stent deformations
are then visualized and analysed by using micro-CT (Computed Tomogra-
phy) [6]. Many interesting results have been obtained in this way. However,
this experimental approach has a number of disadvantages. It is time-
consuming, expensive and requires many stent samples. Furthermore, this
approach only allows to investigate stents that have been manufactured.
During this thesis, innovative finite element analysis techniques have been
developed and used to study the complex problem of bifurcation stenting.
This approach can be used to study stresses and strains and allows to gain
insight in products that are difficult to test experimentally. In addition,
this approach allows to study several ‘What if?’ scenarios addressing differ-
ent materials, geometries and loading conditions before devices are actually
manufactured. Therefore, this technique does not only offer a tool to investi-
gate and compare currently used stents and stenting techniques, but also to
develop new stents where it has the potential to reduce the time-to-market.
The objective of this thesis was to develop and use advanced computational
methods:
 to gain insights in the shortcomings of current stents and stenting
techniques.
 to define optimal design parameters for a bifurcation stent.
 to provide guidelines to interventional cardiologists regarding stent
selection.
 to virtually investigate and design new stents.
Chapter 2: Advances in finite element stent modelling
A first step to study the field of bifurcation stenting using finite element
analysis is to develop validated models to study balloon-expandable stents.
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Therefore, we first developed a model to investigate the free stent expansion.
This model serves as a solid basis to study and optimize the mechanical be-
haviour of balloon-expandable stents as the numerical results correspond
very well with both qualitative and quantitative experimental data. A lim-
itation of many balloon-expandable stents is that they often deploy in a
non-uniform way, both in longitudinal and in circumferential direction. A
uniform expansion is preferred as this reduces the endothelial damage and
leads to a more uniform drug delivery in case of drug eluting stents. Based
on the validated model, a parametric study has been conducted and the
results show that both the balloon length and the folding pattern have an
enormous impact on the uniformity of the expansion. A reduced balloon
length leads to a more uniform deployment in longitudinal direction, while
an increased number of balloon folds positively influences the uniformity in
circumferential direction.
Besides the development of accurate computer models to study stents, it is
also crucial to speed up and automate the generation of these stent models
in order to efficiently investigate many different stents and implantation
techniques. For example, creating a stent model based on an available stent
sample can be time-consuming. The traditional approach to do this involves
a number of time-consuming steps, such as the accurate determination of
the stent and strut dimensions and the generation of the CAD (Computer
Aided Design) model corresponding with the stent. In this chapter, an
alternative method is being presented which allows to generate finite element
stent models in a semi-automatic way starting from micro-CT images of the
stent. The efficiency and accuracy of the developed procedure is illustrated
for the Multi-Link Vision stent.
Chapter 3: Finite element analysis of side branch access
during provisional stenting
In this chapter, one of the currently applied techniques is analysed (i.e. pro-
visional stenting) which involves the implantation of a stent in the main
branch, followed by subsequent inflation of a balloon (which is positioned in
both the main and the side branch) through the side of the stent. The sec-
ond balloon inflation is performed with the intention of improving the side
branch patency by pushing the obstructing struts against the vessel wall.
Experimental research has demonstrated that such inflation indeed has a
positive effect on the side branch access, but may lead to floating struts in
the main branch lumen.
A first objective of this study was to investigate the feasibility of using
computer simulations to accurately study the stent deformations during a
complex procedure as such provisional stenting. The good correspondence
between the numerical results and previously published experimental ob-
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servations clearly show that computer simulations can play a role during
the investigation of bifurcation stenting techniques. The second aim of this
study was to assess the impact of the balloon size and stent type. The in-
flation of a larger balloon through the side of the main branch stent clearly
results in a better side branch access, but may result in overdilation. Fur-
thermore, it was also observed that different stent types may lead to totally
different deformations. For example, for one of the two investigated stents,
this procedure resulted in an obstruction within the main branch.
Chapter 4: Virtual stent insertion in a patient-specific
coronary bifurcation
The study described in this chapter investigates and compares three dif-
ferent second generation drug-eluting stents when being implanted in the
curved main branch of a coronary bifurcation. The aim is to provide better
insights into the related changes of the mechanical environment. The three-
dimensional bifurcation model is based on patient-specific angiographic data
that accurately reproduce the in vivo curvatures of the vessel segments.
The layered structure of the arterial wall and the anisotropic mechanical
behavior of each arterial layer (intima, media and adventitia) are taken
into account by using an existing advanced constitutive model that was
implemented as a user-defined material for Abaqus. The accuracy of the
implementation is verified by comparing the virtual mechanical behaviour
with experimental and analytical data. The use of anisotropic materials
requires a proper definition of the local material orientations. Therefore, a
novel algorithm has been developed to automatically define the fiber ori-
entations. In addition, an innovative simulation strategy considering the
insertion of a folded balloon catheter over a guide wire is proposed in order
to position the stents within the curved vessel.
Analysis of the results reveals that all stents lead to more or less the same
amount of vessel straightening after implantation, but the resulting dis-
tributions of the wall stresses are strongly dependent on the stent design.
Using a parametric modeling approach, two design modifications, which re-
duce the predicted maximum values of the wall stress, are proposed and
analyzed. This illustrates the added value of using computer simulations
during the design phase. Many design variants can be analysed without
having to manufacture every design iteration.
Chapter 5: Geometrical stent analysis
Interventional cardiologists are being overwhelmed by the large number of
available stents offered by various medical device companies. Hence, it
is extremely important to provide objective comparisons of the properties
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(mechanical, geometrical, etc.) of these stents in order to allow physicians
to select appropriate devices for a particular stenotic lesion. In case of
bifurcation lesions, one important stent parameter is the size of the openings
(i.e. cell size). A stent positioned in the main vessel often obstructs the blood
flow into the side branch. Therefore, such implantation is often followed by
a balloon dilation through the side of the stent with the aim of pushing all
struts against the vessel wall by increasing the opening between the struts.
In this chapter, the stent cells of five different stents are being measured
and analysed using an innovative technique. Three-dimensional (3D) recon-
structions of the stent geometries are being generated based on micro-CT
images, resulting in a triangulated surface description of the 3D objects.
These stent models are further processed and analysed using the pyFormex
software. One of the operations which is performed on the stent geometry
consists of the unraveling of the cylindrical stent geometry into a planar
structure. Finally, a line respresenting a planar stent cell is extracted and
its circumference is measured. The results show a substantial variation of
the cell size of the different investigated stents.
Combining the cell size data with anatomical information (main branch
diameter, side branch diameter and bifurcation angle) shows which stents
should preferably be used for which bifurcations, as these stents have cells
that can be sufficiently enlarged by dilating through the side. Implant-
ing a stent with a cell circumference which is smaller than the ostium cir-
cumference will almost inevitably result in a suboptimal deployment and
obstructing struts.
Chapter 6: Virtual investigation of a novel provisional
bifurcation stent system
Besides using the finite element models to better understand the mechanics
of currently available stents, they can also be incorporated in the design
process of new devices to perform virtual prototyping and design optimiza-
tion. In chapter 6, computer simulations are being used to investigate the
feasibility of a new dedicated bifurcation stent and a modified procedure for
provisional stenting. The stent is intended for the main branch and has a
modified strut pattern in the central stent region, which allows the stent to
reach a larger diameter at the location of the bifurcation. This is important
to provide partial scaffolding at the side branch ostium. The modified pro-
cedure consists of a postdilation with a dedicated balloon within the already
expanded main branch stent (for example, a bulge or a compliant balloon).
This postdilation is performed with the aim of:
 opening the stent cells obstructing the side branch access in order to
facilitate the insertion of a balloon catheter into the side branch.
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 causing strut protrusion into the side branch to provide partial ostial
scaffolding.
The first part of this study involves the validation of the different balloon
models and of the free stent expansion using experimental compliance data.
These validated models are then used to simulate the complete bifurcation
stenting procedure. An in-vitro experiment has been performed to verfiy
the accuracy of the predicted deformations after the postdilation.
Based on the finite element model, the impact of a number of device and
procedural parameters (such as balloon pressure, balloon compliance, bal-
loon size, stent design, bifurcation geometry) on the final strut deformation
has been examined. These results provide new insights and allow to further
optimize the stent design and the proposed procedure.
Chapter 7: Stent design guidelines and final remarks
The final chapter gives an overview of the major findings of the research and
contains some guidelines regarding stent design and selection. In addition,
some suggestions for further research are included.
Chapter 1
Introduction
ALL oxygen rich blood leaves the heart through the aortic valve into theaorta, the largest blood vessel in our body. From there, it is distributed
all over the body and supplies every body part (e.g., muscles, organs,...)
with oxygen. This is only possible by the bifurcated nature of the arterial
system. After leaving the heart, the aorta branches into smaller arteries,
which eventually divide into arterioles. Similarly these arterioles branch into
minuscule capillaries where the exchange of oxygen and other substances
takes place with the surrounding tissue. This bifurcated organisation is
often referred to as the vascular tree.
The coronary circulation, a crucial part of this vascular tree, provides oxygen
rich blood to the heart. Obstructions of the blood flow at the largest coro-
nary bifurcations result in suboptimal functioning of a considerable part of
the heart muscle and are difficult to treat. Analysis of the treatment of this
challenging subset of bifurcation lesions by using advanced computational
methods defines the main topic of this thesis.
This chapter begins with a description of both the healthy and the diseased
anatomy of arterial bifurcations, followed by a description of procedures and
dedicated devices applied to treat coronary bifurcation lesions. The third
part of this introduction consists of a brief overview of research methods
which are available to study and to optimize the current coronary bifurcation
treatment procedures. Finally the aim of the doctoral research is formulated
and the organisation of the dissertation is clarified.
2 Introduction
1.1 Anatomy, physiology and pathology of
coronary bifurcations
1.1.1 Healthy coronary bifurcations
In general, there are two main coronary arteries, the left coronary artery
(LCA) and the right coronary artery (RCA), which originate from the root
of the aorta. The part of the LCA between the aorta and the first bifurcation
is known as the left main artery (LM). The left main bifurcates into the left
anterior descending artery (LAD) and the left circumflex artery (LCX). The
RCA, LCA, LM, LAD and LCX are the most important coronary arteries.
In some rare cases, people have only one coronary artery or sometimes
they have a third one, the posterior descending artery. For healthy people
with a balanced distribution of the coronary arteries1, the diameters of the
proximal segments of the RCA, LM, LAD and LCX are respectively 3.0±0.5,
4.4±0.4, 3.6±0.4 and 3.4±0.5 mm according to the data published by Dodge
et al. [7]. A schematic overview of the main coronary arteries is shown in
Fig. 1.1.
Figure 1.1: Schematic overview of the main coronary arteries (RCA = right
coronary artery, LCA = left coronary artery, LM = left main artery, LCX = left
circumflex artery, LAD = left anterior descending artery).
The coronary tree contains many bifurcations (and sometimes trifurcations)
in order to supply the complete heart muscle with oxygen and nutrition. A
1 A balanced distribution means that nor the LCA, nor the RCA is dominant.
3bifurcation typically consists of a proximal main branch (PMB), a distal
main branch (DMB) and a side branch (SB). The SB ostium is the opening
in the main branch (MB) that leads to the SB and the carina is the point
where the two branches split. In this work the bifurcation angle is defined as
the angle between the SB and the DMB axes2. Using this definition, Kaplan
et al. [9] reported angle values of 56.6±21.7° based on 80 coronary bifurca-
tions. All main anatomical bifurcation features are indicated in Fig. 1.2.
Figure 1.2: Schematic representation of a coronary bifurcation with inflow in
the proximal main branch (PMB) and outflow at the distal main branch (DMB)
and the side branch (SB). α indicates the bifurcation angle. The SB ostium and
the carina are represented by a dotted line and a small circle respectively.
Physiological systems such as the coronary tree display a high degree of
organization, for example the stepwise decrease of the vessel diameter up to
the capillary level (i.e. geometrical tapering). There have been numerous
attempts to explain and to quantify the design of the vascular tree. These
theoretical models provide relationships between the diameters of the PMB,
the DMB and the SB. For example, Murray [10] derived an optimal condi-
tion for vascular bifurcations based on the principle of minimum work that
is known as Murray’s law. It states that the cube of the diameter of the
PMB (DPMB) equals the sum of the cubes of the diameters of the DMB
(DDMB) and the SB (DSB):
D3PMB = D
3
DMB +D
3
SB (1.1)
Recently, Finet et al. [11] proposed a linear relationship between the dif-
ferent vessel diameters for coronary bifurcations which is easier to use in
clinical practice:
DPMB = 0.678 ∗ (DDMB +DSB) (1.2)
2 The bifurcation angle is sometimes defined as the angle between the PMB axis and the
SB axis [8].
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The ratio 0.678 is based on angiographic data and is accurate for all coro-
nary arteries. The authors also applied Murray’s law to their data and
observed that the predicted DPMB using formula 1.1 underestimated the
actual DPMB with 5%. The fact that Murray’s law predicts a smaller
DPMB than the relation proposed by Finet et al. is reflected in Fig. 1.3,
where the distal branch diameters (DDMB and DSB) are assumed to be
equal. With this assumption, both relations are linear and the predicted
values for DPMB are always 7% higher using the relation proposed by Finet
et al.
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Figure 1.3: Comparison of the relation between bifurcation vessel diameters
proposed by Murray [10] and Finet et al. [11] when assuming equal distal branch
diameters.
Healthy arteries typically consist of three distinct layers, the tunica intima
(the innermost layer), the tunica media (the middle layer) and the tunica
adventitia (the outermost layer), as depicted in Fig. 1.4. In young arteries,
the intima is a single layer of endothelial cells resting on a basement mem-
brane of connective tissue. However, ex vivo testing of non-stenotic aged
arteries revealed the load bearing capacity of the intima and its considerable
mean thickness of 27% with respect to the total wall thickness [12]. The
occurrence of such a substantial intimal layer in aged arteries is the result of
diffuse intimal hyperplasia, introduced by a non-atherosclerotic process [13].
The media is built up of a three-dimensional network of bundles of collagen
fibrils, elastin and smooth muscle cells. The fibers have a helicoidal organi-
zation with a small pitch angle (20.6±5.5° according to [12]) resulting in a
high circumferential strength. The adventitia mainly consists of fibroblasts
and collagen fibers embedded in a ground-matrix and forms a protective
layer around the arteries [14].
5Figure 1.4: Layered structure of young and healthy arteries [15].
1.1.2 Bifurcation lesions
Cardiovascular disease causes nearly half of all deaths in Europe (48%) [1].
Atherosclerosis is one important type of these diseases and is an inflamma-
tory pathology which affects blood vessels. Whether endothial denudation
or dysfunction initializes the inflammatory process is still a matter of de-
bate. Such endothelial dysfunction or denudation increases the adhesiveness
of the endothelium and its permeability and can be caused by hypertension,
smoking, diabetes and combinations of these or other factors. The higher
permeability leads to an accumulation of low density lipoproteins (LDL) be-
tween the intimal and medial layer. After oxidation of this LDL, monocytes
migrate into the vessel wall and differentiate into macrophages, which then
ingest the oxidized LDL and modify to foam cells. Subsequently, smooth
muscle cells migrate to the inflammation site and a fibrotic collagen cap de-
velops around the plaque. These processes thicken the arterial wall, which
compensates by gradual dilation, so that the lumen remains unaltered. Con-
tinued inflammation leads to the intrusion of the lesion into the lumen. Such
a narrowing of the lumen, called a stenosis, may reduce the supply of oxygen
rich blood to downstream tissues [3].
There is a tendency for atherosclerosis to develop at specific arterial sites
such as bifurcations and curvatures. At these locations, there are some
regions where the blood flow is slow and changes direction during the car-
diac cycle, resulting in a weak net hemodynamic shear stress (see Fig. 1.5).
Such flow conditions with shear stress values below 1 Pa alter the expres-
sion of genes on the endothelial layer, making these arterial regions prone to
atherosclerotic lesions, while normal arterial shear stress levels above 1 Pa
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result in an atheroprotective gene expression profile [16]. Regions subjected
to too high shear stress values (> 7 Pa) such as cardiac valves have an
increased thrombotic risk [16].
Figure 1.5: Schematic illustration of the blood flow in a bifurcation.
Coronary bifurcation lesions occur in many different types and a proper
classification is required to define these lesions and to compare different
treatment techniques. Medina et al. [17] proposed a simple and clear classi-
fication method to distinguish different lesions depending on the distribution
of the plaque as depicted in Fig. 1.6. The method consists of giving a bi-
nary value (1 or 0) to each of the bifurcation vessels segments respecting the
following sequence: PMB, DMB and SB. A value of 1 is assigned when the
segment contains a narrowed section. All possible lesion types are shown in
Fig. 1.6.
Figure 1.6: Medina classification for coronary bifurcation lesions.
7The European Bifurcation Club suggests to use this Medina classification
when describing coronary bifurcation lesions, although it only gives infor-
mation related to the location of the plaque [18]. Other parameters such as
bifurcation angle, lesion length and severity of the stenosis are not incor-
porated. However, assessment of these parameters requires a quantitative
evaluation of coronary angiography data which is still operator dependent.
Advanced software allowing automatic extraction of these parameters may
help at this point (e.g. CAAS 3D quantitative coronary analysis (QCA)
software, Pie Medical).
1.2 Treatment techniques
A severe stenosis in a coronary artery decreases the supply of oxygen rich
blood to the heart muscle (myocardium) and often results in chest pain
(angina pectoris) or a heart attack (myocardial infarction). Treatment can
include weight reduction, cholesterol reduction, change in lifestyle, as well as
control of high blood pressure. Some individuals, however, will require inva-
sive treatment such as coronary artery bypass surgery, balloon angioplasty
or stent placement. An important question is of course: Which stenoses
are severe and should be treated? It has been shown that neither visual
assessment of an angiogram by experienced interventional cardiologists nor
quantitative coronary angiography can accurately predict the significance
of moderate narrowings [19]. Therefore, many lesions are treated with-
out definite evidence that that particular stenosis is causing the symptons.
Fractional flow reserve (FFR) has been proposed as an index to assess the
functional severity of coronary stenoses and is calculated from pressure mea-
surements. More specifically, the FFR is calculated as the ratio of the mean
distal intracoronary pressure measured by a pressure-monitoring guide wire
to the mean arterial pressure measured by the coronary catheter [20,21]. A
threshold value for the FFR of 0.75 is often used [21].
Coronary artery bypass surgery involves the creation of one or more alter-
native conduits to bypass the obstruction(s) in the coronary tree and was
performed for the first time in 1960 [22]. The internal mammary artery
is often used to construct the bypass, but alternatively, a vein from the
leg (saphenous vein) or an artery from the forearm (radial artery) can be
taken. This procedure often requires the opening of the chest via a ster-
notomy (i.e. an incision in the sternum to allow access to the heart) which
makes the procedure highly invasive for the patient.
In 1977, a less invasive alternative called angioplasty was introduced by
Dr. Gruentzig. During a first step of this minimally invasive procedure, a
catheter with a tightly folded balloon at the distal end is mounted over a
guide wire that was already inserted through a small incision in the femoral,
radial or brachial artery. Subsequently, the balloon catheter is advanced to
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the narrowed vessel section using radiopaque markers and inflated at high
pressure. This results in a stretched (or partially dissected) vessel wall and
in an enlarged lumen. After deflating the balloon, part of the lumen gain
is lost by the recoil of the vessel wall. This luminal loss can be limited
by deploying a mechanical scaffold (stent) which provides in most cases a
permanent support to the vessel wall (see section 1.2.1).
All of the techniques (coronary artery bypass surgery, balloon angioplasty
and stent placement) are still used to treat atherosclerotic lesions in clin-
ical practice. The selection of a particular technique or a combination of
different procedures for a specific patient depends on many factors such as
number of lesions, the location and the severity of the stenosed segments,
the personal preference of the clinician (and patient) and many others. A
detailed discussion and comparison on the application of the different tech-
niques in terms of safety, outcome and cost-effectiveness falls outside the
scope of this work. The further discussion will be limited to stent place-
ment.
1.2.1 Stent placement
The first stent was implanted in 1986 and was a major breakthrough. From
1992 to 2004, the total number of percutaneous coronary interventions and
the number of coronary stenting procedures in Europe increased from ap-
proximately 184000 to 885000 and from 3000 to 770000 [2]. The most
important category of coronary stents are balloon-expandable, referring to
the expansion mechanism of the stent which is driven by the inflation of
an angioplasty balloon (see Fig. 1.7). The insertion procedure is very sim-
ilar to the one previously described for balloon angioplasty. However, the
higher stiffness of the system due to the stent structure which is crimped
around the folded balloon slightly increases the technical complexity of the
intervention. Stent placement in patients having high grade stenosis often
requires initial predilatation with a more flexible angioplasty balloon having
a lower profile. After positioning the stent at the location of the narrow-
ing, the stent is deployed by gradual inflation of the balloon. Subsequently,
the balloon is deflated and the complete system is removed from the body,
except for the permanently deformed stent which remains in place, keeping
the artery open (see Fig. 1.8).
A second category of stents based on the expansion mechanism are the self-
expandable stents. During insertion, these spring-like stent structures are
located inside a delivery catheter and removal of this restraining catheter
results in their deployment. Typically, these stents are made of Nitinol, a
Nickel-Titanium based alloy having superelastic properties. Nitinol devices
have the ability to undergo large deformations when loaded and to return
to their original shape when the load is removed. Although rarely used for
9Figure 1.7: Unconstrained expansion of the Endeavor stent (Medtronic): Panel
A shows the stent, crimped around a folded angioplasty balloon. The deployment
starts at the stent ends (panel B) and continues towards the stent center (panel
C).
coronary applications, these self-expandable stents are the preferred choice
for improving blood flow in stenosed peripheral arteries (e.g. carotid artery
and femoral artery), as their spring-like behaviour results in a permanent
outward force on the inner wall of these highly deformable arteries. In
case of balloon-expandable stents, large vessel deformations might lead to
undesired permanent deformations that would jeopardise their scaffolding
function.
Palmaz et al. [23] introduced balloon mounted stents to open up stenosed
pheriperal arteries in 1985. Schatz et al. [24] subsequently modified the
Palmaz stent, leading to the development of the commercially successful
Palmaz-Schatz stent. In 1994, two important randomized clinical trials
confirmed the superiority of the Palmaz-Schatz stent compared to balloon
angioplasty [25,26], establishing the elective placement of coronary stents as
a standard treatment. According to those studies, stent placement signifi-
cantly reduced restenosis (i.e. a renarrowing of a previously treated vessel
segment) levels compared to balloon angioplasty from approximately 30-
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Figure 1.8: Schematic illustration of a balloon-expandable stent placement. Af-
ter correct positioning of the crimped stent (panel A), the balloon is inflated at
high pressure leading to the expansion of the device and to an improved luminal
area (panel B). Finally, the procedure is completed by deflating and extracting
the balloon catheter. The stent remains in place to keep the vessel open (panel
C).
40% to 20-30%.
In 2002, a major revolution was caused by the introduction of Drug-Eluting
Stents (DES), having an active coating to inhibit in-stent restenosis. These
DES typically consist of three components: a metallic stent platform, a
polymer coating, and the drug itself stored within the coating. After
deployment, the drug is slowly released from the coating to the injured
vessel wall. Clinical trials revealed restenosis rates below 10% for both
the sirolimus-eluting Cypher stent (Cordis, Johnson & Johnson) and the
paclitaxel-eluting Taxus stent (Boston Scientific). However, standard Bare
Metal Stents (BMS) are still used on a large scale as the cost-effectiveness
of DES compared to new generation BMS remains a concern [27]. In addi-
tion, discussions regarding the long-term safety of DES caused a decline of
their use in 2006. Nevertheless, some recent studies demonstrate the limited
impact of DES on the long-term safety in comparison with BMS [28].
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Two important current trends in percutaneous coronary intervention are the
development of drug-eluting balloons and biodegradable stents. One type of
drug-eluting balloon (SeQuent Please, B. Braun) has a drug matrix applied
to the outer balloon surface. This matrix consists of paclitaxel, embedded
in a hydrophilic iopromide, which increases the solubility and transfer of
paclitaxel to the vessel wall. The matrix is fragmented into small units at
inflation, the iopromide dissolves and the paclitaxel migrates into the ves-
sel wall. An inflation time of 30 seconds is recommended for optimal drug
delivery. Drug-eluting balloons have the potential to resolve the current lim-
itations of DES and can be used with or without BMS. Treatment of in-stent
restenosis with paclitaxel-coated balloon catheters significantly reduced the
incidence of restenosis [29] and avoids stent-in-stent situations. Further-
more, this approach results in a uniform drug distribution in the vessel wall
whereas DES may lead to an inhomogeneous drug distribution [30].
Current metallic stents remain permanently in the artery, although their
scaffolding function is only required for a number of weeks [31]. There-
fore, considerable efforts have been spent to create safe and effective metal-
lic and polymer based biodegradable stents. Such biodegradable devices
would reduce the duration of the antiplatelet treatment, which is needed to
avoid thrombosis. However, their development is hampered by difficulties in
replicating the properties of conventional stainless-steel or cobalt-chromium
stents [31,32].
The design of the last generation stents differs a lot from the first com-
mercially available stents. Nowadays, stents usually demonstrate a better
mechanical behaviour in terms of the following criteria (non-limiting list):
 Flexibility: The crimped stent must be flexible to pass all tortuous
vessels and bifurcations during insertion. Furthermore, the expanded
stent should have sufficient flexibility in order not to straighten the
often curved vessels.
 Radial strenght: Minimal luminal loss after deflation of the balloon
can only be obtained if the stent has a sufficient radial strength in
order to resist the compressive forces of the vessel wall.
 Elastic recoil: The diameter of the expanded stent may change
(i.e. radial elastic recoil) after deflation of the balloon as illustrated in
Fig. 1.9. It can be defined as (Df−Di)/Di. This elastic recoil should
be minimized as it reduces the final lumen.
 Foreshortening: The longitudinal contraction (see Fig. 1.9) which
may occur during expansion should be as little as possible in order
to minimize the shearing on the endothelial layer. Such shearing may
lead to endothelial damage [33]. It is often quantified as (Lf−Lo)/Lo.
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Figure 1.9: Schematic illustration of stent recoil and foreshortening (Lo and Do
denote the length and diameter of the crimped stent, Lf and Df denote the length
and diameter of the final stent shape after balloon deflation and Di refers to the
intermediate stent diameter at the maximal balloon pressure).
 Crossing profile: To facilitate placement, the crossing profile of the
complete device (i.e. Do in Fig. 1.9) should be minimized.
The large number of design prerequisites turn the development cycle into a
process of compromises as some requirements result in contradictory design
recommendations. For example, reducing the strut thickness will lead to
a lower crossing profile of a stent system, but will have a negative impact
on the radial strength. This explains the large variety of the developed
balloon- and self-expandable stent designs (see Fig. 1.10 and 1.11). It should
be noted that the design process is further complicated by the numerous
patents which limit the available design space. However, spending time and
money to develop adequate stent designs seems justified as it was shown
that restenosis rates are design dependent for BMS [34,35].
1.2.2 Stenting bifurcation lesions
Balloon angioplasty of coronary bifurcation lesions was soon identified as
an unfavorable determinant for angioplasty success [36]. Using advanced
techniques such as kissing balloon inflation (i.e. simultaneous inflation of
an angioplasty balloon in both branches) improved the outcome, but these
interventions were still associated with high complication and restenosis
rates [37]. Using first generation stents for bifurcation lesion treatment
yielded unsatisfactory results, mainly because of the limited access to the
SB [38]. Advances on the stent design level as well as the availability of
very low profile balloons facilitated the deployment of stents at bifurcations
and led to a wave of new bifurcation stenting techniques. However, the
need for re-intervention continued to be high [39, 40]. The introduction
of DES markedly reduced the restenosis rates in the main vessel, but the
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Figure 1.10: Examples of balloon-expandable stents. A: Endeavor (Medtronic),
B: Taxus Liberte´ (Boston Scientific), C: Promus (Boston Scientific), D: PRO-
Kinetic (Biotronik). The images do not have the same scale.
Figure 1.11: Examples of self-expandable stents. A: Wallstent (Boston Scien-
tific), B: RX Acculink (Abbott Vascular), C: Xact (Abbott Vascular), D: SelfX
(Abbott Vascular). The images do not have the same scale.
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results for the SB were disappointing with restenosis rates of approximately
15% [4,41]. Furthermore, the higher incidence of stent thrombosis compared
to conventional stenting remains a concern [41, 42]. Since the treatment
of bifurcation lesions is estimated to be 15% of all percutaneous coronary
interventions, further understanding of this complex issue is required to
optimize the safety and outcome of bifurcation stenting procedures [38,43].
Many different bifurcation stenting techniques have been proposed, with
various levels of complexity and each of them having one or more limita-
tions. In 2000, Lefe`vre et al. [44] proposed a classification system for these
techniques, which was further extended by Louvard et al. [45]. Currently,
the MADS classification (Main, Across, Distal, Side) has been unanimously
accepted by the European Bifurcation Club and divides the techniques into
four major groups depending on in which arterial segment a first stent is
implanted (see Fig. 1.12 and 1.13) [18]. The most important techniques
are outlined below. An important question (which is still unanswered) is
whether or not to systematically predilate the MB and SB before stenting.
The advice of the European Bifurcation Club regarding this is to predilate
the SB in case of long or calcified SB lesions [18].
1.2.2.1 Provisional stenting
The provisional stenting strategy which involves stent placement in the main
vessel first and then the SB when necessary is currently the gold standard for
the majority of the treatments [18]. Elective implantation of two stents may
be considered in case of SB lesions which are longer than 2 or 3 mm [18]. The
first step of provisional stenting is to decide whether a guide wire is needed
in the SB. There are two main advantages of this jailed wire technique3.
First, such a jailed wire favorably alters the bifurcation angle and turns
T-shaped bifurcations into Y-shaped bifurcations, resulting in easier access
to the SB. Second, total occlusion of the SB during stent placement in
the MB is prevented. However, retracting this trapped wire may damage
the endothelial layer and therefore systematic use is still debated. It is
recommended to use this jailed wire technique for complex lesions. If this
jailed wire technique is used, then the MB stent should be initially deployed
at low pressure (8 atm) in order to minimize the vessel wall injury and to
avoid damage of the jailed wire. After having rewired the SB through the
side of the stent using the jailed wire as a landmark (if used), this jailed wire
is removed and the stent can be postdilated at high pressure. Depending on
the angiographic result, the complexity of the lesion and personal preference,
the operator can also decide to perform final kissing balloon postdilatation.
An angiographic assessment of the SB lesions is not always enough, as Koo
3 Expanding the MB stent when a guide wire is placed into the SB ‘jails’ this SB wire
between the stent struts and the vessel wall.
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Figure 1.12: MADS classification of the different bifurcation stenting techniques
(adapted from [18]). Clarification of the abbreviations: MB = main branch, PMB
= proximal main branch, DMB = distal main branch, SB = side branch, prox =
proximal, TAP = T-stenting and small protrusion technique, SKS = simultaneous
kissing stents.
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Figure 1.13: MADS classification of the inverted techniques (adapted from [18]).
Clarification of the abbreviations: MB = main branch, PMB = proximal main
branch, DMB = distal main branch, SB = side branch, prox = proximal, TAP
= T-stenting and small protrusion technique, SKS = simultaneous kissing stents,
inv = inverted.
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et al. [46] have shown that about 70% of all ostial lesions following MB
stenting are functionally not significant. Moreover, in this study, there were
no lesions with < 75% SB diameter stenosis that had a fractional flow reserve
(FFR) < 0.75. The main reasons to perform kissing balloon postdilatation
are to optimise the strut appositioning and improve the SB access. The last
step, stenting the SB, only occurs if the result of the SB is unsatisfactory.
Several techniques that will be described in detail in the next sections are
available to stent the SB at this point, such as T stenting, internal crush
and culotte stenting.
1.2.2.2 T stenting
T stenting involves stenting both the MB and SB in a T-shaped manner and
is best suited to treat bifurcation lesions with an angle close to 90° [47]. Us-
ing this technique for bifurcations where the angle significantly differs from
90° results in incomplete ostial coverage or in stent struts protruding into
the MB. The operator can choose to stent the MB or the SB first. If a provi-
sional SB stenting strategy is applied, then the MB stent is implanted first
and T stenting can be performed when suboptimal SB results occur. In this
case, the SB stent is advanced into the SB through the already expanded
stent. To avoid this technically demanding insertion for lesions where it is a
priori the intention to stent both branches, stenting the SB first may be the
preferred option. This second approach requires very accurate positioning
because protrusion of this stent into the MB may hamper subsequent stent
placement in the main vessel. Therefore, alternative strategies have been
suggested to overcome this limitation. Kobayashi et al. [48] proposed to
position the main vessel stent prior to deployment of the stent in the SB
(modified T stenting). As such, potential strut protrusions do not com-
promise MB stenting. Furthermore, protruding struts will be compressed
against the vessel wall after expansion of the MB stent. A second suggestion
is to inflate a balloon at low pressure (4 atm) in the MB after placing the
undeployed stent in the SB. The stent can then be accurately positioned
at the SB ostium by sligthly pulling back the stent against the already in-
flated balloon while limiting strut protrusion [49]. The same principle can
be applied when the main vessel is stented first to assure minimal protrusion
into the MB while guaranteeing good ostial coverage and is called the TAP
technique (T stenting And small Protrusion) [50].
1.2.2.3 The crush technique
The crush technique was introduced after observation of high restenosis
rates at the ostium of the SB using DES. Incomplete ostial coverage and
the resulting suboptimal drug delivery were assumed to be important con-
tributors to the higher incidence of restenosis at that location. The main
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advantage of the crush technique is the complete coverage of the SB ostium
for a large range of bifurcation angles. The procedure starts with advanc-
ing two stents, one in the SB and one in the MB. The SB stent is then
retracted into the MB over a distance of 4 to 5 mm. The MB stent should
be positioned so that its proximal marker is located more proximal than the
proximal marker of the SB stent. Following the expansion of the SB stent
(which protrudes in the main vessel), the delivery balloon and guide wire
are removed. Subsequently, the MB stent is deployed, crushing the pro-
truded struts of the stent implanted in the SB against the wall of the main
vessel, hereby leading to three layers of struts in the proximal section of the
bifurcation near the SB ostium. Final kissing balloon inflation drastically
improves the outcome and is therefore mandatory [51]. However, recross-
ing three layers of struts can be difficult or even impossible and makes the
procedure laborious. Concerns regarding the risk of thrombosis due to the
relatively large zone with three strut layers lead to the introduction of the
mini-crush technique [52]. Almost the complete mini-crush procedure is
identical to the classic crush technique, except for the retraction of the SB
stent that is limited to 1 or 2 mm instead of 4 to 5 mm. This reduces the
region with increased strut density.
The step crush technique was proposed to make the crush technique com-
patible with a 6 Fr guiding catheter, which may be useful when a radial
vascular approach is being used4. The procedure is again very similar to
the standard crush, but the stents are now sequentially inserted and de-
ployed. The initial position of the SB stent is identical, but a balloon is
advanced in the MB and this balloon is then used to crush the proximal
part of the SB stent against the wall of the main vessel. After removal of
the balloon, the MB stent is positioned and deployed.
The reverse or internal crush can be performed when a provisional SB stent-
ing strategy was applied, but a SB stent is required after stenting the main
vessel and subsequent kissing balloon inflation. First, a second stent is ad-
vanced into the SB through the deployed stent, followed by the placement
of a balloon in the MB. Then the SB stent is retracted into the MB and
deployed. The balloon and the wire are removed and the MB balloon is in-
flated to crush the proximal portion of the SB stent against the struts of the
MB stent. Again, final kissing balloon postdilatation should be performed
to optimize the strut apposition.
1.2.2.4 Culotte stenting
The culotte technique was first described by Chevalier et al. [53] and has
the main advantage of providing complete ostial coverage for a large range
of bifurcation angles. This technique can be used as a two-stent strategy
4 The radial artery is normally slightly smaller than the femoral artery.
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or for bifurcation lesions treated with a provisional stenting approach that
need a second stent after stenting the MB. The most angulated branch
(i.e. usually the SB) is stented first when a two-stent strategy is applied.
The other branch is then rewired through an expanded cell of the deployed
stent and dilated. The next step involves the advancement of the second
stent through the deformed cell and subsequent deployment, hereby creating
a double layer of struts in the proximal part of the bifurcation. Final kissing
balloon inflation can be performed in order to minimize the number of
floating struts. The procedure can be technically demanding due to the two
rewiring steps. Similar to the crush technique, culotte stenting leads to high
metal concentrations in the proximal part of the bifurcation.
1.2.2.5 V stenting and simultaneous kissing stents technique
The current definition of V stenting differs from the originally proposed V
stenting technique [54] in which a non-crimped Palmaz-Schatz stent (PS153,
Johnson & Johnson) was manually bended at one of its connector elements
resulting in two parallel cylinders that were then crimped by the operator on
two balloons. This self-made device was advanced to the bifurcation until
the bended connector touched the carina. Both stent parts were finally
deployed, one in each distal branch. Nowadays, the term V stenting is used
for a technique that involves the implantation of two separate stents in the
two distal branches. These two stents are positioned with their proximal
ends at the carina, and may form a new carina when these two stent ends
touch each other. The Simultaneous Kissing Stent (SKS) technique is very
similar to V stenting, however, after advancing a stent in each branch, both
stents are pulled back into the proximal main vessel until both proximal
stent ends touch each other over a distance of 5 mm or more [55].
1.2.2.6 Skirt technique
The skirt technique was introduced to treat lesions immediately proximal to
a bifurcation and requires manual manipulation of the device [56]. A stent
has to be crimped on two balloons, but this should be done very carefully
because such manipulation may damage the polymer coating of DES. This
stent system is then advanced over two wires, one in each branch, until the
distal stent end hits the carina. Finally, both balloons are simultaneously
inflated.
1.2.2.7 Y stenting
Y stenting involves the deployment of a stent in each distal branch (V-
stenting), followed by a third stent implantation in the proximal MB as
close as possible to the carina to complete the ‘Y’, which can be achieved
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by using the skirt technique. According to the MADS classification system,
this technique is called ‘trousers legs and seat’. The sequence of stent im-
plantation is inverted during the ‘extended Y technique’, starting with the
proximal MB stent and then stenting the distal branches. Also this tech-
nique receives a different name in the MADS classification: the extended V
technique.
1.2.2.8 Clinical outcomes
A large number of clinical studies have been published during the last cou-
ple of years focusing on different bifurcation stenting techniques. However,
these clinical studies did not answer the question of which technique to
use for a particular bifurcation lesion (or type of lesion). One important
reason for this is that most published results are based on nonrandomized
registries, which unfortunately limits the value of the conclusions. To date,
only very few randomized trials have been organised in the field of bifur-
cation stenting [4, 41, 57–59]. The results of these studies and registries are
often difficult to compare because of the various lesion classification systems
that have been adopted in the past and the lack of detailed descriptions of
the applied stenting techniques. The large number of different stent designs
used further complicates the interpretation of the data. For example, the
culotte technique may give a good outcome when using design A, but the
results may be quite poor when using design B. Finally, the high crossover
rate when comparing one to two stenting techniques makes it difficult to
draw solid conclusions. The following paragraphs try to summarize some
of the main findings in the field of bifurcation stenting. The reported num-
bers should however be read critically because of the previously mentioned
limitations.
Before the introduction of DES, several authors [40, 60, 61] reported that
stenting both vessels using a two-stent technique did not provide an ad-
vantage as compared to a single stenting strategy (in combination with a
dilatation of the other branch). At that time, the outcome was often quite
disappointing whatever strategy used. For example, Yamashita et al. [40]
reported major adverse cardiac events rates (defined as death, myocardial
infarction or target lesion revascularization) of 51% and 38% at six-month
follow-up for the two-stent and the single stent cases respectively.
Thuesen et al. [62] published a subgroup analysis of the bifurcation le-
sions treated during the randomized SCANDSTENT trial, which compared
sirolimus-eluting to bare metal stents. It was observed that the sirolimus-
eluting stents reduced the angiographic restenosis rate from 28.3% to 4.9%
in the MB and from 43.4% to 14.8% in the SB. Major adverse cardiac events
occurred in 9% of the cases with sirolimus-eluting stents and 28% with bare
metal stents. These results lead to the widespread use of DES when dealing
with bifurcation lesions. It should be noted, however, that the restenosis
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rate for the SB remains higher as compared to the DES standard values for
unbranched vessels.
In a randomized trial, Pan et al. [63] compared sirolimus-eluting with
paclitaxel-eluting stents for the treatment of bifurcation lesions. Patients
treated with sirolimus-eluting stents showed significantly lower rates of
restenosis and target lesion revascularization than patients treated with
paclitaxel-eluting stents. These findings were consistent with a non ran-
domized study conducted by Hoye et al. [64].
The question whether or not to use two drug-eluting stents on a routinely
basis instead of applying a simpler one stent strategy (using a DES) was
addressed by a number of randomized trials. In 2004, Colombo et al. [41]
did not find a statistical significant difference between the simple and the
complex approach. The main limitation of this study was the extremely
high cross-over rate of more than fifty percent. In the same year, the results
of a study conducted by Pan et al. [57] were published and showed a similar
trend: stenting both branches seems to provide no advantages over stenting
the MB only followed by SB balloon dilation. The cross-over rate in this
study was limited (five out of 91 patients). To date, the largest random-
ized bifurcation trial with 413 patients comparing simple (1 stent) versus
complex (2 stents) stenting techniques for DES is the Nordic Bifurcation
Study [58]. Again, there was no statistically significant difference in terms
of MACE (major adverse cardiac events) and target lesion revasculariza-
tion at six-month and at 14-month follow-up [65]. However, the elective
implantation of two stents was associated with increased procedural and
fluoroscopy times. In addition, implanting two stents obviously leads to a
higher cost and therefore, the authors recommend the simpler, provisional
strategy as the routine bifurcation stenting technique. Ferenc et al. [59]
compared routine T-stenting with provisional T-stenting, hereby limiting
the number of variables of the study. Allowing several two-stent techniques
as was done during the Nordic Bifurcation Study [58] (culotte, crush, etc.)
makes it difficult to draw conclusions for one of these techniques, compared
to the simple one-stent approach. Ferenc et al. [59] concluded that routine
T-stenting did not improve the target lesion revascularization as compared
to provisional T-stenting, which is again in agreement with all previous
studies. Recently, the results of the CACTUS trial have been published
by Colombo et al. [4]. This randomized trial compared the crush tech-
nique with a provisional SB stenting approach. At six months, target lesion
revascularization and MACE did not differ significantly.
Future randomized trials should address the large number of open questions:
Is there a need for systematic kissing balloon postdilatation? If a two-
stent technique is required, which one should be applied for which type
of bifurcations? Does the selected stent design impact the outcome for
a particular technique? But as dr. Wijns (Cardiovascular Center, OLV,
Aalst, Belgium) mentioned during the European Bifurcation Club meeting
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in Prague (2009), the focus should be on the dedicated devices which are
designed for these lesions instead of putting efforts in comparing the various
complex techniques that were developed for suboptimal stent designs.
1.2.3 Dedicated bifurcation stents
The introduction of DES and the improved insights into the different tech-
niques resulted in markedly lower restenosis rates when treating bifurcation
lesions. The very good results observed after stenting unbranched vessels
can, however, not yet be obtained. It should be noted that the acceptable
results for bifurcation stenting that have been published are obtained by
interventional cardiologists who have a particular interest in this specific
domain. These interventional cardiologists are aware of the different causes
of suboptimal strut positioning and probably spend more time to optimize
the result (e.g. advancing a SB balloon catheter through the side of the MB
stent can be very time-consuming). The importance of operator-experience
was clearly demonstrated by Latib et al. [66] who compared the outcomes
of bifurcation stenting at their institution over three consecutive periods. It
is therefore likely that the results obtained by highly skilled operators are
not representative for all centers. Hence, there is a need for user-friendly
dedicated bifurcation stents which further improve the current outcomes
but that also reduce the technical difficulty.
As already stated, bifurcation lesions account for approximately 15-20% of
all lesions that need percutaneous treatment, leading to more than 500000
bifurcation interventions annually [67]. This interesting market attracts the
attention of large medical device companies but also leads to a number of
start-ups focusing on this niche market. As a result, a large number of
dedicated bifurcation stent systems have been developed and other systems
are still under development. The available product information of these
stent systems is often limited because some of these devices are not yet
available on the market. Fortunately, the work of Abizaid et al. [68] and
the very recent review of Latib et al. [66] provide a very nice overview of
the recent bifurcation stents. The discussion of the different stent systems
provided in the next sections is often based on these two papers.
1.2.3.1 Antares Coronary Stent System
The Antares (Trireme Medical, California, USA) is a balloon-expandable
bare metal stent for provisional stenting. The stent is made from stainless
steel and has a strut thickness of 89µm. Only one wire is needed for initial
insertion but a ‘stabilizing wire’ is concealed within a dedicated lumen in
the catheter. Once the stent is positioned at the bifurcation, the operator
should torque the catheter to align the stent’s central opening (indicated
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with radiopaque markers) with the SB ostium. Then, the stabilizing wire
can be released at the central opening of the Antares stent and inserted into
the SB. This approach minimizes the risk of wire wrap. Finally, the stent
can be further advanced on both wires and deployed by inflating a single
balloon. A SB support structure is automatically deployed with elements
protruding approximately 2 mm into the SB that provide ostial scaffolding
(see Fig. 1.14).
The first-in-man study of 11 patients/lesions treated with the Antares stent
demonstrated a device success rate of 100% [66]. At 30 days follow-up, there
were no adverse events reported5.
Figure 1.14: Schematic overview of the insertion and deployment procedure of
the Antares stent system (Trireme Medical). The top panel shows the device when
the stabilizing SB wire is still within the dedicated lumen. Following to correct
positioning, the stabilizing wire is advanced into the SB (middle panel) and the
stent is finally deployed by inflating a single balloon (bottom panel). Adapted
from [66].
5 These numbers are based on the review paper of Latib et al. [66] since the original
report of the first-in-man study could not be accessed by the author.
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1.2.3.2 Axxess Bifurcation Stent System
The Axxess Plus stent (Devax, California, USA) is a self-expandable coni-
cally shaped nitinol stent placed in the parent vessel up to the carina (see
Fig. 1.15). The angle between the branches should be smaller than 60°. In
such bifurcations, it is claimed that the combination of the self-expandable
properties and the conical shape allows adequate scaffolding of the ostia of
the two daughter vessels. The implantation procedure starts with the inser-
tion of a guide wire in both branches, followed by a mandatory predilatation
of the main vessel [69]. The Axxess stent is then inserted over one of the
wires and the stent is partially deployed by retracting a covering sheath,
hereby exposing the three distal markers (see Fig. 1.15). This should allow
accurate positioning of the device at the level of the carina prior to full stent
expansion. A fourth marker is located at the proximal edge of the stent.
The symmetric design of the stent makes rotational orientation unnecessary.
The abluminal surface of the struts (thickness of 152µm) is coated with a
resorbable polymer that delivers Biolimus A9, an anti-restenotic drug [70].
The Axxess Plus trial clearly showed the frequent necessity of implanting
one or more additional stents in the distal branches since a total of three
stents was used in 42% of the patients [69]. The Axxess stent was success-
fully implanted in 130 of 139 cases (93.5%). In six of the failure cases, the
stent was placed distal or proximal to the intended location. At six months
follow-up, the in-stent restenosis within the Axxess stent was 4.8% and the
overall target lesion revascularization was 7.5%.
Figure 1.15: The design of the self-expandable Axxess stent (Devax) aims at
providing adequate coverage in the bifurcation region. Placement is facilitated by
the four radiopaque markers (three distal and one proximal). Adapted from [70].
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1.2.3.3 Multi-Link Frontier
The Multi-Link Frontier stent system (Abbott Vascular, Redwood City,
California, USA) is a 316L stainless steel stent premounted on a dedicated
delivery system with two balloons and two guidewire lumens and requires a
7 Fr guide catheter [71]. The stent design differs along the stent length and
can accomodate to larger diameters in the proximal part. The ends of the
two balloons are joined by a mandrel which leaves the tip of the SB balloon
catheter and is distally enclosed within a pocket in the MB balloon catheter
shaft. This facilitates tracking and avoids the risk on guidewire crossing.
After removing the joining mandrel (and thus unjoining the balloon tips),
a guide wire can be inserted into the SB. The final position of the stent is
obtained by further advancing the device on both wires until resistance is
felt. The device is deployed by kissing balloon inflation since the catheter
incorporates a common inflation lumen for the simultaneous inflation of the
two balloons (see Fig. 1.16).
Lefe`vre et al. [71] evaluated the safety and feasibility of this device during
the FRONTIER stent registry. A device success rate of 91% was achieved
for the 105 enrolled patients. The MACE rate (death, myorcardial infarction
and target lesion revascularization) at six months was 17.1% and the overall
restenosis rate for any branch was 44.8%.
Abbott currently develops and investigates a drug-eluting variant of the
Frontier stent, the Pathfinder, which is based on the Xience V technology
[72]. The Pathfinder will be made from the stronger cobalt-chromium alloy
allowing a reduced strut thickness in comparison to the Multi-Link Frontier
stent (i.e. 81µm instead of 99µm).
Figure 1.16: The Multi-Link Frontier stent (Abbott Vascular) is deployed by
the simultaneous inflation of two balloons [73].
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1.2.3.4 Nile Croco
The Nile Croco (Minvasys, Genevilliers, France) is a device consisting of a
bare metal cobalt-chromium stent mounted on a dedicated delivery system
with two separate balloons requiring independent manipulation and pressure
monitoring. The stent is crimped on the first balloon and on the distal tip
of the second balloon catheter. Insertion requires two guidewires and a 6 Fr
guiding catheter. If wire wrapping occurs, then the SB wire should be pulled
back into the MB and finally re-advanced into the SB. After the stent is
deployed within the MB by inflating the first balloon, the second balloon is
advanced to perform final kissing balloon inflation with the aim of opening
the struts towards the SB and providing ostium scaffolding (see Fig. 1.17).
The proximal part of the SB balloon is designed to avoid overexpansion of
the proximal MB when performing kissing balloon inflation.
Garcia Del Blanco et al. [74] reported a device success rate (defined as suc-
cessful device placement and final kissing balloon postdilatation) of 96%
during a multicentre Nile Croco registry (103 patients). The MACE rate
(defined as cardiac death, myocardial infarction and target lesion revascu-
larization) at six months in the 85 patients that were followed was 12%.
Figure 1.17: Schematic illustration of the deployment of the Nile Croco bifur-
cation stent (Minvasys). Courtesy Minvasys.
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1.2.3.5 Petal
The Petal stent (Boston Scientific, Massachusetts, USA) was originally de-
veloped by Advanced Stent Technologies as a bare-metal stainless steel stent
called AST Petal, but the second generation device (i.e. Taxus Petal) has a
platinum chromium platform and will elute paclitaxel like the Taxus stent.
The stent is characterized by its unique centrally located side aperture, de-
signed to scaffold the SB ostium with outwardly deploying strut elements
(see Fig. 1.18). The crossing profile has been reduced, making the new
device compatible with 6 Fr guiding catheters (instead of 7 Fr for the first
generation Petal stent). After mandatory predilatation, a guide wire is in-
serted in each branch. The dual side-exchange delivery system has a main
lumen that guides the catheter over the MB guide wire, while the secondary
lumen facilitates proper alignment of the aperture to the SB ostium as it
tracks over the SB guide wire [75]. Another particular feature of the device
is the secondary elliptical balloon adjacent to the cylindrical MB balloon.
The Petal stent is crimped over both balloons, which are connected to the
same inflation lumen so that a single inflation device is needed. The crimp-
ing is performed in such a way that the secondary balloon is located under
the side aperture and the petal elements (indicated in Fig. 1.18). Upon in-
flation, the main balloon deploys the stent into the MB, while the secondary
balloon deploys the petal elements into the SB ostium.
A first-in-man study with 13 patients was conducted using the first gener-
ation Petal stent system [75]. The device was succesfully implanted in 12
patients. The device was not used in one case due to vessel dissection after
predilatation. Twisting of the wires occurred in three cases and required
repositioning of one of the wires before delivery could be accomplished. In
one patient, stent rotation was impeded so that alignment with the SB did
not initially occur.
Figure 1.18: The Petal stent (Boston Scientific) has a side aperture with struts
(the so-called petal elements) that deploy into the SB by inflation of the particular
secondary balloon. Adapted from [66].
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1.2.3.6 Sideguard
The Sideguard ostium protection device (Cappella, Massachusetts, USA)
is a trumpet-shaped self-expandable nitinol stent with a low profile (less
than 3.5 Fr). The SB is treated first when using this device, although the
conventional approach is to stent the main vessel first. The combination of
its short length and low crossing profile should lead to greater navigability
even when dealing with calcified lesions. The trumpet-shaped SB stent is
designed to provide complete ostial scaffolding and to minimize the arterial
trauma (see Fig. 1.19) and will be indicated for bifurcation angles from 45°
to 135°. Only one wire is required to insert the Sideguard and there is no
need for rotational orientation, while longitudinal positioning is facilitated
by a number of radiopaque markers attached to the stent. The expansion is
triggered by inflating a balloon which tears a protective sheath that keeps
the Sideguard in place until deployment. After removal of the SB wire, any
conventional main vessel stent can be deployed. The procedure should be
completed with a standard final kissing balloon inflation in order to optimize
the strut appositioning of the MB stent. The current Sideguard stent is a
BMS but the next generation will be drug-eluting with a biodegradable
polymer [66,76].
The device was successfully implanted in 21 of the 25 patients enrolled in a
first-in-man study [77]. A second trial has begun with a modified Sideguard
device [66].
Figure 1.19: Illustration of the Sideguard ostium protection device (Cappella).
Adapted from [76].
1.2.3.7 SideKick
The SideKick (Y-Med, San Diego, California, USA) is a balloon-expandable
stent system advanced over a MB guide wire. The device contains an exit
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port for a SB guide wire intended to preserve SB access during stent de-
ployment. A different SideKick system can be employed depending on the
location of the lesion. The difference between these systems is in the location
of the exit port which is located proximally, in the middle or distally (see
Fig. 1.20). Once the SideKick has reached the implantation position, the SB
protection wire is inserted using the high torquability of the device. A clin-
ical study with 20 lesions showed a device success rate of 80%. One major
adverse cardiac event occurred due to a subacute stent thrombosis [78].
Figure 1.20: Comparison of two SideKick stent systems (Y-Med) with a differ-
ent location of the exit port (left panel: central location, right panel: proximal
location). Adapted from [79].
1.2.3.8 Stentys Coronary Bifurcation Stent
The Stentys Coronary Bifurcation Stent (Stentys, Paris, France) is a self-
expandable nitinol stent for provisional stenting. The 5 Fr rapid-exchange
delivery system requires one guidewire and is compatible with 7 Fr guid-
ing catheters. The positioning of the stent is facilitated by the four stent
markers (one proximal and three distal). After placement, the stent is ex-
panded in the MB by rectracting a constraining sheath. The nitinol design
is characterized by the small Z-shaped struts (strut thickness of 77µm) of
the circumferential ring elements. These ring elements are connected by
a number of small bridges but can be disconnected by balloon angioplasty
through the side of the stent. This unique feature provides the ability to
achieve good ostium scaffolding as the stent has the potential to expand to
a diameter of 7.5 mm (see Fig. 1.21). The procedural success of the device
is independent of accurate positioning in contrast to some other dedicated
bifurcation stents. It is claimed that the design is suitable for the majority
of bifurcation angles (30° to 70°) [80].
The 30 days results of the first-in-man study demonstrated the feasibility
and safety of the Stentys stent [81]. Procedural success was achieved in
39 of the 40 cases. The stent could not be positioned in one patient with
highly tortuous vessels. The stent struts at the SB ostium could not be
disconnected in two cases because the proximal part of the stent with non-
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disconnectable struts was covering the SB ostium. For this first-in-man
study, both a drug-eluting and a bare metal variant of the device were
used. The drug-eluting stent is coated on the abluminal side with a durable
polymer matrix (PESU) which contains paclitaxel.
Figure 1.21: Schematic illustration of the implantation of the self-expandable
Stentys device (Stentys) in the MB (top left), followed by the insertion and infla-
tion of an angioplasty balloon through the cell closest to the carina (top right and
bottom left). This dilation disconnects the struts (the drawings do not show the
bridge elements) and results in improved SB access and ostium scaffolding. The
bottom right panel shows the final stent shape. Courtesy Stentys.
1.2.3.9 Tryton Side-Branch Stent
The Tryton Side-Branch Stent (Tryton Medical, Massachusetts, USA) is a
balloon-expandable cobalt-chromium stent with a strut thickness of 84µm.
The stent design consists of three distinct stent zones as shown in Fig. 1.22:
a ‘distal side-branch zone’, a ‘central transition zone’ and a ‘proximal main
vessel zone’ [82]. The SB zone has similar design characteristics as standard
slotted tube stents and provides sufficient radial strength. The central tran-
sition zone consists in the circumferential direction of three panels, which
can be deformed independently [83]. This central zone is designed with the
intention to provide complete ostium scaffolding and to make the design
suitable for all bifurcation angles (15° to 90°). The proximal main vessel
zone has a very low strut density and consists of a proximal ring element
connected to the transition zone by three long axially oriented bridging
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elements. The stent can be implanted as a conventional stent using a sin-
gle guidewire and does not require rotational orientation. The longitudinal
positioning is facilitated by the four shaft markers: two standard markers
at the balloon ends and two additional markers delineating the transition
zone [82]. Two different delivery systems are available: a straight balloon
that has a constant diameter and a stepped balloon with a larger diameter
of the proximal part as compared to the distal part.
In all the cases of the first-in-man study involving 30 patients, the Tryton
stent was used in conjunction with a standard DES for the MB as depicted
in Fig. 1.22 [83]. This approach is very similar to Culotte stenting, but
the dedicated design reduces the area with a double layer of struts in the
proximal main vessel. The first-in-man study learned that predilatation of
the MB is essential to advance the MB stent through the struts of the Tryton
stent. The Tryton device is compatible with a 5 Fr guiding catheter, but a
6 Fr catheter is necessary to perform final kissing balloon after implantation
of the MB stent. The Tryton stent failed to track to the lesion site in one
patient [83]. At six months follow-up, the MACE rate (defined as cardiac
death, myocardial infarction, coronary artery bypass surgery or target lesion
revascularisation) was 9.9% and no restenosis in the SB was observed [84].
Figure 1.22: Schematic illustration of the Tryton device (Tryton Medical). The
implantation of the Tryton stent using a stepped balloon is depicted in the left
panel, which also indicates the three stent zones. The right panel shows the
placement of a conventional MB stent through the struts of the Tryton stent.
Courtesy Tryton Medical.
1.2.3.10 Twin-Rail
The Twin-Rail (Invatec, Roncadelle, Italy) is a stainless steel stent crimped
on two balloons in its proximal portion and only on the main vessel balloon
in its distal portion. The delivery system is compatible with a 6 Fr guiding
catheter and requires two guidewires. There is only one inflation port,
in contrast with the Nile Croco device which consists of two independent
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balloons, since the single dual lumen catheter splits into the two distal
balloons (see Fig. 1.23). Positioning of the stent is achieved by advancing
the system over the two guidewires up to the carina of the bifurcation. At
this point, no further advancement of the system is possible. The stent has
a variable design along its length and can be expanded to larger diameters
proximally than distally.
In 2005, Lefe`vre [85] presented the results of the DESIRE trial at the Trans-
catheter Cardiovascular Therapeutics meeting and concluded that the an-
giographic success was high despite the relatively low rate of device success
(75%) for this small cohort with 15 patients. At seven months, the target
lesions revascularization rate was 14.3%.
Figure 1.23: Twin Rail bifurcation stent system (Invatec). Adapted from [66].
1.2.3.11 Conclusions
The design and development of dedicated bifurcation stents is an extremely
fascinating technological challenge from an engineering point of view. There
are a large number of often conflicting design requirements and it is there-
fore not surprising that the perfect solution seems not yet to be found. Some
dedicated bifurcation stent systems have already been abandoned (e.g. AST
SLK View, Jostent bifurcation, Bard XT, Medinol NIRside, Cordis DBS,
etc.) because of their bulkiness, low flexibility and the technical complexity
to implant them. The previous sections summarized the main character-
istics of some of the devices currently available or under investigation and
clearly show the large variety of design concepts (e.g. self-expandable ver-
sus balloon-expandable stents, single balloon versus double balloon systems,
single wire versus double wire systems, SB versus MB stents, etc.). However,
this overview is not complete. More devices are currently being developed
but were not included due to a lack of available information. For example,
Medtronic and Abbott Vascular are currently developing dedicated bifurca-
tion stents based on their workhorse DES, the Endeavor and Xience V stent,
respectively. Hexacath (Rueil-Malmaison, France) investigates a double-
balloon stent system but also Boston Scientific further explores alternatives
to their Taxus Petal stent.
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Large trials are needed to evaluate all these different dedicated systems. One
device that will perfectly treat all types of bifurcation lesions will probably
never exist due to the large variety of both the bifurcation anatomy (e.g. an-
gle and diameter) and plaque location. Therefore, it is highly likely that
the current dedicated devices will be further improved in future and that
totally new concepts using for example biodegradable struts or drug-eluting
balloons will be investigated.
1.3 Bifurcation stent research
The previously described bifurcation stenting techniques are usually inves-
tigated and optimized using bench tests. A similar ‘trial and error’ based
experimental approach is in many cases the main tool to develop new (ded-
icated bifurcation) stents [75, 80, 86]. Computer simulations such as finite
element analysis (FEA) are less established as a research and development
tool in the domain of bifurcation stenting. However, a combined virtual-
experimental approach offers a number of advantages as compared to bench
testing only. The next sections give a literature overview of the main find-
ings resulting from bench tests and provide an introduction to finite element
stent analysis.
1.3.1 Bench testing
Many of the current insights in bifurcation stenting are based on the results
of bench (or in-vitro) testing. A number of groups have been active in this
domain but Dr. Ormiston and his co-workers (Mercy Hospital, Auckland,
New Zealand) can be considered the leading experts as they have published
numerous bench testing papers during the last decade [6, 75, 87–89]. They
studied several bifurcation stenting techniques and compared different stan-
dard and dedicated stents. Some of their methods and results will be shortly
mentioned in the following paragraphs but the interested reader is referred
to the original papers for more details.
1.3.1.1 Bench testing techniques
Briefly, bench testing of bifurcation stenting involves the deployment of one
or more stents within an in-vitro bifurcation model and visualization of
the resulting lumen, stent deformations, strut coverage and/or positioning.
Based on these observations, the techniques can be modified and guidelines
can be formulated regarding stent choice and procedural parameters such
as inflation pressure, balloon size and inflation sequence. The basis of this
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approach has remained unaltered since the first papers in 1999, but con-
siderable progress has been made regarding the bifurcation model and the
visualization, two crucial aspects of bench testing.
In the early days, photography was the main tool to visualize and analyse the
bifurcation stenting techniques [87, 90], while nowadays, micro-Computed
Tomography (micro-CT) has become the standard [6, 91, 92]. Micro-CT
allows generating three dimensional reconstructions which can be used to
examine the stents from different perspectives. Parts of the reconstructed
geometry can be removed to improve the clarity and ‘fly-through’ movies
can be created (Fig. 1.24). However, there are limitations to this approach
as reported by Ormiston et al. [6]: micro-CT imaging and the related re-
construction are expensive and time-consuming. In addition, simultaneous
visualization of the balloon, stent and bifurcation model proves to be ex-
tremely difficult due to the large density differences of the individual com-
ponents. A last limitation is related to the fact that only the final stent
configuration has been visualized up to now, although information of the
evolution of the strut deformation with increasing pressure would be very
useful. A dynamic movie of a deploying or deforming stent has not been
created yet due to a number of reasons: (i) The object should perfectly
maintain its shape and position during scanning, but has to rotate over
360°. This is much more complicated if the guide wire and balloon catheter
are present. (ii) This would be very time-consuming since every frame would
require a complete scan. (iii) During the transient expansion phase, it is
sometimes not possible to get a stable stent geometry.
The first bifurcation models were completely rigid and the set-ups allowed
to take the deformed stents out of the model [87, 90]. This was necessary
since photographs were used for visualization. These rigid models have now
been replaced by flexible silicone models, which lead to more realistic stent
deformations. Until now, most bifurcation models had a planar structure
except for the model created by Murasato [91]. In a simple way, he included
the three-dimensional structure of the left main coronary artery bifurcation,
by glueing silicone tubes on the outer surface of a cylinder with a diameter
of 7.5 mm. But as stated by Murasato [91], the observations made in these
in-vitro setups should be interpreted carefully, as they might not accurately
represent the phenomena occurring in human atherosclerotic vessels.
1.3.1.2 Applications
The focus of the first bench testing papers was on stent deformation after
dilatation through the side of the stent [44,87,90]. Such postdilatation may
be required to improve the access to the SB but distorts the stent within
the main vessel and compromises the MB lumen. MB redilatation or kissing
balloon postdilatation almost completely restores the main lumen.
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Figure 1.24: Micro-CT visualization of a Promus stent (Boston Scientific) after
kissing balloon postdilatation. The left panel shows a top view on both branches of
the bifurcation, while the right panel gives a view into the SB. The floating struts
at the SB ostium are clearly visible after removal of the struts at the opposite MB
wall.
The results of the two-stent bench studies also showed the importance of
performing final kissing balloon inflation to improve the stent expansion
and to correct distortion, regardless of the applied technique [6,88,89]. For
the crush technique, better results were obtained after a two step kissing
postdilatation as compared to a one step kissing postdilatation6 [6]. The size
of the stent cells is an important design parameter as a better expansion is
obtained after both culotte and crush stenting when using stents with large
cells [6,89]. It should be stressed that clinical studies are required to assess
whether or not these observations are clinically relevant.
1.3.2 Finite element analysis
Structural Finite Element Analysis (FEA) is a numerical technique used
to virtually predict and investigate the mechanical behaviour of structures,
such as cars, airplanes, mobile telephones and medical devices. Numerous
software programs are available, both commercial and non-commercial, that
perform FEA. The accuracy of the results obtained with these programs
depends on the user input. For each simulation, a geometrical model has
to be created and adequate material properties have to be assigned. In
6 A two step kissing postdilatation starts with an additional high pressure balloon post-
dilatation in the SB followed by the standard simultaneous kissing inflation.
36 Introduction
addition, realistic boundary and loading conditions have to be defined. FEA
gives additional information as compared to physical tests and allows to
study several ‘What if?’ scenarios addressing different materials, geometries
and loading conditions before devices are actually manufactured [93]. This
technique offers many advantages to investigate and compare currently used
stents and stenting techniques, but also to develop new stents where it has
the potential to reduce the time to market.
An extensive overview of the scientific literature regarding finite element
stent modelling in the period 1999-2007 is given by De Beule [94]. This re-
view clearly shows the considerable progress that has been made in this field
during the last decade. Two of the most noteworthy advances are the use of
more realistic arterial geometries and material models and the development
of more accurate device models. Although many papers contributed to the
current level of finite element stent modelling, some of the initially applied
approximations proved to be inaccurate. For example, one of these inaccu-
rate simplifications was to model the deployment of a balloon-expandable
stent by neglecting the balloon and applying a direct pressure on the in-
ner stent surface. This example clearly demonstrates the need to use FEA
in conjunction with physical testing in order to verify the accuracy of the
applied simplifications and to enhance the credibility of the obtained FEA
results.
During the last few years, there has been a significant increase in the number
of publications in the field of finite element stent analysis. More advanced
simulation techniques have been introduced and these techniques have been
applied to address a broad range of challenging research problems. Giving
a complete overview of all the work done in this research domain, starting
from 2008 till now, falls outside the scope of this thesis. However, a few
papers have been selected and each of these is briefly summarized in the
next paragraphs, mainly with the aim of illustrating the recent trends in
the field of finite element stent modelling.
Wu et al. [95] nicely illustrated the potential of using topology optimization
techniques by improving the design of a DES with drug reservoirs. The
optimized design had an increased stiffness and resulted in lower stresses
around the drug reservoirs while maintaining the volume of the reservoirs
and thus the loading capacity. In addition, care was taken that the final
optimized design was manufacturable.
Timmins and colleagues [96] studied the effects of varying stent design and
atherosclerotic plaque stiffness on the vessel wall stresses and on the final
lumen. The obtained results show that the stiffest design leads to a larger
lumen, but also causes the highest stresses within the vessel wall. The
difference in peak stress for the stiff and the less stiff stent was strongly
dependent on the plaque stiffness. Increasing the plaque stiffness results in
a more pronounced difference in peak stress. The authors conclude that
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stent design is more important when dealing with a rigid, calcified lesion.
The work of Gijsen et al. [97] demonstrated the feasibility of using virtual
stent expansions together with an in-vivo and patient based arterial model.
The 3D reconstruction of the artery was obtained by combining angiography
and IVUS as described in [98]. The simulation results reveal higher stresses
in the arterial wall behind the stent struts and in the regions where the
arterial wall was thin.
Finite element analysis is used to study many different aspects of stent
implantations, but the final goal of the majority of the studies is to better
understand stent mechanics in order to improve future stents and thus future
clinical outcomes. Using finite element modelling to investigate and explain
the results from completed clinical studies, as done by Zahedmanesh and
Lally [99] is of course a very nice approach to improve our understanding of
stent mechanics. They analyzed the two stents that were evaluated during
the ISAR-STEREO trial [100], a clinical study that identified strut thickness
as an independent predictor of in-stent restenosis (thinner struts results in
a lower restenosis rate). The results obtained by Zahedmanesh and Lally
support the hypothesis that arteries develop restenosis in response to injury
and also confirm the importance of using computer simulations during the
design phase of new stents.
The paper by Kouisis et al. [101] is a very nice example of how to combine
experimental testing with numerical analysis. The authors developed an
experimental setup that allowed to study the transient expansion of balloon-
expandable stents. The obtained experimental data was first used to develop
a finite element model to study this type of stents, and then also to validate
the numerical results. The authors conclude that the finite element results
are in satisfactory agreement with the experimental data.
Very recently, Gastaldi et al. [102] studied the provisional side branch ap-
proach. In particular, they investigated the impact of stent postioning on
the stent deformations after side branch dilation through the side of the
stent. For the studied closed cell stent design, the results clearly indicate
the importance of a cell perfectly aligned with the side branch. This ‘cen-
tral’ positioning results in a minimal obstruction of the side branch lumen
and may therefore reduce hemodynamic disturbances. It should, however,
be noted that the position of one cell with respect to the side branch can
not be controlled with a single wire system.
1.3.3 Conclusions
FEA has proven to be a powerful technique to study the mechanical be-
haviour of stents. This technique also has the potential to provide new
insights in the field of bifurcation stenting where bench testing is currently
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the main investigation and development tool. Bench testing research con-
tributed significantly to the current understanding of bifurcation stenting,
but is limited to manufactured stents only. Furthermore, it requires the
extensive use of advanced (expensive) visualization methods such as micro-
CT. In contrast, postprocessing the FEA results is inexpensive and leads to
a good (even dynamic) visualization of all components (e.g. balloon, stent
and artery). Furthermore, different device and procedural parameters can
be investigated prior to manufacturing. However, it should be stressed that
FEA should be used in conjunction with a limited number of physical tests
in order to assess the accuracy of the simulations and to enhance their
credibility.
1.4 Aim of the doctoral research
The objective of this thesis is to develop and use advanced computational
methods:
 to gain insights in the shortcomings of current stents and stenting
techniques used to treat bifurcation lesions.
 to define optimal design parameters for a bifurcation stent.
 to provide guidelines to interventional cardiologists regarding stent
selection.
 to virtually investigate and design new stents.
1.5 Organisation of the dissertation
The thesis is organised as follows:
 In chapter 2, a finite element model is described that allows to inves-
tigate the free expansion of balloon-expandable stents. This model is
used to study and optimize the mechanical behaviour of this kind of
stents.
 The most frequently applied bifurcation stenting technique is analysed
in chapter 3 by using numerical analysis. The virtually observed stent
deformations are compared to previously published bench testing re-
sults.
 A comparison of the impact of three different second generation drug-
eluting stents when being implanted in the curved main branch of a
coronary bifurcation is given in chapter 4. The advances with respect
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to the modelling of coronary bifurcations (patient-specific morphology
and anisotropic tissue properties) are described in detail.
 A quantitative analysis of the geometry of different stents is described
in chapter 5.
 In chapter 6, we applied the developed simulation strategies to investi-
gate the feasibility of a new dedicated bifurcation stent and a modified
procedure for provisional stenting.
 Finally, chapter 7 gives an overview of the major findings of the re-
search and contains some guidelines regarding stent design and selec-
tion. In addition, some suggestions for further research are included.
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Chapter 2
Advances in finite element
stent modelling
USING finite element simulations to study bifurcation stenting is nottrivial. All the individual components (balloon, stent, bifurcation)
have a complex geometry and undergo large deformations. These compo-
nents also interact with each other, leading to a difficult contact problem.
The presence of arterial tissue further complicates the simulations as this
inhomogeneous multi-layered structure displays anistropic mechanical be-
haviour. For these reasons, it is important to go step by step instead of
immediately jumping to full scale bifurcation stenting simulations. A first
crucial step to study bifurcation stenting using finite element analysis is to
develop validated models to study balloon-expandable stents as described
in the first part of this chapter. The second part describes a novel method-
ology to develop discretized models for existing stents. This method was
developed with the aim of reducing the amount of pre-processing1.
1 The contents of this chapter were published in the Journal of Biomechanical Engi-
neering:
Numerical study of the uniformity of balloon-expandable stent deployment
P. Mortier, M. De Beule, S. G. Carlier, R. Van Impe, B. Verhegghe, and P. Verdonck
130:021018(1–7), 2008
and in the journal, Medical and Biological Engineering and Computing:
Automated generation of a finite element stent model
P. Mortier, M. De Beule, D. Van Loo, B. Masschaele, P. Verdonck, and B. Verhegghe
46:1169–1173, 2008
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2.1 Uniformity of balloon-expandable stent
deployment
2.1.1 Introduction
The major drawback of coronary stenting is restenosis, the reoccurrence
of stenosis. This phenomenon is related to both arterial injury and an in-
flammatory response of the vessel wall against the stent struts. In the case
of BMS, restenosis occurs in more than 20% of the treated artery sections
[25,26,103]. This problem of renarrowing has been significantly reduced (to
approximately 10% [104, 105]) by the introduction of DES. These promis-
ing results were recently shadowed by concerns regarding thrombogenicity
and long-term outcomes [106]. In addition, ‘real-world’ cost-effectiveness
analyses showed that DES might only be cost effective compared to BMS
for elderly people and patients in specific high-risk groups [27]. Therefore,
efforts aiming at reducing the arterial injury caused by stent implantations
remain very meaningful.
Basically, vascular injury is due to a combination of stent-artery and
balloon-artery interactions, both of which depend among other things on
the stent design [107,108]. Examination of the patterns of endothelial dam-
age shows a higher incidence of injured zones at the stent ends [33, 109].
This observation has been explained by Squire [33] as the result of three
facts: (i) the stent expands in a nonuniform ends-first manner (dogboning),
causing high local contact stresses, (ii) an axial contraction of the geometry
during the stent expansion (foreshortening), and (iii) contact between the
balloon, which is longer than the stent, and the artery.
Computer simulation (e.g., FEA) can be a very useful tool to study and
optimize the stent expansion [110–113]. Several numerical studies discuss
nonuniform stent expansion without simulating the balloon [114–116], al-
though it has been experimentally shown by Squire [33] that nonuniform
stent expansion is related to both stent design and balloon length. The
same conclusion was drawn by Wang et al. [117] based on experiments and
FEA. Their simulations were performed by using a cylindrical (nonfolded)
balloon and were qualitatively validated. To the authors’ knowledge, all the
published numerical studies concerning stent expansions ignore the folding
pattern of the balloon and, consequently, the impact of the folding pattern
on the uniformity of the stent expansion remains unknown. Furthermore,
dogboning has always been considered at one specific moment in time, al-
though this phenomenon changes during the deployment of a stent.
Keeping the previous considerations in mind, the phenomenon of nonuni-
form stent expansion was numerically examined at each moment during the
deployment. More precisely, the consequences of combining different realis-
tic folded balloon catheters with a particular balloon-expandable coronary
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stent were investigated. Catheters with different balloon lengths and folding
patterns were used in the simulations and, consequently, this study allows
choosing the optimal balloon catheter for this specific new generation stent
design. Furthermore, the proposed methodology to obtain a uniform stent
expansion by selecting the most favorable balloon can easily be applied to
all balloon-expandable stents. Finally, attention has been paid to the im-
pact of relatively small positioning inaccuracies during the crimping process
on the expansion behavior. The crimping itself has not been incorporated
in the simulations, as it has been shown by De Beule et al. [118] that in-
cluding the crimping procedure has only a minor influence on the overall
stent expansion behavior. The numerical results of a reference model were
quantitatively validated by comparing the obtained pressure-diameter rela-
tionship with data provided by the manufacturer. In addition, the predicted
deformations were also qualitatively compared to an experimental stent de-
ployment.
2.1.2 Materials and methods
2.1.2.1 Balloon and stent geometry
The whole study is conducted on a three-dimensional stent geometry, re-
sembling the Cypher stent (nominal length of 8 mm, nominal diameter of
3 mm; Cordis, Johnson & Johnson, Warren, NJ). The geometry of the stent,
based on micro-computer-tomography images [119] was created using the
graphical finite element preprocessor ABAQUS/CAE. The length, and inner
and outer diameters of the crimped stent are 8.5 mm, 0.9 mm, and 1.2 mm,
respectively. The resulting strut thickness of 0.15 mm is also confirmed by
data provided by the manufacturer. The commercially available Cypher
stent is crimped on a Raptor balloon (nominal diameter of 3 mm; Cordis),
which is trifolded around the cylindrical catheter tube. This folding pattern
was confirmed by the obtained micro-CT images. The catheter tube was
included in the model as it interacts with the balloon during the unfold-
ing process. The diameter of this tube is considered to be 0.6 mm. The
cylindrical part of the balloon has a length of 10.5 mm, resulting in an over-
length of 1 mm at both stent ends. Finally, the uniform balloon thickness
is considered to be 0.02 mm.
2.1.2.2 Constitutive models
The Cypher stent is made of 316L stainless steel. Before stent expansion,
the stainless steel stent struts are subjected to a range of manufacturing pro-
cesses, which influence the constitutive response of the struts. Consequently,
the material properties should ideally be obtained from tests performed on
stent struts themselves. Therefore, the mechanical properties to describe the
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inelastic behavior are based on the results published by Murphy et al. [120],
who carried out tensile tests on similar stent struts. The impact of using
such data instead of a more general constitutive law for 316L stainless steel
is considerable [121]. The mechanical behavior is described using a Von
Mises plasticity model with isotropic hardening. Young’s modulus, Pois-
son’s ratio, and the yield stress are 196000 N/mm2, 0.3, and 375 N/mm2,
respectively [120].
The semicompliant Raptor balloon is fabricated from Duralyn, a nylon
based material. The constitutive behavior of this material is based on a
pressure/diameter relationship that is provided by the manufacturer for
pressures higher than 0.2 N/mm2. Values according to lower pressures were
obtained by extrapolation, resulting in an initial diameter of 2.85 mm at
the unpressurized state. The geometry of the trifolded balloon has been
developed consistent with this initial diameter, the inner diameter of the
stent, the balloon thickness, and the diameter of the cylindrical catheter
tube. The methodology used to deduce the constitutive law of the balloon
from pressure/diameter data is in accordance with the thin shell membrane
theory [122] and results in stress/strain data, which are approximated by
Young’s modulus of 920 N/mm2. In addition, the balloon material is char-
acterized by a Poisson’s ratio of 0.4.
These material properties have been numerically verified by expanding a
cylindrical balloon (initial diameter of 2.85 mm) with tapered ends, as de-
picted in Fig. 6.2. Because of symmetry considerations, the computational
time could be decreased by simulating only half of the balloon in the longi-
tudinal direction. The application of a linear elastic constitutive model was
satisfactory, as the maximum percentage difference in diameter between the
original manufacturer’s compliance chart and the numerical results is only
0.55% (at p=0.8 N/mm2).
The third part of the stenting device, the catheter tube, is modeled as a rigid
cylinder since the tube is relatively stiff compared to the balloon membrane.
This approximation of reality is acceptable for the simulations undertaken
in this work. In the case of flexibility tests, a more detailed constitutive
model for the catheter tube would be required.
2.1.2.3 Boundary conditions
The tapered ends of the balloon are not taken into account in the folded
balloon model. As a result, axial stresses (resulting from the pressure acting
on the tapered ends in the longitudinal direction) have to be imposed to
the folded balloon. This was done by applying a pressure dependent axial
elongation to the balloon, starting from 0 mm (initial state) to 0.043 mm at
a pressure of 1.5 N/mm2. These values are valid for the 10.5 mm balloon
and are obtained from the numerical expansion of the cylindrical balloon
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Figure 2.1: Numerical inflation of a cylindrical balloon (only half of the balloon
was simulated because of symmetry).
model, which was described above. Adapted values have been used for every
balloon length as these axial elongations are balloon length dependent. In
order to avoid rigid body motion of the stent, six central nodes lying in the
midsection are constrained in both longitudinal and tangential directions.
Finally, the catheter tube is completely constrained in all directions.
2.1.2.4 Discretization
The stent geometry was meshed with 30112 linear eight-node hexahedral
elements (C3D8R) using the preprocessing capabilities within ABAQUS/-
CAE. The regions of the stent geometry subjected to minor deformations
during the stent expansion were meshed with larger elements. The trifolded
balloon (with a length equal to 10.5 mm) consists of 58386 four-node quadri-
lateral membrane elements (M3D4R), but this number varies depending on
the balloon length and the folding pattern. The catheter tube was modeled
with 3410 four-node bilinear rigid quadrilateral elements (R3D4). Further
mesh refinements were unnecessary, since the radial displacements obtained
with a higher number of elements (i.e., stent: 53655, balloon: 103950, and
catheter: 7040 elements) changed less than 1%. A part of the meshed stent-
ing device is visualized in Fig. 2.2.
2.1.2.5 Finite element simulations
All the stent expansion simulations were carried out using the ABAQUS
finite element package. In particular, the ABAQUS/EXPLICIT solver was
used for the highly nonlinear calculations, which additionally involve a com-
plex (self-)contact problem. The general contact algorithm has been used
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Figure 2.2: Meshed section of the balloon-catheter-stent model.
in order to handle the interactions between the balloon, the catheter tube,
and the stent. Friction has been included in the simulations by means of
a Coulomb friction model with a static friction coefficient of 0.2 (valid for
both nylon-nylon and nylon-steel interactions under clean conditions).
The time period of the quasi-static stent expansion process has been de-
creased with the aim of reducing the computational time. The main prob-
lem is that as the event is accelerated, the presence of inertial forces may
modify the response of the system. Energies were monitored during the
stent expansion in order to assure that the inertial forces were acceptable.
During most of the expansion process, the ratio of kinetic to internal en-
ergy of the whole model was less than 5%. Only during the short transition
period between the crimped and the expanded state the ratio was slightly
higher and a maximum of 8% was reached.
Several numerical simulations have been carried out to investigate the im-
pact of combining different realistic balloon catheters with the Cypher stent
geometry. The simulation, which incorporates the correct balloon length
(i.e., 10.5 mm) and folding pattern (i.e., trifolded), was compared to the
pressure-diameter relationship provided by the manufacturer and is termed
reference simulation. In addition, a qualitative validation was performed
by comparing the reference simulation with the experimental deployment
of one Cypher stent which was visualized using micro-CT. The obtained
results from this reference simulation served as a basis for the analysis of
subsequent numerical calculations (see Table 2.1).
Simulations A-J concentrated on the influence of the balloon length on the
uniformity of the stent expansion, while keeping the folding pattern of the
balloon. Then, Simulation K was carried out to examine the influence of
altering the folded shape from a trifolded to a sixfolded balloon, as shown
in Fig. 2.3. In accordance with the trifolded balloon, the sixfolded balloon
has been developed consistent with the initial balloon diameter, the stent
inner diameter, the balloon thickness, and the diameter of the cylindrical
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Table 2.1: Overview of the different models and their characteristics. Axial stent
position refers to the position of the stent on the balloon catheter.
Simulation
Balloon length
[mm] Folding pattern
Axial stent
position
Reference 10.5 trifold central
A 10.3 trifold central
B 10.1 trifold central
C 9.9 trifold central
D 9.7 trifold central
E 9.5 trifold central
F 9.3 trifold central
G 9.1 trifold central
H 8.9 trifold central
I 8.7 trifold central
J 8.5 trifold central
K 10.5 sixfold central
L 10.5 trifold non-central
M 10.5 sixfold non-central
catheter tube. Finally, the influence of positioning inaccuracies was studied
in Simulations L and M by axially translating the previously centrally placed
stent over 0.1 mm. All finite element simulations were carried out on an in-
house built low-cost, high performance computing cluster. With the aim
of quantifying the uniformity of the stent expansion during inflation, the
following dogboning (DB) and asymmetry (AS) coefficients are introduced:
DB =
Rmax(distal,proximal) − Rcentral
Rmax(distal,proximal)
(2.1)
AS =
Rmax(distal,proximal) − Rmin(distal,proximal)
Rmax(distal,proximal)
(2.2)
Rmax(distal,proximal) and Rmin(distal,proximal) stand, respectively, for the max-
imal and the minimal value of the two end radii of the stent measured at
the inner surface at a specific moment during the inflation. This can be
the distal or the proximal radius. This distinction is necessary as the stent
ends may not have the same radii at the same moment during the stent
expansion. Rcentral is the inner radius of the stent midsection.
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Figure 2.3: Comparison of a trifolded (left) and a sixfolded (right) balloon.
Both folding patterns are based on the same initial balloon diameter, namely, Do
= 2.85 mm.
2.1.3 Results and discussion
2.1.3.1 Validation of the reference model
The expansion of the reference model is shown in Fig. 2.4. The stent deploys
in a nonuniform ends-first manner (dogboning) as depicted in the central
panel of Fig. 2.4. The bottom panel shows the stent configuration, which is
reached at a pressure of 1.5 N/mm2. The results of this reference simulation
are quantitatively validated through comparison with data provided by the
manufacturer. In particular, the relation between the central inner diameter
and the applied pressure is considered (compliance chart) as the companies
always deliver such a chart for balloon-expandable stents (Fig. 2.5). The
maximum percent difference in diameter occurs at a pressure of 1.4 N/mm2
and is an underestimation of 4% compared to the manufacturer data. Con-
sequently, our model corresponds well to the provided compliance chart and
serves as a solid, validated basis for further parametric studies.
In addition to the good quantitative agreement with the manufacturer data,
the simulation results correspond well with the qualitative experiment dur-
ing which the deployment of the Cypher stent was visualized using micro-
CT (see Fig. 2.6). Furthermore, the specific deployment pattern in the low
pressure range (i.e., the rapid increase in stent diameter when the inflating
pressure reaches a certain value) and the dogbone shape were also observed
experimentally.
2.1.3.2 Influence of the balloon length
The stent geometry during the transient expansion phase for Simulations E
and J and the reference model is shown in Fig. 2.7. In contrast to the refer-
ence simulation, stent Model J with the shorter balloon length (8.5 mm) does
not open in an ends-first manner. For the Model E with the intermediate
balloon length, the diameters of the stent ends during the transient phase
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Figure 2.4: Expansion of the reference model (trifolded balloon with a length
of 10.5 mm): before inflation (top); transient phase (middle) corresponding to a
pressure between 0.3 MPa and 0.4 MPa (during the transient expansion phase,
the balloon unfolds and the stent diameter rapidly increases); situation after this
transient expansion (pressure higher than 0.4 MPa, bottom).
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Figure 2.5: Quantitative validation of the reference model: the maximum per-
cent difference in diameter between the numerical results and the compliance
chart provided by the manufacturer is 4.1% and occurs at a pressure of 1.4 MPa.
The steep part (pressure between 0.3 MPa and 0.4 MPa) of the curve obtained by
simulation corresponds to the transient central shape from Fig. 2.4.
are only slightly larger than the central diameter, but this phenomenon is
less pronounced compared to the reference model. The dogboning coeffi-
cient (whose value changes during the expansion of a stent) is an appropri-
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Figure 2.6: Qualitative validation of the Cypher stent expansion: the left side
shows the virtually predicted deformations while the right part of the image dis-
plays the micro-CT visualization of the stent deployment.
ate parameter to quantify these observations. For the reference simulation,
this coefficient is 0% at the start of the inflation (Fig. 2.4, top, cylindrical
shape), reaches a maximum of 59% during the short transient expansion
phase (Fig. 2.4, center) after which it decreases again, and finally becomes
approximately 2% at high pressures (Fig. 2.4, bottom, cylindrical shape).
In order to obtain a uniform stent deployment, the maximum value of this
dogboning coefficient during inflation should be kept as low as possible.
Therefore, these maxima have also been determined for models A-J and are
visualized in Fig. 2.8, which shows a strong relation between the balloon
length and the maximum observed dogboning coefficient during the differ-
ent stent expansions. These results can be used to determine the maximum
balloon length that should be combined with a particular stent design in
order to avoid dogboning.
Wang et al. [117] have also investigated the relationship between balloon
length and dogboning by finite element modeling. However, they apply an
increasing pressure on the stent by using a cylindrical balloon with ‘virtual’
material properties. The accuracy of this approximation is still unknown,
as the validation is purely qualitative, whereas the model proposed here
has been quantitatively validated. Furthermore, examining the impact of
using a different number of folds is not possible when discarding the folding
pattern. Nevertheless, this approach remains interesting for balloon length
investigation because the computational effort can be reduced.
Besides the impact of the balloon length on the vascular injury by dogbon-
ing, the balloon itself can cause endothelial damage by direct balloon-artery
interactions [33,108]. As a result, the balloon overlength should be reduced
in order to decrease the balloon-artery contact area at the stent ends. Luck-
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Figure 2.7: Transient expansion shape for Model J (top), Model E (center), and
the reference model (bottom). A shorter balloon length results in a decreased
dogbone effect.
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Figure 2.8: Relationship between the balloon length and the maximal dogboning
coefficient during the transient expansion phase. A more uniform expansion is
obtained by decreasing the balloon length.
ily, these two causes of vascular injury (dogboning and balloon-artery con-
tact) result in the same guideline for the balloon length, namely, that this
length should be kept as small as possible. If a reduction in the balloon
length fails to eliminate dogboning, the stent geometry should be modified,
as dogboning also depends on this geometry [114–117]. In particular, the
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stiffness of the stent ends has to be increased. However, too large an in-
crease will result in an opposite (unwanted) effect (i.e., larger diameter of
the central part of the stent compared to the diameter of the stent ends).
Therefore, the modification of the stiffness should be done with great care.
2.1.3.3 Influence of the folding pattern
A comparison of the results from the reference model with those obtained
from Simulation K is shown in Fig. 2.9. This comparison allows the iden-
tification of the impact of the folding pattern, as all the other variable
parameters (e.g., balloon length) remain unchanged. During the transient
stent expansion, one can observe that the balloon bulges out through some
of the stent openings. As can be seen in Fig. 2.9 (left panel), the trifolded
balloon results in large balloon protrusions in three of the six stent cells
in that cross section. These strongly protruding parts of the balloon cause
larger stent openings at these locations, leading to a nonuniform stent strut
distribution (the maximal angle between two struts is 71 degrees while a
uniform strut distribution corresponds with an angle of 60 degrees). This
nonuniform behaviour was also observed experimentally with micro-CT at
the end of the transient expansion phase (see Fig. 2.9, central panel). As the
number of balloon protrusion (3) corresponds with the number of balloon
folds (3), one should expect that using a sixfolded balloon would result in
a more uniform strut distribution. Indeed, a finite element simulation was
conducted using a sixfolded balloon and a uniform strut distribution was
obtained. This may be an important finding as the uniformity of the strut
distribution affects the tissue scaffolding and the drug delivery in case of
DES.
Figure 2.9: Cross section at the end of the transient expansion phase, show-
ing that a trifolded balloon causes a nonuniform strut distribution (left panel:
simulation; center panel: experiment), whereas a sixfolded balloon (right panel:
simulation) results in a homogeneous strut placement.
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2.1.3.4 Influence of small positioning inaccuracies
The results of Models L and M are shown in Fig. 2.10. Moving the stent
over a small distance (i.e., 0.1 mm) in the longitudinal direction results in
a totally different deployment pattern during the transient phase. Such an
axial translation can be due to positioning inaccuracies during the crimping
process. The stent end corresponding to the longest free balloon end opens
first, because at that end, the same pressure acts on a larger balloon surface.
Results are summarized in Table 2.2 in terms of dogboning coefficients and
coefficients of asymmetry. The coefficient of asymmetry is strongly related
to the position of the stent on the balloon catheter. For the trifolded bal-
loon, the already existing asymmetric expansion of a centrally placed stent
is reinforced by a small axial translation of the stent (coefficient changes
from 34% to 64%). This difference is more pronounced in the case of a six-
folded balloon. A central stent position causes an approximately symmetric
deployment (7%), while a noncentral placement leads to severe asymmetry
(47%). Consequently, minor positioning inaccuracies of the stent should be
avoided, as this leads to asymmetric stent expansions. In the future, more
advanced computer models taking into account the exact stent geometry
and incorporating the balloon ends could be used to tune manufacturing
processes. More precisely, for a given balloon-stent combination and an al-
lowed asymmetric expansion value, the maximum balloon eccentricity could
be calculated.
Figure 2.10: Transient expansion shape for Models L and M. A noncentrally
placed stent results for both folding patterns in a strongly asymmetric expansion.
2.1.4 Limitations
In this study, the balloon ends were discarded from the model. Creating
a balloon model that takes into account both the folding pattern and the
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Table 2.2: Influence of small positioning inaccuracies on the uniformity of the
expansion.
Simulation Folding pattern
Axial stent
position DB (%) AS (%)
Reference trifold central 59 34
K sixfold central 54 7
L trifold non-central 60 64
M sixfold non-central 58 47
balloon ends is a complex problem. Possible ways to overcome this limita-
tion is to directly use a CT based 3D reconstruction of the folded balloon
or to create the folded geometry by applied a coordinate transformation
on the nodal coordinates of an unfolded balloon as proposed by Laroche et
al. [123].
It has been shown that the longitudinal position of the stent on the balloon
catheter has a considerable impact on the symmetry of the expansion, but
the clinical consequences of this observation are still unknown. Therefore,
future numerical models will incorporate the artery and this will allow to
study the resulting stresses in the vessel wall. Including the artery in the si-
mulation models can also be useful to investigate the impact of the presence
of the artery on the obtained stent diameters, since it has been observed
using intravascular ultrasound that in clinical practice, the stents will only
reach on average 75% of the predicted diameter [124], as a consequence of
complex interactions with the atherosclerotic plaque forming the coronary
stenosis.
2.1.5 Conclusions
The proposed stent modeling strategy incorporates the folding pattern of
the balloon. This approach results in a very close quantitative agreement of
our results and the manufacturers’ compliance chart. The model also shows
good qualitative agreement with the experimentally observed stent deploy-
ment. This validated numerical model has been used as a basis for further
investigation of several parameters, such as balloon length, folding pattern,
and relative position of stent with respect to the balloon catheter. It was
shown that changing these parameters can have an enormous influence on
the transient stent expansion behavior. Therefore, the proposed methodol-
ogy can be used to select the most appropriate balloon length and folding
pattern for a particular stent design. Furthermore, it has been shown that
small positioning inaccuracies (e.g., during the crimping process) can con-
siderably modify the stent deployment. Consequently, the positioning of
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the stent on the balloon catheter should be done with the greatest care and
accuracy.
2.2 Automation of pre-processing
2.2.1 Introduction
The applicability of the current finite element stent models is restricted by
the required amount of preprocessing and computational effort, which is
significant. As a result, there is a continuous need to reduce the time cost
of the complete process, from stent sample to simulation. This can be done
by using acceptable model simplifications, such as the one proposed by Hall
and Kasper [125]. They have shown that approximating the stent geometries
with beam elements yields acceptable results when studying the global stent
stress state after expansion and considerably decreases the computational
time.
In addition to the computational cost, there is a considerable effort needed
to obtain accurate finite element meshes (beam and/or solid) starting from
existing stent geometries. The commonly used procedure involves different
manual time-consuming steps: (1) determination of the stent dimensions,
(2) creation of the 3D CAD model, and (3) mesh generation [112, 115, 126,
127] (Fig. 2.11). Furthermore, this procedure may fail to accurately replicate
existing stent designs, because nonuniform deformations resulting from the
crimping process (i.e., a fixation of the stent on a folded angioplasty balloon
by reducing its diameter) are not taken into account.
Therefore, we investigated the feasibility of a novel strategy to create meshed
stent models for finite element analysis starting from stent samples in a semi-
automated way. The method is based on automatic centerline extraction
from a triangulated surface and yields a beam mesh accurately representing
the stent geometry. Such a triangulated surface is obtained from micro-CT
images after segmentation and 3D reconstruction. Micro-CT reconstruction
of stent geometries has been used in the past [128]. However, these works
were related to computational fluid dynamics and a method to create a
suitable mesh for finite element analysis starting from a reconstructed stent
has not been proposed yet. The feasibility and time-effectiveness of the
proposed methodology is demonstrated for the MULTI-LINK Vision stent.
2.2.2 Materials and methods
The micro-CT setup used for this investigation consists of a Feinfocus X-
ray tube with beryllium exit window, a sample manipulator with air bearing
rotation stage and a Varian Paxscan 2520 V X-ray flat panel detector [129].
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Figure 2.11: Two different strategies can be used to obtain a finite element
mesh starting from a stent sample. The left pathway illustrates the previously
used methodology, which involves several manual steps. The different steps of
the alternative (semi-automated) strategy presented here are shown in the right
pathway.
For the measurements we used the X-ray tube at 80 kV and 2.7 W which
results in a focal spot size of 3µm. The detector was used in binning mode
with a pixel size of 254µm. The field of view of the detector is 200 mm
(width) by 160 mm (height). The distance between the source and the
detector was 880 mm and the distance between the center of the stent and
the X-ray source was 36 mm. This geometry results in a magnification of
24 times and a CT voxel size of 10.6µm. The total scan time was 6 min for
900 projection images.
For this study, one commercially available stent was selected and scanned
in its crimped state: the MULTI-LINK Vision (nominal diameter 3 mm,
nominal length 8 mm, Abbott Vascular). The CT reconstruction was con-
ducted with OCTOPUS software2. Mimics (Materialise, Leuven, Belgium)
was used for the segmentation and 3D reconstruction3. The software pack-
age uses simple gray-value thresholding on the CT-slices in order to obtain
a 3D mask of the object of interest. This mask could be considered as a
large 3D matrix with Boolean values in each of its element, determining
2 http://www.xraylab.com
3 http://www.materialise.com/mimics
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whether the element is part of the virtual object or not. This mask is then
used to derive a triangulated mesh which is further processed by triangle
reduction and smoothing operations using MAGICS (Materialise, Leuven,
Belgium), the integrated remeshing feature of MIMICS.
An approximated centerline was determined starting from the triangulated
surface using pyFormex, open-source software currently under development
at our institution [130]. The main steps in the applied centerline algorithm
are:
1. Calculation of the Delaunay tessellation [131].
2. Calculation of the embedded Voronoi diagram [131].
3. For each Voronoi vertex (i.e., the circumcenter of a Delaunay tetrahe-
dron), the radius of the corresponding Voronoi sphere is computed.
4. The Voronoi vertex with the largest corresponding radius is added
to a new list and all Voronoi vertices within this Voronoi sphere are
deleted. This is repeated until all Voronoi vertices are deleted. The
result is a subset of the original list of Voronoi vertices.
5. Two Voronoi vertices from the subset are connected if the distance be-
tween these two vertices is smaller then the sum of their corresponding
radii.
The resulting centerline consists of connected line segments, that can di-
rectly serve as a finite element beam mesh. The beam section can be esti-
mated from the triangulated surface. A flow chart of the complete process
is depicted in Fig. 2.11.
The MULTI-LINK Vision stent was virtually expanded using both the stan-
dard pathway and the new approach (based on the centerline calculation)
in order to verify the accuracy of the new method. The simulations were
performed with the ABAQUS finite element solver (Dassault Syste`mes).
The two beam models were deployed to a 3 mm diameter by increasing the
radius of a rigid cylinder [126]. The foreshorting, defined as (lo−l)lo , was
calculated for both stent models (lo is the stent length in crimped state, l
is the stent length in expanded state).
2.2.3 Results and discussion
The resulting finite element beam mesh (or centerline) is depicted in
Fig. 2.12 (bottom panel) and was obtained from the surface mesh containing
171110 triangles within few minutes on a standard desktop computer (2 Ghz
processor). The mesh consists of 2268 beam elements and accurately resem-
bles the MULTI-LINK Vision stent geometry. This mesh can be used to
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simulate the stent expansion and/or to investigate the mechanical behaviour
of the stent [125,132].
Figure 2.12: The top panel shows a photograph of the stent. The surface
mesh obtained after segmentation of the CT-images is shown in the middle panel.
The resulting finite element beam mesh obtained by centerline determination is
depicted in the bottom panel.
Figure 2.13 shows the comparison between two virtually deployed MULTI-
LINK Vision stents. The simulation based on the traditional approach (2046
beam elements) is depicted in panel A, whereas the beam mesh in panel B
is based on the new approach involving the centerline computation. The
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expanded stent geometries are very similar and this is also quantitatively
reflected by the foreshortening, which is identical in both cases (i.e., 2.5%).
Consequently, the beam mesh obtained by calculating the centerline seems
an accurate alternative to a traditionally created beam mesh.
Traditional approach Centerline approach
Figure 2.13: Comparison of the simulation results using two different methods
to create the stent geometry. The simulation based on the traditional approach
is depicted in the left panel, whereas the beam mesh in the right panel is based
on the new approach involving the centerline computation.
Although the finite element beam mesh is automatically created from a
triangulated surface, a certain amount of manual work is still required to
obtain this surface mesh starting from a stent sample. This manual work
is necessary to prepare the micro-CT setup (positioning of the sample) and
to segment the images (e.g., choice of threshold and visual check of the ob-
tained surface mesh). Nevertheless, this method assures an accurate repre-
sentation of the investigated stent geometry, including the inhomogeneous
deformations resulting from the crimping process. Furthermore, this ap-
proach may allow creating solid meshes in a semi-automated manner by
sweeping the mesh along the centerline. Such a solid mesh may be required
for very detailed stress analyses.
The triangulated surface depends on the threshold used during the segmen-
tation process. Using a lower or higher threshold value may slightly modify
the estimated strut cross-section. Using images with a voxel size of 10.6µm,
this means that the stent strut is approximately 20µm smaller if 2 voxels
are removed by using a different threshold, which is important for a stent
with struts of approximately 80µm. However, the impact of the applied
threshold on the resulting centerline will be small on condition that the
surface mesh is not connected at locations where two separate struts come
close to each other (Fig. 2.14). A second micro-CT scan was performed
using a higher resolution (CT voxel size of 1.05µm) in order to obtain a
more accurate estimate of the strut cross-section (see Fig. 2.15), which is
required for the definition of the beam elements. Using this high resolution,
only a small portion of the stent could be scanned.
60 Advances in finite element stent modelling
A
B
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Figure 2.14: A and B: The same stent geometry using a different segmentation
threshold. The resulting centerline in both cases is almost identical and therefore,
the applied threshold has a limited impact on the resulting centerline. However,
the centerline can be modified by the segmentation threshold in case that the
reconstructed stent geometry contains connections between different struts which
are not connected in reality (C).
Figure 2.15: A second micro-CT scan was performed using a higher resolution
(CT voxel size of 1.05µm) in order to obtain a more accurate estimate for the
strut cross-section (see right panel). Only a small portion of the stent was scanned
at this resolution.
A limitation of the proposed approach is that the size of the elements of
the finite element beam mesh is determined by the centerline algorithm and
is independent of the curvature of the stent struts. However, it may be
necessary to have more elements in regions of sharp geometry transitions.
Furthermore, it should be emphasized that the developed strategy is meant
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to create a finite element mesh of existing stent designs in order to compare
their mechanical behavior. The method does not provide the possibility
for parametric modeling, which is useful during the design phase of new
devices [94]. It is mainly because of this reason that parametric stent meshes
were created using the traditional approach for the studies described in the
remaining chapters.
2.2.4 Conclusion
Studying the mechanical behavior of current stenting devices by using fi-
nite element simulations is sometimes time-consuming, partially because
the different manual steps that occur during the preprocessing phase. We
developed a new methodology to automate the process of generating a finite
element beam mesh starting from a stent sample. The proposed strategy
is time-effective and results in a beam mesh, accurately representing the
investigated stent geometry.
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Chapter 3
Accuracy of finite element
analysis of side branch
access during provisional
stenting
THE developed methodologies to simulate the mechanical behaviour ofballoon-expandable stents can now be applied in the field of bifurcation
stenting. The main goal of this chapter is to prove the feasibility of using
finite element analysis in this domain by comparing the numerical results
with previous bench test observations1.
3.1 Introduction
Stenting the MB only (often referred to as provisional stenting) is currently
the preferred strategy to treat bifurcation lesions as stenting both branches
applying a complex technique seems to offer no advantages [5, 40, 58]. This
approach offers the possibility of placing a second stent in the SB in case of
suboptimal results (e.g., T-stenting). Provisional stenting compromises the
access to the SB due to obstructing stent struts. Balloon dilatation through
the side of the MB stent can improve the SB patency (Fig. 3.1).
1 The contents of this chapter were published in the journal, Medical Engineering and
Physics:
Finite element analysis of side branch access during bifurcation stenting
P. Mortier, M. De Beule, D. Van Loo, B. Verhegghe, and P. Verdonck
31:434–440, 2009
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Stent
Side branch
Main branch
Balloon
Step 1
Step 2
Figure 3.1: Concept of SB balloon dilatation through the MB stent.
Ormiston et al. [87] performed in vitro experiments in order to study the
stent deformations following to SB dilatation. They have shown that such
a balloon inflation results in unwanted distortions of the stent, compromis-
ing the downstream MB lumen. Their results also evidenced the need for
final kissing balloon inflation (i.e., simultaneous dilatation of MB and SB)
or MB redilatation. These in vitro tests require a large number of (expen-
sive) stent samples. Even more stents will be needed to investigate other,
more complex techniques, involving two or three stents, such as the crush
technique, culotte stenting, etc. This may explain the scarcity of in vitro
studies in the domain of bifurcation stenting. Therefore, computer models
addressing these complex stenting techniques may be a valuable research
tool complementing experimental studies. Numerical models have already
proven to be a useful tool to investigate the free expansion [94,115,126,127]
and the fracture behaviour [133] of these devices, but also to study the
supraphysiological loading state in the arterial wall after stent implanta-
tion [112,113,132,134]. Using numerical models to study bifurcation stent-
ing may also help in this specific field to understand the shortcomings of
current clinical techniques and devices.
Therefore, an innovative simulation strategy is described to study SB bal-
loon dilatation through a stent implanted in the MB. The proposed method-
ology incorporates the interactions between balloon, stent and arterial wall,
and also the nonlinear material behaviour of the artery is taken into ac-
count. The value of the described model is in its ability to compare different
balloon-stent combinations. This is illustrated by investigating the impact
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of using two different balloon sizes (2.5 and 3 mm) and two commercially
available stent designs (Cypher and MULTI-LINK Vision) on the stent cell
deformation and on the global stent distortion. The deformed stent cells
are quantitatively analysed in order to allow easy comparison between the
different balloon-stent combinations. The proposed computer model pro-
vides a useful tool for stent designers to create dedicated bifurcation stents
and may help clinicians to choose the optimal balloon size and stent design.
3.2 Materials and methods
3.2.1 Geometry
For this study, two commercially available stents were selected: the Cypher
(nominal diameter 3 mm, nominal length 8 mm, Cordis, Johnson & John-
son) and the MULTI-LINK Vision (nominal diameter 3 mm, nominal length
8 mm, Abbott Vascular) balloon-expandable stents. These nominal dimen-
sions are provided by the manufacturers and should be obtained at a pres-
sure of 10 atm (Cypher) or 9 atm (MULTI-LINK Vision). CT-images were
used to determine the main stent dimensions and the 3D stent models were
created based on these measurements (see Fig. 3.2). The length, inner di-
ameter and strut thickness of the crimped Cypher stent are, respectively
8.5, 0.9 and 0.15 mm. For the MULTI-LINK Vision stent, these values are,
respectively 7.9, 0.895 and 0.08 mm.
Figure 3.2: 3D model of Cypher (left) and MULTI-LINK Vision (right) stent.
The semi-compliant Raptor balloon catheters (Cordis, Johnson & John-
son) with nominal diameter 2.5 and 3 mm were used for the SB balloon
dilatation. Micro-CT images clearly revealed the trifolded configuration of
these commercially available balloon catheters [126]. Figure 3.3 shows the
balloon catheters in an idealized folded configuration used for the simu-
lations. These approximated folded balloon geometries are based on the
initial diameters (i.e., at 0 MPa) which were obtained by extrapolation of
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Table 3.1: Material properties for SS316L and L605 Co-Cr alloy.
Alloy Young’s modulus Yield stress Poisson’s ratio
SS316L 196000 MPa 375 MPa 0.30
L605 Co-Cr 243000 MPa 629 MPa 0.35
the pressure-diameter data provided by the company (only available for
pressures higher than 0.2 MPa). A uniform membrane thickness equal to
0.02 mm is assumed for both balloon catheters. Both folded configurations
have an outer diameter of 0.88 mm.
Figure 3.3: Geometrical models representing trifolded Raptor balloon catheters
with a nominal diameter of 2.5 mm (left panel) and 3 mm (right panel).
The bifurcation geometry is determined by the angle of intersection, MB
inner diameter, SB inner diameter and wall thickness, which was supposed
to be uniform. These four parameters are, respectively 45°, 3, 2.5 and
0.5 mm.
3.2.2 Constitutive behaviour
The Cypher stent is laser-cut from a stainless steel 316L tube in contrast
to the tubes used to manufacture the MULTI-LINK Vision stent that are
made from L605 cobalt-chromium alloy. Material properties for these alloys
were taken from literature [120,135] and are summarized in Table 3.1.
The Raptor balloon catheters are made from Duralyn, a nylon-based ma-
terial. Material properties for both balloon catheters were derived starting
from the compliance data provided by the manufacturer. The followed
approach is based on the thin shell membrane theory [122] and results in
stress-strain data which are approximated by a Young’s modulus of 600 and
920 MPa, for the 2.5 and 3 mm balloon catheter, respectively. The different
Young’s moduli are a result of the membrane thickness, which was consid-
ered to be the same for both balloon catheters. Poisson’s ratio is set to
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0.4. The compliance of both balloon catheters was validated by inflating a
cylindrical balloon (with the same initial diameter as the one used for the
folded configuration) with tapered ends and comparing the results in terms
of pressure-diameter with the original compliance data. The arterial wall
behaviour was modelled using a homogeneous isotropic hyperelastic law as
described by Prendergast et al. [136].
3.2.3 Simulation details
During a first simulation step, a stent was expanded in the MB by enforcing
a radial displacement to a cylindrical balloon until the cylinder reached a
diameter of 3 mm. De Beule et al. [126] have shown that this expansion
strategy yields good results to study free expanding stents in the high-
pressure range. This approach was used to expand stents within a vessel
in order to reduce the computational cost of the simulations. This seems
a reasonable simplification because of the assumed cylindrical shape of the
MB. Following to the expansion, the diameter of the cylindrical balloon was
gradually decreased, allowing for a recoil phase. During a second step, a
folded balloon was inflated (up to 1.5 MPa) while positioned in both the
MB and SB, resulting in a distortion of the stent geometry. Finally, the
pressure in the balloon was gradually removed. This procedure is illustrated
in Fig. 3.4 and was repeated for both stent designs combined with the two
different balloon sizes, resulting in four simulations.
The original stent positions were chosen in such a way that after stent de-
ployment, the folded balloon passed through a stent cell while avoiding inter-
secting elements. For the MULTI-LINK Vision stent, such a configuration
was not found and a local external pressure was applied prior to inflation
on the outer balloon surface in order to avoid intersecting elements.
The ABAQUS/Explicit solver was used for the large deformation analyses,
as this code provides a very stable contact algorithm (i.e., the general con-
tact algorithm). All contacts were assumed to be frictionless. During the
stent deployment in the MB, contact between the folded balloon (used for
subsequent dilatation through the side of the stent) and any other part in
the model was not taken into account. A similar technique was used for
the second step, which involved the SB balloon dilatation, where the con-
tact with the cylindrical tube (used for the stent expansion in the MB) was
ignored. All other contact pairs were taken into account.
Inertia was assumed to have a negligible impact on both the stent expansion
and the balloon inflation. Therefore, the expansion scenarios were consid-
ered to be quasi-static phenomena. A well established technique to reduce
the required computational effort is to accelerate the process in comparison
with the physical procedure. However, this approach could introduce un-
wanted dynamic effects and may change the response of the system. There-
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Figure 3.4: Illustration of the simulation procedure for the Cypher stent (panel
A: initial configuration, panel B: fully expanded stent, panel C: stent configu-
ration after recoil, panel D: initial position of the 2.5 mm SB balloon, panel E:
deformed configuration at the maximum pressure of 1.5 MPa, panel F: final state
after balloon deflation).
fore, energies were monitored during the simulations in order to assure that
the inertial forces remained insignificant.
In order to avoid rigid body motions, the ends of all branches were con-
strained in both axial and tangential direction. Furthermore, pressure-
dependent axial elongations were imposed to the balloon ends ranging from
0 mm(initial state) to 0.06 mm (2.5 mm balloon) or 0.035 mm (3 mm bal-
loon) at a pressure of 1.5 N/mm2, in order to account for the axial stresses
which occur in a balloon with tapered ends. These axial elongations were
obtained from the numerical expansion of the cylindrical balloon model (in-
cluding the tapered ends), which was described above.
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3.2.4 Postprocessing
In order to compare different stent designs and balloon sizes, operator inde-
pendent criteria are required to assess the deformation of the stent. As the
SB balloon dilatation aims to improve the SB patency a new parameter is
introduced, the Projected Cell Area (PCA), which is related to the defor-
mation of the stent cell through which the balloon is inflated (see Fig. 3.5).
This stent cell is defined by a 3D curve and consequently, a projection is
required for area calculations. The curve at the inner side of the stent cell
was chosen for the PCA calculations as shown in Fig. 3.5. The curve pro-
jections and area calculations were performed using pyFormex, an in-house
developed open source program [130]. Furthermore, the proposed projection
direction also yields adequate results for stents that deploy partially within
the SB without compromising the SB patency. A PCA that is greater than
the circular area of the SB, means that the stent cells can be sufficiently
enlarged by the employed balloon, but does not necessarily indicate optimal
stent deformation.
Stent cell
Projection of stent cell
Figure 3.5: Schematic drawing illustrating the projection method used to cal-
culate the Projected Cell Area (PCA).
3.2.5 Discretization
The finite element mesh of the Cypher and MULTI-LINK Vision stent con-
sisted of 25992, respectively 29736 8-node hexahedral elements (C3D8R).
The same element type was chosen for the arterial wall mesh, which con-
tains 9561 hexahedrons. For the 2.5 mm balloon, 9858 4-node quadrilateral
membrane elements (M3D4R) were used, whereas the 3 mm balloon was
meshed with 12084 quadrilaterals. Finally, the cylindrical tube was also
meshed with M3D4R elements (i.e., 6300).
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A mesh sensitivity analysis was performed for the simulation of the Cypher
stent, combined with the 2.5 mm balloon. Increasing the total number of
elements with approximately fifty percent (79197 instead of 51711 elements)
changed the resulting PCA after dilatation through the side of the stent with
less then two percent. Therefore, mesh densities were considered acceptable
for the analysis of the cell deformation.
3.3 Results and discussion
3.3.1 Validation of balloon models
The validation of the compliance behaviour of both balloons is depicted
in Fig. 3.6. For the 2.5 mm balloon, the maximum percentage difference
in diameter is less than four percent and occurs at a pressure of 1 MPa.
The numerical results of the 3 mm balloon expansion differ less than one
percent from the original data (i.e. at a pressure of 0.8 MPa). Both balloon
models demonstrate realistic deformations under pressure and consequently,
the linear elastic approximation of the stress-strain data seems justified.
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Figure 3.6: Comparison of the manufacturer data (crosses) with the simulation
results (line).
3.3.2 Side branch access
Figure 3.7 shows the deformed stent geometries after deployment in the MB
and after subsequent SB balloon dilatation. Inflating a balloon, positioned
in both the MB and SB, through an already expanded stent clearly improves
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the SB patency. Furthermore, such balloon inflation facilitates access to
the SB through the stent struts. This is of major importance during T-
stenting, a bifurcation stenting technique which involves the implantation
of two stents, a first one in the MB and a second one in the SB.
CYPHER
CYPHER - 2.5 mm balloon
CYPHER - 3 mm balloon
MULTI-LINK VISION
MULTI-LINK VISION - 2.5 mm balloon
MULTI-LINK VISION - 3 mm balloon
Figure 3.7: Stent distortion after expansion in the MB and following subsequent
balloon dilatation through a stent side-hole. The stent opening in front of the SB
considerably enlarges due to this balloon inflation and the effect depends on the
balloon size.
The balloon inflation through a stent opening results in a significant enlarge-
ment of that stent opening and as intuitively expected, the largest opening
is obtained by a 3 mm balloon dilatation. This effect is also quantitatively
reflected by the previously introduced Projected Cell Area (see Table 3.2).
The projected curves defining the stent cells are depicted in Fig. 3.8. The
PCA increases noticeably when using a larger balloon (3.65–4.36 mm2 for
the Cypher stent and 5.74–6.64 mm2 for the MULTI-LINK Vison stent).
However, using a larger balloon will also induce a higher stress state within
the unstented SB vessel wall. This is pure balloon angioplasty, which is
known to cause high restenosis rates [25] and therefore a clinical study
addressing the choice of balloon size when dilating through the side of a
stent could be very valuable. It is likely that a trade-off between optimal
cell opening and minimal injury to the SB will be needed. Restricting the
length of the balloon outside the stent may already improve the outcome of
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this procedure [45].
Table 3.2: Projected Cell Area (PCA) for the two investigated stents prior to
and after SB balloon dilatation. Both the 2.5 and 3 mm balloon considerably
increase the cell covering the SB, and this cell enlargement is maximal for the
3 mm balloon.
Cypher MULTI-LINK Vision
After stenting the MB 1.97 mm2 2.21 mm2
After 2.5 mm balloon dilatation 3.65 mm2 5.74 mm2
After 3 mm balloon dilatation 4.36 mm2 6.64 mm2
Ideally, all stent material should make contact with the vessel wall and all
‘floating’ struts should disappear. However, floating struts still occur for
both stent designs (Fig. 3.7) and this might induce thrombosis formation
[87]. The PCA for the MULTI-LINK Vision exceeds the cross-sectional
area of the SB, which is 4.91 mm2 and this is true for both the 2.5 and
3 mm SB balloon. Consequently the enlargement caused by these balloons
is acceptable for this stent design. However, this does not guarantee optimal
stent deformation and SB access, because this enlarged cell may be badly
positioned with respect to the SB. In contrast, the PCA for the Cypher
stent is lower than this cross-sectional SB area for the two different balloon
sizes. This indicates that these balloons do not sufficiently enlarge the
stent opening in front of the SB. The substantial difference in PCA for the
two stent designs investigated is related to the different design concepts.
The Cypher stent is a typical example of a closed cell design, whereas the
MULTI-LINK Vison can be classified as open cell [137].
3.3.3 Stent distortion in the MB
A view into the MB (Fig. 3.9) clearly shows that dilating through the side
of a stent may compromise the MB lumen. This phenomenon was also
experimentally observed by Ormiston et al. [87] who carried out in vitro
tests on five different stent designs. The distortion of the MULTI-LINK
Vision stent corresponds well with the in vitro observed deformation of the
MultiLink stent, which has a design very similar to the MULTI-LINK Vision
stent (see Fig. 3.10). Both designs consist of different ring elements with
three connection elements between each two subsequent rings. In particular,
a significant distortion immediately distal to the SB after dilatation with
a 3 mm balloon was also observed experimentally. The cut view shown in
Fig. 3.11 illustrates this type of deformation behaviour.
The horizontal cut view also shows the markedly different deformation be-
haviour of the Cypher stent compared to the MULTI-LINK Vision stent.
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CYPHER MULTI-LINK VISION
after stent
expansion
2.5 mm
balloon
3 mm
balloon
Figure 3.8: Projected stent cells prior to and after SB balloon dilatation. These
2D curves were used to determine the PCA.
For the Cypher stent, all struts remain very close to the MB wall after SB
dilatation through a stent opening, although Ormiston et al. [87] reported
that dilating through the side of stent compromises the downstream main-
vessel lumen regardless of the stent design. However, it should be noted
that none of the stent designs investigated in their work has a design simi-
lar to the Cypher stent. Furthermore, the impact of the balloon size seems
to have a minor effect on the MB scaffolding properties for both stents.
The distortion of the MULTI-LINK Vision stent evidences the need for
final kissing balloon (i.e., simultaneous dilatation of MB and SB). This
well-known procedure improves the long-term outcome of several bifurca-
tion stenting techniques [8, 51]. Final kissing balloon inflation may also be
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CYPHER - 2.5 mm balloon MULTI-LINK VISION - 2.5 mm balloon
CYPHER - 3 mm balloon MULTI-LINK VISION - 3 mm balloon
line indicating cut
Figure 3.9: View into the MB (from proximal side) showing the impact of the
SB balloon dilatation on the MB lumen. The results strongly depend on the stent
design, in contrast to the balloon size, which seems to have a minor effect. The
horizontal line indicates the cut views depicted in Fig. 3.11.
Figure 3.10: Comparison of the distortion of the MultiLink stent observed in
bench tests [87] (top panel) with the numerically predicted deformation of the
MULTI-LINK Vision stent (bottom panel).
required after dilating through the side of the Cypher stent, although the
numerical results show good apposition of the struts. This is due to the
fact that the SB balloon inflation has only been performed for one position
of the expanded Cypher stent. Furthermore, only one bifurcation geometry
has been considered.
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CYPHER
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MULTI-LINK VISION
2.5 mm balloon
MULTI-LINK VISION
3 mm balloon
Figure 3.11: Cut view showing the stent strut positions. The circles indicate
floating struts in the MB lumen.
3.3.4 Study limitations
The main limitations of this work are related to both the bifurcation mor-
phology and the constitutive behaviour of the vascular tissue. The presence
of a plaque is discarded and real-life coronary bifurcations certainly have
a more complex geometry. Simulations based on a patient-specific bifurca-
tion lesion including different components (e.g. intima, media, adventitia,
lipid pool, etc.) would certainly improve the current model [132]. The
anisotropic behaviour of the arterial tissue was discarded and the applied
constitutive model should ideally be based on data from human coronary
arteries. Furthermore, axial pre-stretch and arterial blood pressure were
neglected.
In clinical practice, the balloon catheters for the SB dilatation are being in-
serted using a guiding catheter. The very small cross-section of this guiding
catheter facilitates the placement of the balloon through the stent. A con-
sequence of discarding this insertion procedure from the simulations is the
possible presence of intersecting balloon and stent elements after the stent
expansion. For the MULTI-LINK Vision stent, a local external pressure
was applied on the outer balloon surface in order to avoid such intersections.
Furthermore, the balloon catheter is normally (i.e., in clinical practice) bent
during insertion through the side of an implanted stent. This bending was
taken into account in the numerical model by using folded balloon geometry
with an initial curvature. As a result, initial stresses in the balloon mem-
brane due to this bending were neglected. However, the impact of these
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stresses on the global deformation is believed to be of minor importance.
3.4 Conclusion
Numerical simulations are a valuable research tool complementing in vitro
studies when investigating complex bifurcation stenting techniques due to
the accurate prediction of the occurring deformations. The proposed model
allows the impact of balloon size and stent design on balloon dilatations
through the side of a stent to be quantified, without the need for various
expensive stent samples. Furthermore, similar simulation strategies can be
developed to study other (in clinical practice) proposed bifurcation stent-
ing techniques, such as crush stenting, T-stenting, etc. This may lead to
improved devices and/or procedures to treat bifurcation lesions.
Chapter 4
Virtual stent insertion in a
patient-specific coronary
bifurcation
THE previous chapter has demonstrated the usefulness of finite elementanalysis for bifurcation stent research. These simulations allow to study
the mechanics of different techniques and devices with an acceptable degree
of accuracy. However, advances in simulation techniques and medical imag-
ing combined with the exponential increase in computational capacity open
up new horizons in the domain of computational biomechanics. Models,
considered state-of-art one day, are quickly replaced by more detailed sim-
ulations as shown in this chapter1. It is important to stress that results
obtained with more simplified models remain useful as long as the assump-
tion are jusitified by, for example, experimental observations.
4.1 Introduction
Stents have demonstrated good results in terms of safety and efficiency
when being implanted in unbranched vessel segments, in particular since
the introduction DES [138]. However, stenting coronary bifurcation lesions
1 The contents of this chapter were published in the journal, Annals of Biomedical En-
gineering:
A novel simulation strategy for stent insertion and deployment in curved
coronary bifurcations: Comparison of three drug-eluting stents
P. Mortier, G. A. Holzapfel, M. De Beule, D. Van Loo, Y. Taeymans, P. Segers, P.
Verdonck, and B. Verhegghe
38:88-99, 2010
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remains challenging due to the increased complication rate and the frequent
need for re-intervention [4]. Several bifurcation stenting techniques have
been proposed with various levels of complexity, and each of them has one
or more limitations [5]. The provisional side-branch stenting strategy, which
first involves stent placement in the main branch and second in the side
branch, if necessary, is currently the gold standard for the majority of the
treatments [18]. Using this provisional approach in combination with a DES
yields an acceptable restenosis rate for the main branch, but the results for
the SB remain disappointing with a restenosis rate of approximately 15% [4].
In the last couple of years, the second generation of DESs has been intro-
duced on the market. The platform of the first generation DESs (Cypher
by Cordis, Johnson & Johnson; Taxus by Boston Scientific) has been modi-
fied, and these DESs are now available as Cypher Select and Taxus Liberte´,
respectively. In addition, new DESs have been developed such as the En-
deavor stent (Medtronic), the Xience V stent (Abbott Vascular) and the
Promus stent (Boston Scientific). The growing number of available DESs
increases the freedom for the physicians to choose from, but it also brings
along the question of which stent to use for which particular case/type of
stenosis. For example, a very flexible stent with a low crossing profile may be
required to treat patients with highly tortuous vessels. Therefore, objective
comparisons of these DESs are needed in terms of pharmacological effect,
thrombogenicity, geometrical aspects of the design and mechanical perfor-
mance among many others, because all of these parameters are important
for optimal stent selection.
Using finite element analysis, we compared the mechanical effects of three
different second generation DESs on the arterial wall of a coronary bifurca-
tion with a (highly) curved main vessel when performing provisional stent-
ing. A new method is used to generate a three-dimensional bifurcation
model starting from patient-specific angiographic data obtained in vivo.
The layered structure of the arterial wall and the anisotropic behavior of
each of these layers are considered by applying a novel algorithm to de-
fine the fiber orientations. The suitability of the implemented anisotropic
constitutive model is shown by comparing the numerically obtained virtual
stress-strain response to experimental and analytical results. Innovative si-
mulation strategies are proposed to deploy the stents in the curved main
branch including the insertion of the folded balloon catheter over a guide
wire. The stent design leading to the highest arterial stresses has been mod-
ified using a parametric model with the aim of reducing the arterial trauma
while maintaining a sufficient radial strength.
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4.2 Materials and methods
4.2.1 Arterial model
4.2.1.1 Geometry
Three-dimensional geometrical information on the lumen of a left coronary
tree was obtained by rotational angiography using the dedicated Allura
3D-CA software [139]. The in vivo-based data consist of a stack of circu-
lar representations of vessel cross-sections, defined by their center, radius
and inclination. A small portion of this set of data was selected for further
reconstruction, namely that region where the left (main) coronary artery bi-
furcates into the left anterior descending and the left circumflex artery. Sub-
sequently, NURBS surfaces were created using Rhinoceros 4.0 [140] based
on a point cloud that describes the luminal cross sections.
Two luminal cross sections, which were non-diseased, were selected (one
proximal and one distal) for both the side and the main branch, and they
served as a starting point for generation of the outer wall. At those loca-
tions, a circular approximation of the outer wall was obtained by scaling the
selected luminal circles. A scaling factor of 1.6 was applied, which resulted
in a realistic wall thickness as this factor is based on the anatomical data for
non-atherosclerotic coronary arteries published in [12]. A further descrip-
tion of the outer wall was obtained by scaling the remaining luminal circles
to a diameter, based on linear interpolation (and extrapolation) of the di-
ameters of the previously calculated cross sections. The resulting circular
representations of the outer wall were then used as input for the generation
of a second NURBS surface corresponding to the outer boundary.
The commercial software Gambit [141] was used to create a structured hex-
ahedral mesh of the vessel wall starting from the two NURBS surfaces. Fi-
nally, the mesh was imported into the open source software pyFormex [130],
where it was split into three layers with equal thickness, corresponding to
the intima, media and adventitia. Figure 4.1 shows the bifurcation model
and clarifies the applied procedure.
4.2.1.2 Arterial tissue
The arterial wall consists of three distinct layers (intima, media, adven-
titia), and each of these layers is reinforced by collagen fibers leading to
a heterogeneous and anisotropic material behavior. These fiber-reinforced
composites are assumed to behave nearly incompressible and demonstrate
highly nonlinear stress-strain responses. It is assumed that the collagen
fibers are organized in two families which can be represented by unit vec-
tors M and M′ with respect to the undeformed reference configuration.
These unit vectors represent the average directions of the two fiber families
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Figure 4.1: Three-dimensional model of the lumen of the left coronary artery
bifurcation obtained by rotational angiography. The luminal geometry consists of
circular cross-sections. Sections A-D of the lumen were considered non-diseased,
and at those locations, the circles were scaled by a factor of 1.6 according to the
data published by Holzapfel et al. [12]. Two scaled circles (at sections A and B for
the main branch, and at sections C and D for the SB) served as a starting point
to generate the outer wall of that branch. All other luminal circles were scaled to
a diameter based on a linear interpolation (or extrapolation) of the diameters at
sections A and B in case of the main branch or sections C and D for the SB.
embedded in an isotropic ground matrix. The volume preserving part of
the strain-energy function Ψ to model the mechanical behavior of arterial
tissues, as proposed by Holzapfel et al. [12], may be written as
Ψ = Ψiso + Ψaniso, (4.1)
which is the sum of an isotropic term Ψiso, related to the matrix material,
and an anisotropic term Ψaniso, related to the embedded families of collagen
fibers [142]. The two terms are particularized as
Ψiso = µ(I¯1 − 3), (4.2)
81
Table 4.1: Material parameters for the constitutive model (4.1)–(4.3) determined
by Holzapfel et al. [12]. The data correspond to Specimen I documented in [12].
Layer µ [kPa] k1 [kPa] k2 [−] ρ [−] α [◦]
Intima 28.62 124.01 180.43 0.55 69.5
Media 0.94 13.28 10.81 0.25 21.0
Adventitia 4.04 32.50 103.63 0.65 72.7
Ψaniso =
k1
2k2
∑
i=4,6
(exp
[
k2
{
(1 − ρ)(I¯1 − 3)2 + ρ(I¯i − 1)2
}]
− 1), (4.3)
where I¯1 = trC is the first invariant of the modified right Cauchy-Green
tensor C = J−2/3C, with the volume ratio J = (detC)1/2 > 0 and the right
Cauchy-Green tensor C, and I¯4 = C : M ⊗M and I¯6 = C : M′ ⊗M′ are
two modified invariants responsible for the anisotropic behavior [143]. By
assuming a symmetric arrangement of the two families of collagen fibers
and neglecting their radial component allows to define the unit vectors M,
M′ in terms of an angle α measured between the fiber reinforcement and
the circumferential direction. The (non-negative) material parameters k2,
ρ ∈ [0, 1] are dimensionless, whereas k1, µ have the dimension of stress.
Holzapfel et al. [12] determined the set of parameters (µ,k1,k2, ρ,α) for the
three arterial layers of 13 postmortem non-stenotic coronary arteries corre-
sponding to the model described in (4.1)–(4.3). The angle α was treated as
a phenomenological parameter because the collagen structure of the indi-
vidual layers was not investigated. Uniaxial testing of both longitudinally
and circumferentially oriented arterial segments allowed the determination
of all parameters by a least-square fitting algorithm. All simulations are
based on the material parameters of one (randomly chosen) specimen (i.e.
Specimen I in [12]). The used values are summarized in Table 4.1.
A standard approach to model nearly incompressible materials is to add
a term of the form κ(J − 1)2/2 to the strain-energy function Ψ, where κ
is treated as a (positive) penalty parameter (see Chapter 7 in [143]). The
penalty parameter κ influences the incompressibility constraint and is de-
termined through numerical experiments.
The constitutive model stated above was implemented as a user-defined
material (VUMAT) in ABAQUS/Explicit. The accuracy of material defi-
nition was verified by simulating displacement driven uniaxial tension tests
for the individual layers both in the longitudinal and the circumferential
directions. The resulting stress-strain responses were compared to the ex-
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perimental data. In addition, a biaxial test was simulated and the results
were compared with the analytical solution as documented in, for exam-
ple, [144]. This provides an alternative way to verify the implementation of
the material model. The simulations of the uniaxial and biaxial tests are
performed with a single hexahedral element.
4.2.1.3 Fiber orientation
The anisotropic constitutive model requires an adequate assignment of the
radial, circumferential and longitudinal directions in each finite element at
the reference configuration. Only then the average fiber directions M and
M′ are properly defined. However, assigning local material orientations is
not a straightforward task when dealing with complex geometries as in the
present (three-dimensional) study.
The local orientations were defined on an element by element basis in an
automated manner, making use of the structured nature of hexahedral dis-
cretization. The applied methodology was implemented in pyFormex and
is illustrated in Fig. 4.2.
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Figure 4.2: Outermost layer of the structured hexahedral discretization at the
location of the bifurcation with an enlarged view of the indicated element. Local
material orientations (n′1, n2, n3) are computed for every finite element based on
its edges.
For each element, two edges were selected: a first edge which has a radial
orientation (denoted by vector n1) and a second edge of which the direction
was considered circumferentially (denoted by vector n2). In most cases, n1
and n2 are not perpendicular. Taking the vector product n1×n2 yields the
longitudinal direction n3. A second vector product n2×n3 gives a modified
radial direction n′1. The three perpendicular vectors n
′
1, n2, n3 define the
local material orientations.
The local axes and the angle α, as given in Table 4.1, define the mean fiber
directions M, M′ for each finite element. These mean fiber orientations were
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computed at the center of each finite element and are depicted in Fig. 4.3 for
a small portion of the superficial elements, located close to the bifurcation.
As can be seen the proposed methodology results in a proper description of
the fiber orientations for the bifurcated arterial geometry. An alternative
method is proposed in [145].
Figure 4.3: Illustration of the (local) mean fiber directions M and M′ for the
finite elements. The directions are depicted for a small portion of the superficial
elements, located close to the bifurcation, as shown in Fig. 4.2.
4.2.2 Stent models
Three second generation coronary DES were selected for this study: (i)
Cypher Select Sirolimus-eluting stent (Cordis, Johnson & Johnson); (ii) En-
deavor Zotarolimus-eluting stent (Medtronic); (iii) Taxus Liberte´ Paclitaxel-
eluting stent (Boston Scientific). Their geometries were acquired by micro-
CT imaging of a sample of the devices in their balloon mounted state.
The voxel pitch of the scans was 1µm allowing an accurate assessment of
all stent dimensions. This geometrical information was then used to gen-
erate three-dimensional parametric computer models using pyFormex. A
comparison between a CT-based Endeavor stent geometry and the corre-
sponding discretized model is shown in Fig. 4.4. The Cypher Select and
the Taxus Liberte´ stents have rectangular strut cross-sections, while the
Endeavor stent has circular cross-sections. The main characteristics of the
three second generation DESs used in the numerical analyses are summa-
rized in Table 4.2.
Both the Cypher Select and the Taxus Liberte´ stents are laser-cut from 316L
stainless steel tubes. The Endeavor stent is made from a cobalt-chromium
alloy (F562) and has a modular design where the individual segments are
welded to each other. One of these welds is indicated in Fig. 4.4. The
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weld
Figure 4.4: Comparison between a part of the micro-CT-based Endeavor stent
geometry (left) and the discretized model (right). A weld is also indicated in the
left figure.
Table 4.2: Overview of the analyzed stents and their main characteristics.
Stent
Nominal
diameter
Nominal
length
Strut
thickness
Strut
width Material
Cypher Select 3.5 mm 13 mm 140µm 130µm SS316L
Endeavor 3.5 mm 12 mm 91µm 91µm CoCr F562
Taxus Liberte´ 3.5 mm 12 mm 97µm 76µm SS316L
behavior of both alloys was described by an elasto-plastic material model.
Related material properties were taken from [135], and are summarized in
Table 4.3.
4.2.3 Balloon model
All stents were inserted and deployed using a semi-compliant Raptor bal-
loon (Cordis, Johnson & Johnson) with a nominal diameter and length of
3.5 mm and 15 mm, respectively. Micro-CT images revealed that this bal-
loon is pleated around the catheter shaft with three folds [126]. A geomet-
rical model of this trifolded Raptor balloon was created using the two step
strategy proposed in [123]. First, a discretized model of the unfolded balloon
was generated based on the initial balloon diameter (i.e. at 0 MPa) which
was obtained after extrapolation of the pressure-diameter data provided
by the manufacturer (only available for pressures higher than 0.2 MPa).
Second, the folded configuration was created by applying a mathematical
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Table 4.3: Stent material properties for the Cypher Select and the Taxus Liberte´,
made from stainless steel (SS316L), and for the Endeavor, made from a stronger
cobalt-chromium alloy (F562), see [135].
Material
Young’s
modulus
Poisson’s
ratio
Yield
stress
Ultimate
tensile
stress
Ultimate
elongation
SS316L 193 GPa 0.30 366 MPa 675 MPa 43%
CoCr F562 233 GPa 0.35 414 MPa 930 MPa 45%
transformation to all the nodal coordinates (for a detailed description of
this transformation see the original work [123]). A uniform thickness of
0.02 mm was assigned to the balloon membrane which was then connected
to the catheter shaft by merging the corresponding nodes of the shaft and
the membrane. A longitudinal cross-sectional view of the unfolded balloon
catheter at 0 bar with the main catheter dimensions are depicted in Fig. 4.5.
Thereby the balloon diameter is 3.27 mm, while the nominal diameter of
3.5 mm is reached at the nominal pressure (for the Raptor balloon this is
6 bar).
0.36 mm
30°
15 mm
0.86 mm
3.27 mm
Figure 4.5: Longitudinal cross-sectional view of the unfolded balloon catheter
(at 0 bar) with the related dimensions (Raptor balloon from Cordis, Johnson &
Johnson; at nominal pressure the nominal diameter is 3.5 mm).
The semi-compliant Raptor balloon catheter is manufactured from a nylon-
based material. The mechanical properties of the balloon membrane were
derived starting from the compliance chart provided by the manufacturer.
The approach, which is described in detail by De Beule [94], is based on
the membrane theory and results in stress-strain data which were approx-
imated by a Young’s modulus of 850 MPa. Poisson’s ratio was assumed
to be 0.4. The accuracy of the applied methodology was confirmed by
the pressure-diameter data obtained by simulating the unconstrained bal-
loon expansion. The maximum difference in diameter was less than three
percent when comparing the simulation results to the manufacturer’s orig-
inal pressure-diameter data. Catheter shafts often contain high density
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polyethylene components and, therefore, a linear elastic material was used
in the present case, with a Young’s modulus of 1000 MPa and a Poisson’s
ratio of 0.4.
4.2.4 Numerical simulations
All 3.5 mm stents were advanced to the location of implantation by simulat-
ing the insertion of the stent system over a guide wire. It was not possible
to immediately position the stent system at the implantation site without
protruding the vessel wall because of the highly curved main branch. Guide
wires are often manufactured from nitinol and typically have a diameter of
0.36 mm (i.e. 0.014 inch). The superelastic nitinol properties were neglected
because the guide wire deformations were small. A Young’s modulus and
Poisson’s ratio of 62 GPa and 0.3 were assigned, respectively, to represent
the elastic behavior in the austenite phase [146]. The guide wire was fixed
at both ends. Insertion was simulated by enforcing a displacement at the
proximal end of the catheter shaft. An additional (equal) displacement
boundary condition was imposed to the proximal stent end. Without this
condition, it was impossible to adequately position the stent because sliding
occurred between the balloon membrane and the inner stent surface. This
sliding was due to insufficient frictional forces, although a pressure was ap-
plied to the outer stent surface during insertion to mimic the stent fixation
after crimping. After positioning, the Raptor balloon was subsequently in-
flated and deflated to deploy the stent. The maximum balloon pressure was
12 bar. The bifurcation model was constrained at its three ends in all direc-
tions. Figure 4.6 shows the complete insertion and deployment procedure
for the Taxus Liberte´ stent.
Implanting stents in curved vessels cause stress concentrations at the stent
ends, see, for example, [147, 148]. Therefore, in order to analyze this effect
with the aim to reduce stress concentration at the stent ends, two design
modifications of the Cypher Select stent were generated using the paramet-
ric modeling capabilities of pyFormex. The first modification, labeled as
CSthin, has a strut thickness of 100µm everywhere (as compared to 140µm
of the original Cypher Select design). All other design parameters remain
unaltered. The second modification, labeled as CSend, only differs from the
original Cypher Select design at its proximal and distal ring segment. These
two end rings have a reduced strut width w1 of 90µm (as compared to a
strut width w2 of 130µm of the original Cypher Select design) in order to
reduce the change in stiffness between the stented and non-stented vessel
segments, see Fig. 4.7.
Such a modification has a relatively minor impact on the radial strength in
the central region of the stent. A sufficient radial strength is required in or-
der to resist the compressive forces of the arterial wall after deployment and
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C D
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Figure 4.6: Illustration of the simulated stent insertion and deployment pro-
cedure: panel A – initial configuration; panel B – intermediate position during
insertion; panel C – final position prior to expansion; panel D – partially inflated
stent at a balloon pressure of 3 bar; panel E – configuration at the maximum
pressure of 12 bar; panel F – final state after balloon deflation.
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Figure 4.7: Unrolled model showing one end of the modified Cypher Select stent
CSend: The strut width w1 of the proximal and distal ring segments is 90µm,
whereas all central ring segments have a strut width w2 of 130µm. For the
original Cypher Select stent model, w1 and w2 are equal to 130µm.
to guarantee a sufficient luminal area. Therefore, all original and modified
stent designs with 3.5 mm nominal diameter were subjected to a ‘virtual ra-
dial strength test’. The stents were expanded in a cylindrical polyurethane
tube, which is 4 mm longer than the crimped stent, having an internal diam-
eter of 3.5 mm and a wall thickness of 50µm [149]. A displacement driven
deployment method was used to expand all stents to an inner diameter
of 3.5 mm [126]. The tube was fixed at both ends and the polyurethane
was described by an elastic constitutive model with a Young’s modulus of
40 MPa and a Poisson’s ratio of 0.3 [150]. Subsequently, a gradually in-
creasing pressure was applied on the outer tube surface. At low pressures,
this typically resulted in a small, approximately linear decrease of the stent
diameter. However, when the pressure exceeded a certain threshold value,
the stent diameter suddenly decreased considerably. The radial strength
was then defined as the pressure causing this sudden diameter decrease (or
collapse of the stent structure).
All three-dimensional models with the exception of the balloon membrane
are discretized using linear hexahedral elements using reduced integration
and hourglass control (Cypher Select stent and the modified stent designs:
15848; Endeavor stent: 46800; Taxus Liberte´: 21000; arterial model for the
bifurcation: 12000; guide wire: 1500; catheter shaft: 960; tube to be used
for the radial compression test: 2016). The circular cross-sections of the
Endeavor stent struts require a higher number of elements as compared to
the other stent models, which have struts that can be approximated with
rectangular cross-sections. The meshes of the bifurcation arterial model are
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generated with matching nodes on the tissue interfaces, leading to a proper
connection between the individual arterial layers. The discretization of the
balloon consists of both triangular (4662) and quadrilateral (10875) fully
integrated linear membrane elements.
The ABAQUS/Explicit solver was used for the large deformation analy-
ses, as this code provides a very stable general contact algorithm. Friction
was included in the simulations by means of a Coulomb friction model.
The coefficient used for all contact pairs was assumed to be 0.2. A well-
established technique to reduce the computational effort of explicit analyses
is to ‘accelerate’ the virtual process in comparison with the physical proce-
dure. However, this approach can lead to unrealistic dynamic effects that
may change the response of the system. Since the insertion and deployment
were considered to be quasi-static phenomena, where inertial forces have a
negligible impact, such an artificial acceleration was applied in a controlled
manner by monitoring the kinetic energy of all components involved.
4.3 Results and discussion
4.3.1 Verification of the implemented arterial model
The numerically obtained stress-strain responses after uniaxial extensions of
the arterial strips in the axial and circumferential directions are depicted in
Fig. 4.8. A comparison with experimental data, as published by Holzapfel
et al. [12], is also provided and shows a very good agreement with the model
results.
The results of the simulated biaxial deformation of the media and the cor-
responding analytical results (see, for example, [144]) in terms of Cauchy
stress versus stretch also show a very good correlation (see Fig. 4.9), which
confirms the accuracy of the implemented constitutive model.
4.3.2 Comparison of the second generation DES
Implantation of the stents in the curved main branch changes the three-
dimensional vessel geometry significantly. In particular, a straightening
effect of the stented vessel was observed in all cases considered, and an
illustration for the Cypher Select stent is provided in Fig. 4.10. This effect
can be explained by the relatively high bending and radial stiffness of the
stent as compared to the vessel. Hence, a compliance mismatch occurs at
the stent ends leading to discontinuities as indicated in Fig. 4.10.
This abrupt compliance change, in combination with a slightly smaller initial
luminal diameter at the distal stent end, causes the highest circumferential
stresses in the vessel wall at that location (see Fig. 4.11). These results
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Figure 4.8: Comparison of simulated uniaxial extensions of arterial strips in the
axial and circumferential directions shows very good agreement with experimental
data documented in [12].
correspond in particular with the observations of Wu et al. [148], who com-
pared the stresses in the arterial wall after stent implantation in a straight
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Figure 4.9: Comparison of simulated biaxial deformation of the media in terms of
Cauchy stress/stretch and corresponding analytical results shows good agreement.
Pre-stenting lumen
Post-stenting lumen
Cypher Select position
Figure 4.10: Comparison of the pre- and post-stenting luminal curvatures. Stent
implantation results in vessel straightening here shown for the Cypher Select stent.
and a curved vessel. In the curved vessel model, these authors also identified
the highest arterial stresses at the stent ends. The circumferential (Cauchy)
stress peaks for the Cypher Select, the Endeavor and the Taxus Liberte´ in
our simulations are 0.38, 0.15 and 0.15 MPa, respectively. The substantially
higher maximum stresses for the Cypher Select stent after deployment is re-
lated to the higher stiffness of this device, which is mainly due to its closed
cell design and large strut thickness (compare with Table 4.2). In contrast,
the Endeavor and Taxus Liberte´ stents have more flexible open cell designs
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and smaller strut thicknesses.
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Figure 4.11: Comparison of the circumferential (Cauchy) stress distribution
after implantation of the Cypher Select, the Endeavor and the Taxus Liberte´
stents, with maximal stresses of 0.38, 0.15 and 0.15 MPa from left to right.
Similar changes in the curvature have been reported in the past using in vivo
imaging before and after stent deployment [151, 152]. Considerable vessel
straightening was identified as a predictor for major adverse cardiac events
such as death, acute myocardial infarction or revascularization [153]. This
increased complication rate might be explained by the high stresses or stress
gradients which occur at the stent ends in case of the vessel straightening,
but the impact on the blood flow dynamics might also play an important
role. For example, Wentzel et al. [152] showed that changes in vessel cur-
vature lead to areas with decreased and increased wall shear stresses at
the stent ends, and suggested that this might contribute to the occurrence
of restenosis. A large randomized trial comparing sirolimus-eluting stents
with bare metal stents showed an in-stent restenosis rate of 3.2% for the
drug-eluting stent group [138]. However, by considering the stented vessel
segment and the non-stented regions 5 mm proximal and distal to the stent,
a restenosis rate of 8.9% was obtained. These results clearly demonstrate
the vulnerability of the unstented segments near the stent ends. Vessel
straightening and the resulting stress concentrations may have contributed
to the restenotic reaction at the edges of the stent, regions that are less
protected by drug delivery. Many other factors are of course involved. For
example, the higher incidence of endothelial injury observed at the stent
ends may also induce local reactions. Squire [33] explained this particu-
lar injury pattern to be the result of three mechanical factors: (i) direct
balloon-artery contact due to a protrusion of the balloon at the stent ends,
(ii) an axial contraction of the stent (foreshortening), (iii) a nonuniform
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ends-first expansion behavior of the stents (dogboning). Based on finite el-
ement simulations, a reduction of the balloon overhang has been suggested
to eliminate the dogboning effect, while at the same time minimizing the
area with direct balloon-artery contact [127].
Figure 4.12 compares the circumferential stress distributions caused by the
implantation of the two modified stent designs (CSthin, CSend), while the left
image of Fig. 4.11 is the analogue for the original Cypher Select stent.
0.4
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0.1
0.0
CS CS
Circumferential
stress (MPa) thin end
Figure 4.12: Comparison of the circumferential (Cauchy) stress distributions
caused by the implantation of the two modified (Cypher Select) stent designs,
CSthin and CSend, while the left image of Fig. 4.11 shows the analogue for the
original Cypher Select stent: a reduction of the overall strut thickness (CSthin)
or of the strut width of the distal and proximal ring segments (CSend) leads to a
bisection of the maximal stresses around one stent end.
The stress patterns are very similar, however, the maximum circumferential
stresses at the distal stent end are much lower for the two modified de-
signs. The original Cypher Select stent design caused a maximum stress of
0.38 MPa, while the maximum stresses induced by the CSthin and CSend stent
are 0.19 and 0.18 MPa, respectively. Hence, a stress reduction of 50% was
obtained by reducing the strut thickness of the complete stent (i.e., mod-
ification CSthin) or by reducing the strut width of the distal and proximal
ring segments only (i.e., modification CSend). Hence, these two completely
different design modifications decrease the arterial trauma caused by stent
implantation for this specific vessel morphology. The CSthin-design leads to
an overall decrease in the bending stiffness, while the CSend-design reduces
the compliance mismatch at the stent ends. It should be noted that reduc-
ing the strut width or thickness will have a negative effect on the obtained
luminal gain after stent implantation. This parameter was, however, not
studied since the stents were implanted in a non-diseased vessel segment.
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Table 4.4: Radial strength, defined to be the external pressure causing a sudden
collapse of the stent structure, numerically determined for all stent designs, i.e.
the original ones and the modified stents CSthin and CSend.
Stent Radial strength [MPa]
Cypher Select 0.15
Endeavor 0.10
Taxus Liberte´ 0.10
CSthin 0.11
CSend 0.14
Stent designs are always a compromise between (often conflicting) design re-
quirements. They should be flexible enough to allow easy placement and to
minimize vessel straightening after deployment, while simultaneously offer-
ing a sufficient radial strength to resist the compressive forces of the dilated
vessel. Therefore, the three original DESs and the two modified stent de-
signs (CSthin and CSend) were subjected to a ‘virtual radial compression test’.
The results are reported in Table 4.4 in terms of radial strength defined as
the external pressure causing a sudden large decrease of the stent diameter.
The Cypher Select stent has the highest radial strength, although being
made of a weaker material than the Endeavor stent. This radial strength
results from the stent’s closed cell structure in combination with the robust
struts (width: 130µm, thickness: 140µm). The modified Cypher Select de-
sign with a reduced strut thickness of 100µm (CSthin) induces lower stresses
in the vessel wall, but this modification also significantly reduces the radial
strength. Therefore, the CSend stent might represent a good design com-
promise since it also leads to reduced arterial stresses, while maintaining a
high radial strength which might be required for certain types of lesions.
High restenosis rates up to 15% have been observed in the side branch after
stenting the main vessel, even in the drug-eluting stent area [4]. Suboptimal
drug delivery at the side-branch ostium due to incomplete strut coverage
and disturbed blood flow have been suggested as possible causes [154]. A
well-established procedure to improve the flow conditions and strut coverage
involves the dilation of an angioplasty balloon through the side of stent, fre-
quently performed simultaneously with a main branch dilation (i.e. kissing
balloon inflation) to avoid undesired stent deformation [87, 155]. However,
such an inflation may again cause additional endothelial damage at the
unstented entry of the SB. Our results show stress concentrations in the
neighborhood of the side-branch ostium for all stent designs. Hence, sig-
nificant stress gradients occur since the circumferential stresses within the
SB are negligible. These gradients may also contribute to or initiate the
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observed restenotic processes. Two stent techniques have been proposed
with the aim of providing full ostium scaffolding but they are often difficult
to perform and do not improve the outcome [4].
During the last decade, many advances have been made in the field of fi-
nite element stent modeling. On the tissue level, considerable progress has
been achieved regarding the accurateness of the arterial geometries and the
constitutive modeling of soft biological tissues, see, for example, [113, 156].
On the device level, more realistic balloon models have been introduced
and methods have been proposed to generate realistic models of existing
stents [126, 127]. In this study, the insertion of the stent system was in-
corporated in the simulations in order to position the stents in the curved
vessel. This introduces an additional level of complexity and provides more
refined results with the drawback of an increased CPU time.
One limitation of the current bifurcation model is the absence of a stenotic
plaque, although the feasibility of generating patient-specific stenotic ge-
ometries has been demonstrated in previous works [147, 157]. However,
these stenotic models are based on high-resolution images of ex vivo tissue
samples. Since the aim of the current study was to assess the influence of
stent implantations on vessel walls with realistic curvatures, in vivo-based
images were required. To the best of our knowledge, in vivo-based arterial
models including the various three-dimensional diseased components have
not yet been generated. Starting from luminal information originating from
rotational angiography, a three-dimensional model was here generated based
on assumptions regarding the wall thickness. The currently applied proce-
dure may be further improved by combining the angiographic images with
intravascular ultrasound data [98].
4.4 Conclusion
A novel simulation strategy considering the insertion of a stent system over
a guide wire in a curved coronary bifurcation has been proposed; the effect
of different second generation drug-eluting stents on arterial wall stresses
has been analyzed. The curved MB of the three-dimensional bifurcation
model was straightened after implantation of every stent investigated. The
compliance mismatch at the stent ends induced stress concentrations that
may cause biological responses. The maximum wall stresses caused by the
analyzed drug-eluting stents differ considerably. Two modified stent de-
signs, created by a parametric modeling technique, have been proposed as
an illustration of the virtual design methodology. Both designs significantly
reduce the stress peak at one stent end, demonstrating the potential of using
finite element modeling during the design phase of new devices.
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Chapter 5
Geometrical stent analysis
INTERVENTIONAL cardiologists are being overwhelmed by the largenumber of available stents offered by various medical device companies.
The optimal stent to treat every lesions will probably never exist because
the multitude of product requirements (e.g. optimal drug-delivery, biocom-
patibility, radiopacity, mechanical behaviour, etc.) turns the development
into a process of making compromises and results in dedicated stents opti-
mal for certain subsets of lesions. For example, reducing the strut thickness
(and thus the crossing profile) often has a negative impact on the radial
strength. This rises the question: ‘Which stents are preferred for which
types of lesions?’ For the given, simplified example, the most flexible stent
should be used when the vascular tree is highly tortuous, while the stent
having a high radial strength might be preferred to treat severely stenosed
vessels. In this chapter, an attempt is made to quantify and compare some
design aspects important for bifurcation stenting of a number of frequently
used stents1.
5.1 Stent cell size
5.1.1 Introduction
Stenting coronary bifurcation lesions is still associated with higher restenosis
rates compared to conventional stent implantation, even in the drug-eluting
1 Parts of this chapter were published in the journal, EuroIntervention:
Comparison of drug-eluting stent cell size using micro-CT: important data
for bifurcation stent selection
P. Mortier, D. Van Loo, M. De Beule, P. Segers, Y. Taeymans, P. Verdonck, and B.
Verhegghe
4:391–396, 2008
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stent era [41]. Adequate wall coverage and good positioning of the stent
struts against the vessel wall are considered as two crucial factors for suc-
cessful bifurcation stenting [41, 87]. This can be accomplished by applying
a suitable stenting technique and using an appropriate stent design. Select-
ing a stent design with a sufficiently large cell size reduces the possibility of
compromising the MB or SB lumen. For example, stent placement in the
MB is often followed by inflating a balloon through the side of the stent in
order to improve the SB lumen (and sometimes to create access for subse-
quent stent placement in the SB). In this case, the size of the cell through
which the balloon is inflated should preferably be as large as the SB ostium
(Fig. 5.1, panel A). The same condition applies to stents used during the
so-called ‘crush’ procedure. This is a technique which should be ended by
kissing balloon postdilatation [51] to obtain optimal deployment (Fig. 5.1,
panel B). The cell opening also plays a major role for culotte stenting, dur-
ing which a stent is implanted in the proximal part of the MB and in the
SB. Kissing balloon postdilatation is often performed to optimize the down-
stream lumen. To achieve optimal results, the cell size of this stent should
preferably be as large as the cross-section of the main branch (Fig. 5.1,
panel C).
The size of stent cells has already been reported in previous studies, based
on data provided by the manufacturers [45], or by measuring the width and
height of expanded stent cells [89, 158]. To our knowledge, an independent
method to measure stent cells with high precision has not been proposed
yet. Therefore, we developed a methodology to accurately quantify the cell
circumference of stents based on micro-CT scans. Furthermore, the size of
the ostium is calculated based on diameter and angle information for several
bifurcation geometries. Combining cell size with anatomical information
may assist to select the appropriate stent design for the applied treatment
technique and for the particular patient.
5.1.2 Materials and methods
5.1.2.1 Investigated stents
The cell circumference was determined for the following five ‘3 mm’ stents:
the sirolimus eluting Cypher (8 mm length, Cordis, Johnson & Johnson,
Warren, NJ, USA), PRO-Kinetic (18 mm length, Biotronik, Berlin, Ger-
many), the paclitaxel eluting Taxus Liberte´ (32 mm length, Boston Sci-
entific, Natick, MA, USA), the everolimus eluting Promus (12 mm length,
Boston Scientific, Natick, MA, USA) and the ABT-578 eluting Endeavor
(12 mm length, Medtronic, Minneapolis, MN, USA ) stent. The Cypher
and Taxus Liberte´ stent are stainless steel stents, while the others are made
of the stronger cobalt chromium alloy. The PRO-Kinetic stent is coated
with a silicon carbide layer. The Promus stent uses the Multi-Link Vision
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Figure 5.1: Stent cell requirements for different stenting strategies (the zone of
interest is indicated with a dotted line). When performing provisional bifurcation
stenting, the stent cells should be at least as large as the SB ostium (panel A). The
same condition is valid for both the side and MB stent during crush stenting (panel
B). The situation as shown in panel C is encountered during culotte stenting and
in this case, the cells should be at least as large as the cross-section of the MB..
stent platform and is identical to the Xience V stent (Abbott Vascular,
Redwood City, CA, USA).
5.1.2.2 Micro-CT
All stents were scanned as delivered by the manufacturer in their crimped,
balloon-mounted state. In order to obtain accurate results on the stent cell
dimensions, only 8 mm of the total stent length was scanned using a Varian
Paxscan 2520V X-ray amorphous-Si flat panel detector with 1536x1920 pix-
els of 127µm. With a magnification factor of 34, this results in a CT voxel
size of 4.3µm. The in-house built high resolution set-up at the UGCT
facility [119] used for this investigation consists of a Feinfocus open type
X-ray tube (Xylon/Feinfocus, Comet Group, Flamatt, Switzerland) with
transmission target and a sample manipulator with air bearing rotation
stage. The X-ray tube was used at 100 kV and 2.7 W with the resolution
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of this total system under 2µm. The scans consisted of 600 projection
images (0.8 sec integration time) that were reconstructed using Octopus
reconstruction software developed at UGCT [159]. The resulting dataset
of cross-sectional images was imported into Mimics (Materialise, Leuven,
Belgium) where a triangulated surface mesh of the stents was created and
exported in the stl format.
5.1.2.3 Cell circumference determination
The triangulated surfaces representing the stents outer surfaces were im-
ported in pyFormex [130], open-source software currently under develop-
ment at our institution. pyFormex is a tool for generating, manipulating
and operating on large geometrical models of 3D structures by sequences
of mathematical transformations. The stent geometries were unrolled by
transforming the coordinates and were cut by a plane after selection of a
smaller zone in order to obtain planar line segments. Subsequently, a cell
was selected for each stent from the resulting collection of two-dimensional
lines and used to determine the cell circumference. This cell circumference
was then used to calculate the corresponding maximum achievable diameter
(Dmax) of the cell opening that can be obtained upon inflation of a balloon
through the side of the stent. This Dmax is equal to the cell circumference
divided by pi.
5.1.2.4 Calculation of ostium circumference
The ostium circumference was determined for idealised bifurcations with a
cylindrical MB and SB starting from a parametric description of the ostium,
which is the threedimensional line indicated in Fig. 5.2. The ostium was
written as a function of the MB axial position: x = f(z) and y = f(z) with
z the MB axis. Subsequently, the ostium circumference was calculated as
the sum of the length of infinitesimal small line segments. The resulting
circumference depends on the MB and SB diameters and on the angle of
intersection.
5.1.3 Results
5.1.3.1 Cell circumference
The different steps of the cell circumference measurement procedure are
shown in Fig. 5.3 for the Cypher stent. Panel A shows the triangulated
surface obtained after reconstruction and segmentation of the micro-CT
images. A mathematical transformation of the coordinates of all trian-
gles results in an unrolled stent geometry (panel B), which is still three-
dimensional. Subsequently, a small zone containing one cell is selected
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Figure 5.2: The size of the ostium depends on the bifurcation angle and the SB
and MB diameters. The ostium is described by a three-dimensional curve from
which the circumference can be calculated.
(panel C). The planar line segments depicted in panel D are obtained after
intersection of this three-dimensional geometry with a plane. This can then
be used to select a single cell and to calculate its circumference, as shown
in panel E.
Applying the same methodology to the other stents results in the planar cells
shown in Fig. 5.4. The cell circumferences and the corresponding maximum
achievable diameters of the different stents are summarized in Table 5.1.
The cells of the Cypher stent have the smallest circumference (i.e. 9.5 mm
or Dmax = 3.0 mm), whereas the Endeavor stent has the largest openings
(circumference = 19.8 mm or Dmax = 6.3 mm).
Table 5.1: Overview of the cell circumferences and the corresponding equivalent
diameters. These are the maximum diameters of the strut openings that can be
obtained upon inflation of a balloon through those openings.
Stent Cell circumference
Maximum achievable
cell diameter Dmax
Cypher 9.5 mm 3.0 mm
Endeavor 19.8 mm 6.3 mm
PRO-Kinetic 10.8 mm 3.4 mm
Promus 12.6 mm 4.0 mm
Taxus Liberte´ 12.6 mm 4.0 mm
5.1.3.2 Ostium circumference
The ostium circumference is displayed as a function of the angle of inter-
section for a 3 mm MB (Fig. 5.5). The results are shown for three possible
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Figure 5.3: Demonstration of the complete procedure to obtain a single cell of
the Cypher stent. The cell circumference can then easily be calculated as the sum
of the length of all planar line segments of this cell.
SB diameters (i.e. 2.25, 2.50 and 2.75 mm).
5.1.4 Discussion
Cell circumferences of the studied DES designs differ considerably, with val-
ues ranging from 9.5 to 19.8 mm or with a maximal achievable cell diameter
103
Figure 5.4: Comparison of microscopic images with the resulting planar repre-
sentations of the cells. The microscopic images do not have the same scale. From
top to bottom: Endeavor, PRO-Kinetic, Promus and Taxus Liberte´.
(Dmax) varying between 3.0 and 6.3 mm. These stent openings play an
important role, especially during bifurcation stenting [45,89]. For example,
dilating a balloon through the side of a main branch stent with openings
that are too small will fail to completely restore the SB lumen due to ob-
structing stent struts. Struts not in contact with the vessel wall should be
avoided as this may cause thrombus formation [87]. The large variation of
the cell sizes of the investigated stents are explained by the different design
concepts. The Cypher stent is a typical example of a closed cell design,
whereas all other stents can be classified as open cell designs.
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Figure 5.5: The ostium circumference of a 3 mm parent vessel is shown as a
function of the SB diameter and the bifurcation angle.
Combining cell size with anatomical data may assist to select a stent for
a given bifurcation stenting problem. This requires knowledge of the os-
tium circumference, which, as we have shown, can be mathematically calcu-
lated when idealizing the bifurcation geometries with a cylindrical MB and
SB. Real-life bifurcations will certainly have a more complex anatomy [11]
(e.g. ostial calcification and/or tortuosity), but these calculated values are
still valuable as they are at least indicative and provide an idea of the order
of magnitude. In the idealized case, the ostium circumference depends on
the MB and SB diameter and on the angle of intersection. The relation be-
tween the angle and the ostium circumference is clearly nonlinear (Fig. 5.5)
as the circumference varies more rapidly at small angles. This indicates
that special attention should be paid to the selection of a stent which will
be implanted in the MB of a small angled bifurcation. In Fig. 5.6, the stent
cell circumferences are plotted on these graphs. The dark zones show the
cases in which the ostium circumference is larger than the cell circumference
when the stents are deployed in a 3 mm MB (for three different SB sizes).
For example, when a Cypher stent is implanted in a bifurcation with a 3 mm
MB, 2.5 mm SB and a 40 degree angle, the ostium circumference (10.8 mm)
is larger then the cell circumference (9.5 mm). Therefore, it is highly likely
that in these cases the cells will not be sufficiently enlarged by balloon di-
latation through the side (and final kissing balloon postdilatation) and that
not all stent struts will be in contact with the vessel wall.
The presented cell data are also useful for stents partially deployed in the
MB and SB as encountered during culotte stenting. These stents should
preferably have cells with a Dmax greater than the distal MB diameter.
If this condition is not respected, it is highly likely that gaps will occur
between some struts and the vessel wall.
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Figure 5.6: The grey zones indicate the cases in which the ostium circumference
is larger than the cell circumference when the stents are deployed in a 3 mm MB
(for three different SB sizes). Therefore, it is highly likely that in these cases
(i.e. cases within grey zone) the cells will not be sufficiently enlarged by balloon
dilatation through the side. The Endeavor stent is not shown because the cells
can be sufficiently enlarged in all cases.
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Accurate geometrical information of the bifurcation (MB and SB diameters
and angle) is very important in order to apply the presented stent selec-
tion method in clinical practice. The most critical parameter is the angle
of intersection. Dedicated software may help to accurately determine this
bifurcation angle [160].
Selecting stents with large openings will reduce the risk of limited side (or
main) branch patency after dilating through the side, but using such stents
may result in inferior wall scaffolding/coverage and larger tissue prolapse
[161]. Besides the stent cell size, a large number of other stent properties
influence the choice for a particular stent, such as flexibility, conformability,
trackability and radial strength. Furthermore, such careful selection based
on cell size does not guarantee optimal stent deformation as these stents
are not developed to treat bifurcation lesions. There is clearly a need for
dedicated devices allowing easy and safe treatment while providing optimal
scaffolding and minimizing luminal obstruction.
5.1.5 Limitations
Although the proposed method gives additional information to interven-
tional cardiologists, it should be stressed that selecting an appropriate stent
is more complex than depicted by mathematical modelling. For example,
bifurcation angles may change following stent implantation. In addition,
stent selection in clinical practice is based on a large number of design as-
pects and cell size is only one of them (e.g. flexibility, radial strength, etc.).
It has been shown that strut fracture may occur after SB dilatation [87] at
high pressures using a large balloon (e.g., 4 mm nominal diameter). Such
behaviour is not taken into account by the proposed methodology, which
uses the original (non-fractured) cells as input. However, strut fracture
should be avoided since it has been suggested for peripheral vessels that
stent fracture is related to higher restenosis rates [162].
The proposed criterion to select stents with a cell circumference which is
larger than the ostium circumference is too strict in case of partial stent
deployment within the SB as demonstrated in Fig. 5.7. This means that the
criterion is worst-case and guarantees the selection of stents with sufficiently
large openings independent of the deployment behaviour of the stent (partial
deployment within side branch or not).
5.1.6 Conclusion
We applied an innovative measurement technique based on micro-CT im-
ages to assess cell sizes of five 3 mm stents, and observed a considerable
variation. This should be taken into account when applying a particular
bifurcation stenting technique for a specific lesion as the selection of a stent
107
A
B
Figure 5.7: Panel A shows the worst-case situation which was used in this work
(no partial stent deployment in the SB). This situation requires larger cells (at
least as large as ostium) than in case of partial stent deployment in the SB (panel
B).
with cells that are too small will inherently lead to suboptimal deployment
and obstructing struts.
5.2 Strut density
5.2.1 Introduction
The cell size is not the only important design parameter for bifurcation
stenting. At the European Bifurcation Club in Prague (2008), dr. van Ge-
uns (Erasmus Medical Center, Rotterdam, The Netherlands) mentioned
that he experienced a different level of complexity when inserting a balloon
catheter into the SB through the struts of a MB stent, depending on the
implanted stent design. This could be explained by the observation that
some stents lead to more obstructing struts at the SB ostium, as depicted
in Fig. 5.8. Of course, the number of obstructing struts will also depend on
the relative position of the stent with respect to the SB ostium. The degree
of obstruction is related to the size of the gaps between individual struts.
Some expanded stents display a high strut density, meaning that the gaps
between the struts are small, while the Cypher Select leads to a lower strut
density.
Beside the SB accessibility, the strut density also affects a number of other
parameters, such as drug delivery, tissue scaffolding and balloon-artery con-
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Cypher Select Endeavor Taxus Liberte
Figure 5.8: View into the SB after virtual implantation of three different DES in
the MB. The number of struts at the SB ostium, which is indicated with a dotted
line, is totally different for the three stent designs. Intuitively, it seems easier to
advance a guide wire and a balloon catheter into the SB after implantation of the
Cypher Select stent.
tact. Stent designs with a high strut density will lead to a more uniform
drug delivery and will minimize the tissue prolapse between the struts. A
higher strut density also reduces the contact area between the balloon and
the endothelial cells. This is important since Squire [33] has shown that
direct balloon-artery contact leads to endothelial denudation. This param-
eter clearly illustrates the conflicting design requirements which are often
encountered. On one hand, strut density should be as high as possible for
optimal drug delivery and tissue scaffolding, while on the other hand, good
SB accessibility requires a low strut density.
A novel methodology is proposed to quantify the strut density, as this is an
important design parameter. Different stent designs are compared and also
the impact of the stent expansion diameter is investigated.
5.2.2 Materials and methods
Five coronary balloon-expandable ‘3 mm’ stents were included in this study:
the Taxus Liberte´ stent (Boston Scientific), the Cypher stent (Cordis,
Johnson & Johnson), the Coroflex stent (BBraun), the Endeavor stent
(Medtronic) and the Promus stent (Boston Scientific). Two micro-CT scans
were performed on each crimped stent in order to get accurate geometri-
cal information. The in-house built high resolution set-up at the UGCT
facility [119] was used for the scans. All stents were first scanned at lower
resolution (7µm voxel pitch) in order to obtain the entire geometry of the
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stents and subsequently at high resolution (1µm voxel pitch) to obtain more
detailed information on the stent strut dimensions.
The CT data was used to generate parametric models in pyFormex [130],
which are easily adaptable and readily converted to high quality hexahedral
meshes which are used for the finite element simulations in ABAQUS (Das-
sault Syste`mes). A displacement driven simulation strategy was adopted to
virtually expand the stents up to 3.5 mm inner diameter as shown in Fig. 5.9
for the Coroflex stent [126].
Figure 5.9: Illustration of the cylindrical, displacement driven expansion proce-
dure for the Coroflex stent. The crimped stent is shown in the left panel, while the
right panel depicts the deformed stent when the cylindrical tube has a diameter
of 3 mm.
The strut density was quantitatively analyzed by calculating the maximum
inscribed circle for a deformed, unrolled cell of the virtually expanded stent.
This approach clearly has a number of limitations but is straightforward to
calculate. The most important disadvantage is that stent A with completely
circular cells with a certain radius R will have the same maximum inscribed
circle as design B with ellipsoid cells with small radius R. Although both
designs have the same maximum inscribed circles, design B will lead to more
tissue protrusion and lower drug concentrations.
The maximum inscribed circle was determined for every output frame and
thus the strut density could be monitored as a function of the stent diameter.
The main steps to calculate the maximum inscribed circle are listed below:
1. A deformed stent cell was selected and unrolled in order to obtain a
planar curve.
2. A regular grid was generated within the bounding box of the unrolled
cell.
3. The set of grid points was split into two subsets, the points within the
cell and the points outside the cell.
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4. For every point lying within the cell, the minimal distance from that
point to the stent cell was calculated. This gives a list with minimal
distance values.
5. From the list with the minimal distance values, the maximum value
gives the radius of the maximum inscribed circle.
The grid density was increased until the radius of the maximum inscribed
circle converged. The applied procedure to determine the maximum in-
scribed circle is illustrated in Fig. 5.10.
Figure 5.10: Illustration of the procedure to determine the maximum inscribed
circle for the Cypher stent. The black line represents an unrolled stent cell at a
stent diameter of 3 mm. The generated regular grid of points is divided into the
points within (green) and outside (red) the cell. From all inner points, the point
lying at the maximum distance from the cell is selected. This point is the center
of the maximum inscribed circle. The grid used to generate this figure is clearly
not fine enough, since the circle only touches the cell at one location.
5.2.3 Results and discussion
The basic principle of all balloon-expandable stents is identical. Inflation of
a balloon leads to an important diameter increase of a cylindrical (mostly
metal) strut pattern by plastic deformation. But the number of possible
strut patterns is almost infinite, and this leads to important differences
in the (mechanical) characteristics of these types of stents. This is also
reflected in Fig. 5.11, which shows the deformed cells and the associated
maximum inscribed circles at a stent diameter of 3 mm. Analyzing one cell
per stent seems sufficient for these stents, since they have a very regular
design with one type of cell. In addition, the displacement driven expansion
mechanism leads to almost identical deformations of all the cells. This is,
111
of course, a simplification of reality, since non-uniform stent deformations
occur, caused for example by the folded shape of the balloon and the non-
uniform stent deformation after crimping.
Promus Coroflex
Taxus Liberte Cypher Endeavor
0.65 mm
1.13 mm
1.07 mm
1.23 mm 0.72 mm
Figure 5.11: Comparison of the deformed cells of the five investigated stents at
an inner stent diameter of 3 mm. The maximum inscribed circle and the corre-
sponding diameter are drawn in red.
Figure 5.11 only shows the cell deformation for one particular stent diame-
ter (i.e., 3 mm), but stents may be underexpanded or overdilated in clinical
practice. Therefore, it is important to know how the cells deform and how
the maximum inscribed circles change when the stent diameter varies. Fig-
ure 5.12 shows the deformed cell of the Taxus Liberte´ stent at a diameter
of 2.5, 3.0 and 3.5 mm. The diameter of the maximum inscribed circle in-
creases considerably as the individual struts tend to move away from each
other.
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2.5 mm 3.0 mm 3.5 mm
0.50 mm
0.65 mm 0.74 mm
Figure 5.12: Comparison of the deformed cell of the Taxus Liberte´ stent at
different stent diameters. The corresponding stent diameter is indicated below
every cell.
The observation that the diameter of the maximum inscribed circle increases
when the stent diameter enlarges is true for all investigated stents as quan-
titatively illustrated in Fig. 5.13 since the slope of all the curves is positive.
This observation has an important clinical consequence as it means that an
overdilation of the main vessel stent may facilitate guide wire and balloon
catheter introduction into the SB. Ideally, this should be done by postdilat-
ing the expanded stent with a short dedicated balloon in order to minimize
the arterial trauma. This effect may be less pronounced for the Promus
stent, since the strut density seems quite constant in the considered stent
diameter interval. A constant strut density may be preferred for unbranched
vessels since this results in the same amount of tissue scaffolding, indepen-
dent of the stent diameter. Figure 5.13 also shows that the strut density
is markedly higher for the Endeavor and Taxus Liberte´ stent. Advancing a
balloon catheter through the struts of these cells may be more difficult then
for the other three stents.
5.2.4 Limitations
This purely geometrical analysis clearly has a number of limitations. The
maximum inscribed circle gives some information about strut density, but
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Figure 5.13: Quantitative comparison of the impact of the stent diameter on the
strut density which is here reflected by the diameter of the maximum inscribed
circle.
does not take into account some other aspects which also might have an
impact on the SB accessibility. For example, a particular stent design can
have cells with a large maximum inscribed circle with a lot of struts between
the individual cells. If one of the cells is aligned with the SB ostium, then
it should be relatively easy to insert a balloon catheter into the SB. But, on
the other hand, when one of the zones between these large cells is positioned
at the SB ostium, then the SB accessibility will be much lower. In addition,
the side branch accessibility may also be influenced by the stent material,
strut thickness and strut shape.
Strut deformations during the insertion of the SB balloon catheter through
the MB stent were neglected. However, this insertion might exert forces on
some struts and lead to strut deformations and improved SB accessibility.
Parameters such as strut thickness and stent material will probably have an
effect on these deformations.
5.2.5 Conclusions
Strut density is an important design parameter which affects the SB acces-
sibility during provisional stenting, drug delivery and tissue scaffolding. An
attempt was made to quantify the strut density of five different stents by
calculating the maximum inscribed circle for the deformed stent cells. This
parameter varied considerably among the considered stents. An important
observation is that the size of the maximum inscribed circle increases when
the stent diameter enlarges. Translated into practice, this means that over-
expansion may help to advance a balloon catheter into the SB after stenting
the MB.
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Chapter 6
Virtual investigation of a
novel provisional bifurcation
stent system
THE usefulness of the developed finite element simulation techniqueswas clearly demonstrated in the previous chapters, where they were
applied in the field of bifurcation stenting to compare different existing
stent designs. But besides using these models to better understand the me-
chanics of currently available stents, they can also be incorporated in the
design process of new devices to perform virtual prototyping and design op-
timization. This virtual approach can lead to a reduced time-to-market and
to better performing device designs as it avoids the need to manufacture
every design iteration and provides a better understanding of the device
mechanics, especially when the device dimensions are small as is the case
for stents. This is illustrated in this chapter where finite element simula-
tions were employed during the initial design phase of a novel provisional
bifurcation stent system1.
6.1 Introduction
6.1.1 Current limitations of provisional stenting
Although the provisional approach is currently the gold standard to treat
bifurcation lesions, it still faces a number of challenges. First, recrossing
1 There is a conflict of interest regarding the study described in this chapter, as it is
based on investigations carried out as a consultancy project for Boston Scientific.
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into the SB with a guide wire and balloon catheter to perform final kissing
balloon inflation can sometimes be time consuming due to the obstructing
floating struts at the SB ostium. This was discussed in chapter 5 where
the strut density of different expanded stents was compared. A lower strut
density improves the SB accessibility but negatively affects the drug delivery
and tissue scaffolding. This immediately leads to the second limitation
of using current DES for provisional stenting. If the proximal or distal
MB diameter is used to determine the stent diameter, then the stent will
be overexpanded in the bifurcation region where the vessel cross-section is
much larger. This leads to a lower strut density in the bifurcation region
as compared to the proximal and distal segment and therefore, results in
suboptimal tissue scaffolding and drug delivery. A denser packing of the
struts is required in the bifurcation region in order to obtain the same
level of tissue scaffolding after final kissing balloon inflation as compared to
the proximal and distal section. This obviously leads to conflicting design
requirements with respect to the SB accessibility. A denser packing of the
struts will lead to a higher strut density after the initial MB stent expansion
and thus increase the degree of obstruction at the SB ostium. The third
limitation is related to the introduction of the guide wire into the SB. It has
been shown by bench testing that this wire has to be advanced through the
most distal cell at the SB ostium in order to obtain optimal strut positioning
after final kissing balloon inflation [163]. However, doing this in clinical
practice may not always be obvious.
In order to minimize the previously mentioned limitations, Boston Scientific
currently investigates the feasibility of a novel dedicated stent design and
procedure for provisional stenting, that has been developed in conjunction
with dr. Sjo¨gren (Falun Hospital, Falun, Sweden).
6.1.2 Dedicated bifurcation stent design
The design of the dedicated bifurcation stent is based on the Liberte´ stent
(Boston Scientific, Natick, MA, USA), though has an adapted denser strut
pattern in the central stent region. The ring elements in this central zone
(one ring is indicated with a red line in Fig. 6.1) can be expanded to a
larger diameter as compared to the ring elements in the distal and proximal
stent sections because the circumference of these rings is larger. There-
fore, this central part of the stent should be positioned at the bifurcation
ostium. Within this denser central part, the circumference of the ring ele-
ments gradually increases from the proximal to the distal side in order to
provide optimal ostium scaffolding. The distal and proximal stent sections
are identical to the Liberte´ design. The complete single wire stent system
is further characterized by a low crossing profile (similar to conventional
stents), and does not require rotational orientation.
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Distal Proximal
Modified central stent region
Figure 6.1: Unrolled bifurcation stent geometry which is based on the Liberte´
design with an altered central strut pattern. One ring element in the central zone
is indicated with a red line. The length of this red line or ring element is larger
then the length of similar ring elements in the distal or proximal zone. Therefore,
the central part can be expanded to a larger diameter which is necessary at the
location of the bifurcation in order to provide at least partial support to the SB.
6.1.3 Bifurcation stenting procedure
In an attempt to overcome the current limitations of provisional stenting,
Boston Scientific investigates the feasibility of applying a slightly modified
provisional stenting procedure which involves the following steps:
 First, the dedicated stent is deployed within the MB using a standard
non-compliant 72D PEBAX balloon (i.e. provisional stenting).
 During a second step, a dedicated balloon (a compliant 63D PEBAX
balloon or a bulge balloon) will be inflated within the already ex-
panded stent with the aim of (i) causing strut protrusion within the
SB, hereby improving the SB accessibility; (ii) providing ostium scaf-
folding and (iii) facilitating guide wire and balloon catheter insertion
through a distal cell at the ostium as this is not always trivial in
current clinical practice.
 Finally, single or kissing balloon inflation should be performed to push
all struts against the vessel wall. In some cases, it might be necessary
to implant a second stent in the SB.
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6.1.4 Objectives
The previously described device and procedure was investigated using finite
element simulations in which balloon materials and size, inflation pressure,
stent design and target vessel geometry were varied with the aim of assessing
the most important design and or procedural parameters. Furthermore, the
impact of small positioning inaccuracies was investigated.
6.2 Materials and methods
6.2.1 Geometrical models
6.2.1.1 Stent
The unrolled geometrical model2 of the dedicated bifurcation stent is de-
picted in Fig. 6.1. This CAD model was imported into pyFormex [130] and
subsequently approximated by a hexahedral mesh which was created using
a sweep based meshing approach. Finally, the cylindrical stent structure
was obtained by performing a mathematical transformation of the nodal
coordinates of each element.
6.2.1.2 Balloon
Three balloon geometries were created (see Fig. 6.2): (i) The bifurcation
stent is crimped on a non-compliant 72D PEBAX balloon (3.31 mm initial
diameter, 3.5 mm nominal diameter, 16 mm length), which is pleated with
5 folds around the catheter. During a first step, a hybrid mesh (i.e. both
triangular and quadrilateral elements) of the unfolded balloon was created
using pyFormex. Subsequently, a mathematical transformation as described
by Laroche et al. [123] was used to obtain the 5-folded balloon. (ii) An
identical method was used to generate the folded geometry of a compliant
63D PEBAX balloon (4.24 mm initial diameter, 4.5 mm nominal diameter,
8 mm length). (iii) The unfolded geometry of the bulge balloon was created
with ABAQUS/CAE (a folded configuration was not necessary for both
the compliant and the bulge balloon as these balloons are inflated within an
already expanded stent). A uniform wall thickness of 17.78µm was assumed
for all the investigated balloons3.
2 Data provided by Boston Scientific
3 Data provided by Boston Scientific
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Figure 6.2: Non-inflated unfolded balloon geometries (left panel: standard non-
compliant 72D PEBAX balloon, middle panel: compliant 63D PEBAX balloon,
right panel: non-compliant bulge balloon). The scale of the different balloons is
not exactly the same.
6.2.1.3 Arterial bifurcation
The hexahedral meshes of the bifurcation models were created using the
isoparametric transformations, which are implemented in pyFormex. The
reference bifurcation model has a proximal MB diameter of 3.5 mm, a distal
MB diameter of 2.8 mm and a SB diameter of 2.4 mm which is in accordance
with the anatomical analysis of Finet et al. [11]. The bifurcation angle is
50 degrees and the outer diameter was determined as 1.6 times the inner
diameter [12]. The complete bifurcation is shown in Fig. 6.3.
2.8 mm 3.5 mm
2.4 mm
50 degrees
Outer diameter =
1.6 times inner diameter
Figure 6.3: Reference bifurcation model.
6.2.2 Constitutive models
6.2.2.1 Stent
The bifurcation stent is made of stainless steel, which is characterized by a
Young’s modulus of 213756 MPa, a Poisson’s ratio of 0.25 and a yield stress
of 210 MPa.
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6.2.2.2 Balloons
The applied constitutive models of the three balloons are based on the ex-
perimentally observed pressure/diameter relationship of each balloon4. The
methodology to derive the material behaviour from pressure/diameter data
is based on the thin shell membrane theory [94, 126, 127]. The Poisson’s
ratio was assumed to be 0.4 for all balloons and the resulting elastic ma-
terial properties are summarized in Table 6.1. Since the material of the
non-compliant bulge balloon is identical to the one of the standard non-
compliant balloon used for the initial stent expansion, it was expected to
obtain a similar Young’s modulus (i.e. 970 MPa). However, using a Young’s
modulus of 970 MPa makes the bulge balloon too stiff as compared to the
experimental data provided by Boston Scientific. This is probably related
to the manufacturing procedure of the bulge balloon, which may result in
modified material properties and/or membrane thickness. Using a value of
700 MPa provided pressure-diameter data matching the experimental data.
As such, a value of 700 MPa was further assumed.
Table 6.1: The material properties of each balloon were calculated based on the
provided pressure/diameter data. This calculation results in stress/strain data,
which are approximated by a Young’s modulus. However, the compliant balloon
demonstrates a considerable non-linear behaviour, and therefore, the constitu-
tive behaviour is approximated by a first Young’s modulus in the low pressure
range (i.e. 465 MPa) and a second Young’s modulus in the high pressure range
(i.e. 700 MPa).
Balloon
Young’s modulus
[MPa]
non-compliant 72D PEBAX balloon 970
compliant 63D PEBAX balloon (low pressures) 465
compliant 63D PEBAX balloon (high pressures) 700
non-compliant 72D PEBAX bulge balloon 700
6.2.2.3 Arterial wall
The arterial wall behaviour was modelled using a homogeneous hyperelastic
law as described by Prendergast et al. [136]. The strain energy function has
a polynomial structure of the third order and the non-zero coefficients are
given in Table 6.2.
4 Data provided by Boston Scientific
121
Table 6.2: Non-zero coefficients of the third order polynomial strain energy
function used to describe the mechanical behaviour of the arterial wall (according
to the ABAQUS conventions).
C10 0.0189
C01 0.00275
C20 0.59043
C11 0.08572
6.2.3 Discretization
The finite element mesh of the stent model consisted of 33444 8-node hexa-
hedral elements with reduced integration (C3D8R). The same element type
was chosen for the arterial wall mesh, which contains 5760 hexahedrons.
The balloons were meshed with membrane type elements and both trian-
gular (M3D3) and quadrilateral elements were used (M3D4). The mesh
of the non-compliant 72D PEBAX balloon consisted of 11305 M3D4 and
2640 M3D3 elements, whereas the compliant 63D PEBAX balloon model
contained 7370 M3D4 and 4590 M3D3 elements. Only quadrilateral M3D4
elements were used to mesh the non-compliant 72D PEBAX bulge balloon
(i.e. 5796 elements).
6.2.4 Simulation steps
ABAQUS/Explicit was used to solve the large deformation problems, as
this solver provides a very stable general contact algorithm. A static fric-
tion coefficient of 0.2 was used to define all contacts. This penalty factor
is acceptable for steel-steel and nylon-steel contact [94]. The friction coef-
ficient for stent-artery interactions however is unknown, though assuming
frictionless behaviour would also be incorrect. The balloon and arterial ends
were completely constrained during the analyses. No boundary conditions
were imposed on the stent.
The simulation of the complete bifurcation stenting procedure was per-
formed in a number of steps (see Fig. 6.4):
1. The stent is crimped on the folded balloon by reducing the diameter
of a semi-rigid cylinder.
2. A gradually increasing pressure acts on the inner surface of the folded
balloon in order to expand the crimped stent in the bifurcated blood
vessel. After reaching the maximum (i.e. 1.8 MPa), the pressure was
slowly removed to account for the recoil of the system.
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3. The unfolding of the balloons (i.e. bulge and compliant balloon) used
for the postdilatation was not simulated in order to decrease the com-
plexity of the computations. The diameter of the unfolded unpressur-
ized balloon geometry was decreased by reducing the diameter of a
semi-rigid cylinder. This was necessary as the unfolded balloon diam-
eter was larger then the expanded stent diameter.
4. Finally, the postdilatation balloon was gradually inflated and subse-
quently deflated.
The semi-rigid cylinders used for the crimping of the stent and for the
diameter reduction of the bulge balloon are not shown in Fig. 6.4 in order
not to overload the figure.
1) Initial configuration 2) Crimped stent
3) Stent expansion 4) Diameter reduction bulge balloon
5) Bulge balloon inflation 6) Final stent deformation
Figure 6.4: Schematic overview of the different simulation steps.
6.2.5 Finite element simulations
First, the accuracy of both the simulations and the calculated balloon ma-
terial models was verified. Therefore, all three balloon models were inflated
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and the compliance behaviour (i.e. pressure-diameter relation) was com-
pared with experimental data5. Similarly, the free stent expansion was
validated using experimental pressure-diameter data. Finally, the expan-
sion of the stent within a rigid bifurcation (the diameter of all branches was
3 mm and a bifurcation angle of 45 degrees) followed by a postdilatation
with the non-compliant bulge balloon was simulated. The same procedure
was carried out experimentally in a similar rigid in vitro model. The result-
ing strut protrusions into the SB are compared to assess the accuracy of the
finite element simulation of the complete bifurcation stenting procedure.
Based on preliminary animal experiments and on two simulations comparing
the non-compliant bulge balloon with the compliant balloon for postdilat-
ing the expanded stent (see section 6.4), Boston Scientific decided to only
continue with the compliant balloon in the subsequent investigation and
optimization phase. In this final phase, the effect of the following design
and procedural parameters was quantified:
 Stent design: the stiffness of central stent region was decreased by
reducing the strut width in that area to 60 and 80 percent of the
original strut width (see Fig. 6.5).
 Pressure: the maximum inflation pressure within the compliant bal-
loon was modified (0.8, 1.1, and 1.4 MPa).
 Balloon size: compliant balloons with different sizes were compared
(initial diameter 4.0, 4.24 and 4.5 mm).
 Balloon compliance: the Young’s modulus of the compliant balloon
was varied (Young’s modulus of 400, 500, 600 and 700 MPa).
 Bifurcation anatomy: both the impact of bifurcation angle and ves-
sel diameters was investigated by comparing the bifurcation stenting
technique for six bifurcation models (see Table 6.3 and Fig. 6.6). All
bifurcation models are in accordance with the anatomical data of Finet
et al. [11].
 Positioning inaccuracies: two simulations were performed to examine
the impact of inaccurate placement. In the first one, the stent was
translated over 4 mm resulting in misplacement of the central stent
zone. This modified part of the stent design was then no longer located
at the bifurcation ostium. During a second simulation, the stent was
accurately positioned but the compliant balloon was translated over
6 mm.
5 Data provided by Boston Scientific
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Distal Proximal
Central stent region
Figure 6.5: The three depicted stent designs have a different strut width in the
central stent region, but the distal and proximal ends are identical. The upper
panel shows the design where the strut width has been reduced to 60 percent of
the original width, whereas the middle panel shows the design with a reduction
to 80 percent of the original width. The bottom panel depicts the original design
as shown in Fig. 6.1 without reduced strut width.
Unless otherwise stated, the stent is expanded in the reference bifurcation
model (see Table 6.3) and the postdilatation is carried out using a compli-
ant balloon with an initial diameter of 4.24 mm and a Young’s modulus of
700 MPa.
6.2.6 Postprocessing
Comparison and quantification of different design and/or procedural param-
eters requires the introduction of operator independent criteria. As the aim
of postdilatation is to obtain partial ostium scaffolding and strut protrusion
into the SB, a first new quantification parameter is introduced: the maxi-
mal strut protrusion (MSP). The MSP is the maximum distance from the
centerline of the MB to a stent strut at the location of the ostium minus the
radius of the proximal main vessel. Figure 6.7 shows the MSP schematically.
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Table 6.3: Overview of the investigated bifurcation models (DPMB = proximal
MB diameter, DDMB = distal MB diameter, DSB = SB diameter). The model
abbreviation is related to the model size (Small, Medium and Large) in combi-
nation with the bifurcation angle (50 or 80). The reference bifurcation model is
indicated in bold (i.e. M50).
DPMB / DDMB / DSB
50 degrees
bifurcation angle
80 degrees
bifurcation angle
3.0 mm / 2.4 mm / 2.0 mm S50 S80
3.5 mm / 2.8 mm / 2.4 mm M50 M80
4.0 mm / 3.2 mm / 2.7 mm L50 L80
S50 S80
M50 M80
L50 L80
Figure 6.6: Overview of the different bifurcation models (the abbreviations are
explained in Table 6.3).
A second quantification parameter reflects the overdilatation of the distal
MB, because using an oversized compliant balloon at too high pressure
might result in too large distal MB diameters and potentially in rupture of
the vessel. Therefore, the overdilatation coefficient (OC) is the percentage
increase of the distal MB diameter:
OC =
DDMB,post −DDMB,pre
DDMB,pre
(6.1)
DDMB,pre is the distal MB diameter prior to stenting, whereas DDMB,post
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MSP
Figure 6.7: Schematic illustration of the maximal strut protrusion (MSP). The
MSP is the maximal distance from the axis of the main vessel to a stent strut at
the SB ostium minus the radius of the proximal main vessel.
is the distal MB diameter after stenting and subsequent postdilatation. This
distal MB diameter is measured 7 mm distal to the bifurcation center as
indicated in Fig. 6.8.
7 mm
Figure 6.8: Schematic illustration of the overdilatation coefficient (OC). The ver-
tical line within the distal MB indicates the cross section used for the calculation
of the overdilatation coefficient (OC).
6.3 Validation of the finite element simula-
tions
6.3.1 Validation of free balloon expansion
The calculated material properties for all balloons were validated by com-
paring the numerical results of a free balloon expansion with experimental
data (i.e. pressure-diameter relationship)6.
6 Data provided by Boston Scientific
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6.3.1.1 Non-compliant 72D PEBAX balloon
The validation of the compliance behaviour of the non-compliant 72D PE-
BAX balloon is depicted in Fig. 6.9. The maximum percentage difference
in diameter is less than 6 percent and occurs at a pressure of 0.1 MPa. At
this pressure, the balloon is already unfolded but is still in a transient state
as shown in Fig. 6.9 (right panel). The experimental values and the nu-
merically predicted behaviour correspond well in the low (between 0.2 and
0.6 MPa) and high pressure range (above 1.6 MPa). However, at average
pressures, the numerically predicted diameters underestimate the experi-
mentally determined diameter and this is probably the result of the linear
elastic material behaviour that was assigned to the balloon membrane (for
detailed information about this linear elastic approximation, please see [94]).
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Figure 6.9: Comparison of the experimental data with the numerical results for
the non-compliant 72D PEBAX balloon.
6.3.1.2 Compliant 63D PEBAX balloon
The validation of the compliance behaviour of the compliant 63D PEBAX
balloon is depicted in Fig. 6.10. This compliant balloon material can not
be accurately approximated by a single elastic modulus as it is highly non
linear. As introducing hyperelastic material models increases the complex-
ity and computational cost, two Young’s moduli were used. A first one
(465 MPa) was chosen in order to obtain acceptable compliance behaviour
in the low pressure range (i.e. pressure below 0.8 MPa) and a second one
(700 MPa) that resulted in a good match for high pressures (i.e. pressure
above 0.8 MPa).
128 Virtual investigation of a novel provisional bifurcation stent system
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6
D
ia
m
et
er
 [
m
m
]
Pressure [MPa]
Experimental data
Simulation (E = 465 MPa)
Simulation (E = 700 MPa)
0 MPa
0.1 MPa
1.4 MPa
Figure 6.10: Comparison of the experimental data (filled diamonds) with the
numerical results (solid line corresponds with a Young’s modulus of 465 MPa,
the dashed line corresponds with a Young’s modulus of 700 MPa). The balloon
unfolding and stretching is shown on the right for the simulation with the Young’s
modulus of 700 MPa.
6.3.1.3 Non-compliant 72D PEBAX bulge balloon
The validation of the compliance behaviour of the non-compliant 72D PE-
BAX bulge balloon is depicted in Fig. 6.11. The maximum diameter of the
bulge balloon was used. The maximum percentage difference in diameter is
2 percent and occurs at a pressure of 1.4 MPa.
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Figure 6.11: Comparison of the experimental data with the numerical results.
The diameter refers to the maximum diameter of the bulge balloon.
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6.3.2 Validation of free stent expansion
The validation of the free expansion (i.e. pressure-diameter relationship) of
the dedicated stent using the non-compliant 72D PEBAX balloon is de-
picted in Fig. 6.12. The maximum percentage difference in diameter is 3
percent and occurs at a pressure of 0.8 MPa. Although there was a small dis-
crepancy between the numerical and experimental compliance behaviour of
the balloon itself (see section 6.3.1.1), the simulated compliance behaviour
of the balloon-stent system corresponds well with the experimental data.
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Figure 6.12: Comparison of the experimental data with the numerical results.
6.3.3 In vitro validation of the complete bifurcation
stenting procedure
The dedicated bifurcation stent was numerically and experimentally de-
ployed within a rigid bifurcation model. After inflation of the bulge balloon
(1.0 MPa) within the deployed stent, the maximal stent diameter was mea-
sured. For the in-vitro experiment which was only performed once, this
diameter was equal to 3.56 mm. The numerically predicted maximum stent
diameter was equal to 3.66 mm. Consequently, we concluded that the com-
plete procedure (including postdilatation with a dedicated balloon) can be
simulated with good accuracy (see Fig. 6.13).
6.4 Strut protrusion: compliant versus bulge
balloon
Inflating both the bulge and the compliant balloon at 1.1 MPa within an
already expanded stent (in bifurcation M50) clearly reveals the major dif-
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Figure 6.13: Comparison of the experiment (left panel) with the numerical
results (right panel). Due to a different initial position of the expanded stent in
the experiment and in the simulation, it is difficult to identify the corresponding
stent struts.
ferences between both approaches (see Fig. 6.14). Using the bulge balloon
results in a local overdilatation of the parent vessel, whereas the overdi-
latation after inflating the compliant balloon affects a larger vessel section.
A local overdilatation may cause additional damage to the vessel wall and
unwanted disturbances of the blood flow. In addition, using the bulge bal-
loon results in floating stent struts which are not in contact with the vessel
wall (indicated in Fig. 6.14). Such floating struts should be avoided as they
increase the thrombosis risk, reduce the effectiveness of the drug release in
case of drug eluting stents and amplify the disturbance of the blood flow.
Furthermore, performing the investigated bifurcation stenting technique in
vivo in porcine coronary arteries (these animal tests were carried out at the
Erasmus MC, Rotterdam, The Netherlands) revealed another limitation of
using the bulge balloon: it is extremely difficult to inflate this bulge balloon
exactly at the location of the bifurcation. As observed by IVUS, small
placement errors result in an overdilatation of the proximal or distal MB,
and do not cause strut protrusion into the SB (cfr. meeting in Erasmus MC
on 21 October 2008).
Based on the limitations of the bulge balloon that were observed both by
computer simulations and by performing animal tests, Boston Scientific de-
cided to abandon this bulge balloon and to only further investigate and
optimize the compliant balloon for this study. The preliminary animal ex-
periments also highlighted the importance of accurate selection of the bal-
loon size and the applied pressure when using the compliant balloon. Too
high pressures and too large balloons may result in excessive overdilatation.
Therefore, the impact of the balloon size and pressure was investigated in
the next section and the standard applied pressure for the compliant balloon
was reduced to 0.8 MPa unless otherwise stated.
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Figure 6.14: Comparison of the effect of postdilating the stent with a non-
compliant bulge balloon (left side) or with a compliant balloon (right side). The
upper panels show the stent deformation and the inflated balloons at 1.1 MPa.
The final configuration after balloon deflation is depicted in the bottom panels.
The circles indicate the floating stent struts (i.e. struts not in contact with the
vessel wall).
6.5 Parametric analyses
The first part of this section contains qualitative information regarding the
impact of a number of design and procedural parameters. Quantitative
information (MSP and OC) are given at the end of the section for all sim-
ulations.
The M50 bifurcation model and the standard compliant balloon (initial di-
ameter of 4.24 mm, a Young’s modulus of 700 MPa and inflation at 0.8 MPa)
will be used unless otherwise stated.
6.5.1 Stent geometry
The stiffness of the central stent section was decreased by reducing the
strut width in this section to 60 and 80 percent of the original width (see
Fig. 6.15). Reducing the strut width clearly improves the strut protrusion
and ostium scaffolding as intuitively expected. Therefore, all simulations
from now on are carried out with the modified design with a strut width re-
duction in the central section to 80 percent of the original width. Postdilata-
tion at 0.8 MPa of this modified design with a compliant balloon (Young’s
modulus of 700 MPa, initial diameter of 4.24 mm) in the M50 bifurcation
model will be termed ‘reference simulation (or REF)’.
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Figure 6.15: Impact of strut width reductions in the central stent section (left
panel: reduction to 60 percent of the original width, middle panel: reduction to
80 percent of the original width, right panel: original design).
6.5.2 Balloon pressure
Increasing the maximal pressure in the compliant balloon improves the strut
protrusion as depicted in Fig. 6.16, but as already mentioned, higher pres-
sures probably increase the risk of excessive overdilatation. The initial bal-
loon diameter (i.e. at zero pressure) and the Young’s modulus were kept
constant at respectively 4.24 mm and 700 MPa.
Figure 6.16: Impact of the inflation pressure (left panel: reference simulation
with inflation at 0.8 MPa, middle panel: inflation at 1.1 MPa, right panel: inflation
at 1.4 MPa).
6.5.3 Balloon size
Increasing the size of the compliant balloon improves the strut protrusion,
but again, larger balloons might increase the risk of excessive overdilatation
(see Fig. 6.17). The elastic modulus of the balloon and the inflation pressure
were kept constant at respectively 700 MPa and 0.8 MPa.
Figure 6.17: Impact of the balloon size (left panel: initial balloon diameter of
4 mm, middle panel: reference simulation with initial balloon diameter of 4.24 mm,
right panel: initial balloon diameter of 4.5 mm).
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6.5.4 Balloon compliance
Decreasing the stiffness of the compliant balloon (i.e. Young’s modulus)
improves the strut protrusion (see Fig. 6.18). The initial balloon diameter
and the inflation pressure were kept constant at respectively 4.24 mm and
0.8 MPa.
Figure 6.18: Impact of the balloon compliance (top left panel: elastic modulus of
400 MPa, top right panel: elastic modulus of 500 MPa, bottom left panel: elastic
modulus of 600 MPa, bottom right panel: reference simulation with an elastic
modulus of 700 MPa).
6.5.5 Impact of vessel anatomy
The same stent design and postdilatation procedure were applied using dif-
ferent bifurcation geometries. The strut protrusion is much more expressed
when the same stent and compliant balloon are used in a smaller bifurcation
(see Fig. 6.19). Logically, using oversized stents/balloons increases the risk
of excessive overdilatation or vessel rupture. The bifurcation angle seems
to have a minor impact on the strut protrusion.
6.5.6 Quantification
The previous sections clearly showed the impact of the different investigated
parameters on the strut protrusion but the overview is purely qualitative
and assessing the overdilatation is impossible. Therefore, the MSP and
the OC were determined for every simulation (see Fig. 6.20 and 6.21) and
analysis of these graphs provides the following information:
 Changing balloon parameters (size, compliance, pressure) has a larger
effect on the MSP than reducing the strut width of the central stent
section.
 Selecting an oversized balloon/stent for a particular bifurcation has a
positive effect on the MSP but logically results in a larger OC.
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Figure 6.19: Impact of the bifurcation geometry (top left panel: S50, bottom
left panel: S80, top middle panel: reference simulation with M50, bottom middle
panel: M80, top right panel: L50, bottom right panel: L80).
 The OC seems insensitive to changes in the balloon or stent parame-
ters. This is a limitation of the model that uses a purely hyperelastic
model for the vessel wall. Consequently, effects such as permanent
deformation due to remodelling or rupture are not included in the
simulations. Using a higher pressure in a real vessel will cause more
permanent deformation and/or rupture and therefore, this will enlarge
the finally obtained lumen.
Figure 6.20: Maximal Strut Protusion (MSP) for all the simulations (Do =
original balloon diameter at zero pressure, E = Young’s modulus)
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Figure 6.21: Overdilatation coefficient (OC) for all the simulations (Do = orig-
inal balloon diameter at zero pressure, E = Young’s modulus)
6.6 Mechanism of strut protrusion
Figure 6.22 shows cross sectional views at the location of the bifurcation for
the simulation in which the Young’s modulus of the compliant balloon was
reduced to 400 MPa. Deflating the compliant balloon results in an increased
strut protrusion as indicated by the vertical line in figure 22. This interesting
observation can be explained by the radial compression acting on the struts
in contact with the parent vessel. As such compression is not acting on
the struts pushed into the SB, the stent shape changes from circular to
ellipsoid. No in-vivo imaging data were available to experimentally validate
this observation.
6.7 Positioning inaccuracies
6.7.1 Impact of balloon misplacement
Inflating the compliant balloon not exactly at the location of the bifurcation
yields minimal strut protrusion. In addition, such inaccurate placement may
result in a considerable area with direct balloon-artery interaction outside
the deployed stent (see Fig. 6.23). This is pure balloon angioplasty which
is associated with high restenosis rates. It can be noticed that the section
which was subjected to direct balloon contact springs back to its original
136 Virtual investigation of a novel provisional bifurcation stent system
0.8 MPa
0.4 MPa
0 MPa
Figure 6.22: The stent struts are moving into the SB during deflation of the
compliant balloon.
diameter after deflating the balloon. As already mentioned, this is related
to the simplified material model used for the vessel wall.
6.7.2 Impact of stent misplacement
Inaccurate placement of the stent is suboptimal as the standard Liberte´
strut design may be located at the bifurcation ostium instead of the modified
central stent structure which was specifically designed for this region. The
modified region has a higher expansion range which is necessary to provide
optimal support in the bifurcation region. Increasing the length of the
modified stent region may limit the effect of inaccurate placement, but also
increases the total metal volume as this stent section has a much denser
strut pattern. Again, direct balloon-artery contact may occur outside the
stented vessel section (see Fig. 6.24).
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Figure 6.23: The compliant balloon should be positioned as precise as possible,
because inaccuracies limit the strut protrusion and may damage the vessel wall
outside the stented region.
Figure 6.24: The modified stent pattern has no effect when it is placed outside
the bifurcation region.
6.8 Limitations
The vessel wall is modelled as an homogeneous isotropic hyperelastic mate-
rial which is clearly an important approximation of the complex mechanical
behaviour of real blood vessels which demonstrate anisotropic, viscoelas-
tic and inhomogeneous behaviour. Furthermore, residual stresses were not
included and the bifurcation models were non-stenotic.
The finite element simulations were optimized to study the global stent
deformation patterns and the accuracy of the predicted deformations was
validated for several simulations. Detailed stress-strain analyses were not
performed but may be necessary in case of very large strut deformations
that might lead to strut fracture.
6.9 Conclusions
The finite element simulations provided interesting insights regarding the
innovative bifurcation stent design and stenting procedure:
 Performing the postdilatation with the bulge balloon has important
limitations (e.g. resulting floating struts) and was therefore not further
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optimized and investigated.
 The parameters related to the compliant balloon used for postdilata-
tion, such as balloon size, compliance and inflation pressure have a
higher impact on the strut protrusion than modifications of the strut
width in the central stent section.
 The procedure was repeated for a number of bifurcation models and
this study showed the considerable impact of balloon and stent size in
comparison with the MB diameter on the overdilatation of the parent
vessel.
 The strut protrusion is further improved during the deflation of the
compliant balloon.
 Accurate placement of both the stent and the compliant balloon are
crucial factors for a successful procedure. Decreasing the length of the
compliant balloon and/or increasing the length of the modified stent
structure may limit the effects of small positioning inaccuracies.
Chapter 7
Stent design guidelines and
final remarks
The work described in this thesis provides novel strategies to investigate the
complex problem of bifurcation stenting. The application of these tools has
led to a number of useful insights that are summarized in this chapter. Some
suggestions for future research are also included as this work is certainly not
an endpoint.
7.1 Conclusion
In chapter 2, a finite element model is described that allows to investigate
the free expansion of balloon-expandable stents. The numerical results of
this model correspond very well with both qualitative and quantitative ex-
perimental data, and therefore this model serves as a solid basis to study and
optimize the mechanical behavior of this kind of stents. It has for example
been observed that many balloon-expandable stents deploy in a non-uniform
way, both in longitudinal and in circumferential direction. However, the
preferred stent expansion would be perfectly uniform as this minimizes the
endothelial damage and leads to a more uniform drug delivery in the case of
drug eluting stents. Using the validated model, a parametric study has been
conducted and the results show that both the balloon length and the folding
pattern have an enormous impact on the uniformity of the expansion. A
reduced balloon length leads to a more uniform deployment in longitudinal
direction, whereas an increased number of balloon folds positively influences
the uniformity in circumferential direction.
We investigated the most frequently applied bifurcation stenting technique
in chapter 3 (i.e. provisional stenting). This technique involves the implan-
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tation of a stent in the MB, followed by subsequent inflation of a balloon
(which is positioned in both the MB and the SB) through the side of the
stent. This postdilation through the side of the stent is performed with the
aim of improving the SB patency by pushing the obstructing struts against
the vessel wall. Bench testing results have shown that such inflation in-
deed has a positive effect on the SB access, but may lead to floating struts
in the MB lumen. Very similar results were obtained using finite element
analysis. This clearly demonstrates the feasibility of using computer simu-
lation to investigate bifurcation stenting techniques. Furthermore, it was
also observed that different stent designs may lead to very different strut
deformation patterns, showing the importance of thorough design efforts by
stent manufacturers and of appropriate stent selection in clinical practice.
The study described in chapter 4 investigates and compares three different
second generation drug-eluting stents when being implanted in the curved
MB of a coronary bifurcation. The three-dimensional bifurcation model is
based on patient-specific angiographic data that accurately reproduce the
in vivo curvatures of the vessel segments. The layered structure of the arte-
rial wall and the anisotropic mechanical behavior of each arterial layer are
taken into account by using an existing advanced constitutive model. This
constitutive model was implemented as a user-defined material for Abaqus
and the accuracy of the implementation is verified by comparing the vir-
tual mechanical behavior with experimental and analytical data. The use
of anisotropic materials requires a proper definition of the local material
orientations and therefore, a novel algorithm has been developed to auto-
matically define the fiber orientations. In addition, an innovative simulation
strategy considering the insertion of a folded balloon catheter over a guide
wire has been developed in order to position the stents within the curved ves-
sel. The results show that all stents lead to more or less the same amount
of vessel straightening after implantation, but the resulting distributions
of the wall stresses are strongly dependent on the stent design. Using a
parametric modeling approach, two design modifications, which reduce the
predicted maximum values of the wall stress, are proposed and analyzed.
This illustrates the added value of using computer simulations during the
design phase as many design variants can be analyzed without having to
manufacture every design iteration.
In chapter 5, we quantitatively analyzed the geometry of different exist-
ing stents. Such objective comparisons allow interventional cardiologists to
select appropriate devices for a particular stenotic lesion. The maximum
size of the openings (i.e. cell size) is an important design parameter when
stenting bifurcation lesions because these openings are often enlarged by
a balloon inflation through the side of the stent. An innovative technique,
based on micro-CT images and using the pyFormex software, was developed
to accurately measure the cell size. A considerable variation of the cell size
of the different investigated stents was observed. By combining the cell size
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data with anatomical information (MB diameter, SB diameter and bifurca-
tion angle) we proposed a technique that may help to select the appropriate
stent for a particular lesion. Implanting a stent with a cell circumference
which is smaller then the ostium circumference will almost inevitably result
in a suboptimal deployment and obstructing struts.
In chapter 6, computer simulations are being used to investigate the fea-
sibility of a new dedicated bifurcation stent and a modified procedure for
provisional stenting. The stent is intended for the MB and has a modified
strut pattern in the central stent region, which allows the stent to reach a
larger diameter at the location of the bifurcation. This is important to pro-
vide partial scaffolding at the SB ostium. The modified procedure consists
of a postdilation with a dedicated balloon within the already expanded MB
stent (for example, a bulge or a compliant balloon). The two motivations
for such postdilation are: (i) to open the stent cells obstructing the SB
access in order to facilitate the insertion of a balloon catheter into the SB
and (ii) to cause strut protrusion into the SB to provide partial ostial scaf-
folding. We were able to develop accurate models of the different balloon
models and of the free stent expansion. These validated models were then
used to simulate the complete bifurcation stenting procedure. The results
of an in-vitro experiment also demonstrated the accuracy of the predicted
deformation patterns after the postdilation. Based on the finite element
model, the impact of a number of device and procedural parameters (such
as balloon pressure, balloon compliance, balloon size, stent design, bifurca-
tion geometry) on the final strut deformation have been examined. These
results provided new insights and allow to further optimize the stent design
and the proposed procedure.
In conclusion, the main achievements of the work described in this thesis are
(i) the development of new simulation strategies allowing to study complex
bifurcation stenting techniques, (ii) the new insights into the shortcomings
of currently applied techniques, (iii) the objective comparison of existing
stents, (iv) the application of subject-specific modelling (morphological and
constitutive) in the field of coronary bifurcation stenting, and (v) the use
of simulations to optimize a new dedicated bifurcation stent and a modified
stenting procedure.
7.2 Future work
The findings and methods of this thesis can be used as a starting point for
further research topics. Without the aim of being complete, some sugges-
tions are made in this section.
Patient-specific (or location-specific) modelling provides the possibility to
assess the impact of stent implantations in realistic environments. However,
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the widespread use of this patient-based approach for bifurcation stenting is
limited by the required significant amount of pre-processing. For example,
the use of high quality hexahedral meshes is crucial for many reasons but the
generation of such meshes is currently time-consuming. Therefore, automa-
tion of this process (including the subdivision of the grid in the different
arterial layers) is a very important step if we want to study multiple bifurca-
tions, which would considerably increase the value of these patient-specific
simulations. Including multiple bifurcations is necessary if one wants to
make more (scientific) general conclusions using common statistical meth-
ods. Similarly, each morphology should be combined with multiple sets of
material data as these data show a considerable variation.
With respect to constitutive modelling, an infinite list of suggestions can be
made to further improve the models used in this work. Therefore, we just
list a few items:
 To date, residuals stresses have not yet been included in (patient-
specific) bifurcation models.
 Some work has been done on the numerical modelling of dissection and
rupture of the arterial tissue, phenoma which are frequently observed
in clinical practice. However, further efforts are required in order to
include such models in large-scale applications.
 Stent implantation and balloon angioplasty leads to permanent de-
formations of the vessel wall. Attempts have been made to include
these permanent deformations, but again, more experimental research
needs to be done to improve the quality of the proposed models.
 The remodelling of the vessel wall after stent implantation is a time-
dependent process. Including this temporal component in the simula-
tions would be very interesting.
There is also a need for a better integration of in-vitro experiments during
the virtual design process. In addition, these in-vitro experiments should
be further improved. For example, both the morphology and material of
the silicon arteries are currently not realistic.
Numerous bifurcation stenting techniques have been proposed in literature,
but only the provisional approach has been studied in this thesis. Applying
the developed models to address other stenting techniques would be very
interesting. Lastly, only conventional stents (intended for unbranched ves-
sels) have been compared with each other. Providing objective comparisons
of the different dedicated bifurcation stent systems is of course a next step.
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Abbreviations and
symbols
Abbreviations
3D three-dimensional
AS asymmetry coefficient
AST advanced stent technologies
BMS bare metal stent
C3D8R three-dimensional 8-node brick reduced integration
element
CA coronary angiography
CAD computer aided design
CAE computer aided engineering
CoCr cobalt-chromium
CS Cypher Select design variant
CT computed tomography
DB dogboning coefficient
DES drug eluting stent
DMB distal main branch
FEA finite element analysis
FFR fractional flow reserve
IVUS intravascular ultrasound
L50 large bifurcation model with a 50 degrees bifurcation
angle
L80 large bifurcation model with a 80 degrees bifurcation
angle
LAD left anterior descending artery
LCA left coronary artery
LCX left circumflex artery
LDL low density lipoprotein
LM left main artery
M3D3 3-node triangular membrane element
178 Abbreviations and Symbols
M3D4 4-node quadrilateral membrane element
M3D4R 4-node quadrilateral membrane reduced integration
element
M50 medium sized bifurcation model with a 50 degrees
bifurcation angle
M80 medium sized bifurcation model with a 80 degrees
bifurcation angle
MACE major adverse cardiac events
MADS main, across, distal, side
MB main branch
MC medical center
MSP maximal strut protrusion
NURBS non-uniform rational B-splines
OC overdilatation coefficient
PCA projected cell area
PMB proximal main branch
QCA quantitative coronary analysis
R3D4 4-node bilinear rigid quadrilateral element
RCA right coronary artery
REF reference simulation
S50 small bifurcation model with a 50 degrees bifurcation
angle
S80 small bifurcation model with a 80 degrees bifurcation
angle
SB side branch
SKS simultaneous kissing stents
SS316L 316-L stainless steel
TAP T-stenting and small protrusion technique
VUMAT user-defined material in ABAQUS/Explicit
Symbols
C right Cauchy-Green tensor
C modified right Cauchy-Green tensor
D diameter
E Young’s modulus
I invariant
J volume ratio
k material parameter
L length
M unit vector indicating collagen fiber direction
M’ unit vector indicating collagen fiber direction
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n local material orientation
p pressure
R radius
w width
Greek Symbols
α bifurcation angle or angle between the collagen fiber
reinforcement and the cirumferential direction
κ penalty parameter
µ micro or material parameter
Ψ volume preserving part of the strain energy function
ρ material parameter
Subscripts
aniso anisotropic
DMB distal main branch
end modified end rings
f final
i intermediate
iso isotropic
max maximum
min minimum
o original
pre prior to a certain operation
post after a certain operation
PMB proximal main branch
SB side branch
thin reduced strut thickness
Units
atm atmosphere
bar bar
Fr french
GPa gigapascal
hz Hertz
180 Abbreviations and Symbols
inch inch
kPa kilopascal
µm micrometer
m meter
min minute
mm millimeter
MPa megapascal
N Newton
Pa Pascal
sec second
V Volt
W Watt


